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1. Introduction 
 
1.1. Neuronal cell death in CNS damage 
The central nervous system (CNS) is an exceptional organ in many aspects: It functions as the 
control unit of the organism by recording and evaluating information from in- and outside and 
regulating body functions. There are over 100 billion neurons in the human CNS which 
interact which each other; they are the smallest units in a dense network that processes 
immense amounts of information. A single neuron can receive signals from up to 100,000 
other cells and transfer the signal to a maximum of 10,000 cells by branches of its axon. An 
incredible amount of signals are exchanged, and by today, the function of the brain remains a 
miracle in a lot of aspects. In humans, the final number of neurons is reached shortly after 
birth, from then on they mature, interact with each other but do not divide and multiply. 
Although limited neurogenesis has been observed in some parts of the brain in adult primates 
by activation of stem cells, neurogenesis does not significantly influence the total number of 
cerebral neurons in mature animals. Neurons as carriers of information are meant to last a life 
time and when they are damaged and die, there is no replacement for them. Through 
improved life conditions in industrial countries the life expectation rose to 80 years for 
women and 74 years for men, however, the life span of neurons has not been extended. With 
increasing age chances are getting higher that neurons cannot maintain their physiological 
function and degenerate like all kind of cell types. The number of aged people in the 
population of western countries increased with the prolonged life expectation, which is 
associated with larger numbers of patients with neurodegenerative disorders like Morbus 
Alzheimer and Morbus Parkinson, or other age-dependent neuronal diseases like stroke and 
dementia. Stroke, for example, is the third frequent cause of death worldwide after cancer and 
cardiovascular diseases, and surviving patients often need lifelong intensive care as a result of 
insufficient regeneration from neuronal loss, not allowing full recovery (Bronner et al., 1995) 
(de Freitas et al., 2001). 
Visualizing the impact of these diseases on patients and on expenses of health care shows 
how important the study of mechanisms of neuronal cell death is. Gaining knowledge about 
the pathophysiology of ischemia and neurodegenerative disorders could help to find potent 
therapies which could improve the prognosis and the life quality of patients.  
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Neuronal apoptosis versus necrosis 
All multicellular organisms including humans experience cell death as part of their existence 
during their developmental phase and their adult life. During development, cell death is 
absolutely necessary to shape organs and tissues. A genetic masterplan determines which cells 
survive or die in different developmental phases to allow the patterning of tissues and organs, 
thereby building a functional organism. Cell death also constantly occurs in adult organisms: 
Damaged or dysfunctional cells die and are removed; a delicate balance is kept between cell 
proliferation and death. The lifespan of a cell is determined by its function in the organism, 
and neurons are exceptional cells designed to maintain their function throughout the 
organism’s life. However, acute brain damage and pathological neurodegeneration can cause 
cell death and the irreplaceable loss of neurons. Neuronal death in neurodegenerative diseases 
and brain damage can follow one of two different modes, necrosis or apoptosis. These types 
of cells death are two extremes at the opposite ends of a wide-ranged scale of possible 
mechanisms of cell death. Neuronal apoptosis, one the one hand, is defined as an active form 
of cell death. Biochemically, protein biosynthesis and activated death pathways can be 
detected including activation of caspases and nucleases which leads to DNA fragmentation. 
Morphologically, apoptosis shows typical features such as nuclear condensation, cell 
shrinkage and formation of apoptotic bodies. The process ends with disintegration of the cell 
and phagocytosis, ideally without involving inflammation. Neuronal necrosis, on the other 
hand, is passive, uncontrolled cell death due to lack of energy in which oxidative stress, 
excitotoxicity, disruption of the cellular Ca2+ homeostasis, mitochondrial dysfunction, ATP 
depletion and failure of Na+/K+ ion pumps lead to cell swelling, lysis and release of its 
intracellular content into the surrounding tissue. It is followed by inflammatory response that 
further damages the surrounding cells. Cell death in different diseases or experimental models 
often can not be assigned, unequivocally, to one of these two categories since the cells do not 
display all typical features. This can partly be explained by the fact that a cell’s determination 
to undergo apoptosis or necrosis is very often a matter of its energy supply. The intracellular 
ATP level determines the damaged cells for either necrosis (ATP level below 15 %) or 
apoptosis (25-75 % normal ATP level). Cells initially undergoing apoptosis can switch to 
necrosis any time the cell runs out of energy (Eguchi et al., 1997) (Lieberthal et al., 1998) 
(Nicotera et al., 1998). Considering just the two extreme categories might be too simple to 
grasp the whole concept of cell death, however, it is helpful in the elucidation of the 
mechanisms involved and it is acceptable as long as one is aware that a fluent transition from 
apoptosis to necrosis is possible.  
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So far, a vast amount of information has been gathered about both types of cell death, 
especially apoptosis. Programmed cell death has been shown to play an important role in the 
development and homeostasis of multicellular organisms by triggering an intrinsic cellular 
death program when cells are damaged, infected, aged or no longer receiving survival signals 
from their extracellular environment (Raff, 1998) (Vaux and Korsmeyer, 1999). 
Environmental stimuli that induce apoptosis are irradiation leading to DNA damage, oxidative 
stress, toxins, viruses and withdrawal of neurotrophic support. Apoptosis has been shown in 
numerous degenerative CNS diseases like Huntington’s disease (Butterworth et al., 1998) and 
contributes to trauma and stroke (Mattson et al., 2000) (Li et al., 1995a); (MacManus et al., 
1993) (Rink et al., 1995). 
Induction of apoptosis in mammalian cells has been described to be mediated via two major 
pathways: a) Via death receptor stimulation and b) via a mitochondrial pathway in which 
apoptotic stimuli trigger the release of apoptogenic molecules from the mitochondria (Peter 
and Krammer, 1998) (Scaffidi et al., 1998) (Fig. 1).  
A series of molecular key players of the apoptotic program are known so far which allow 
insight in the complexity of this process. Among them are the following ones: 
- Apoptosis-inducing or death receptors (e.g. Apo-1/Fas) whose activation triggers apoptosis. 
- Apaf-1 (apoptotic protease-activating factor 1) and other apoptosis-initiating factors (AIFs), 
molecules which activate cell death cascades. 
- Small proteins released from damaged mitochondria into the cytoplasm in early stages of 
cell death like cytochrome c which activate postmitochondrial cascades of apoptosis. In 
general, release of cytochrome c from the mitochondrial inner membrane into the cytosol 
initiates the mitochondrial-dependent apoptosis pathway (Liu et al., 1996b) (Yang and 
Cortopassi, 1998).  
- The Bcl-2 and p53 oncogene families and mitogen-activated protein kinase pathways 
regulated by neurotrophins which are key modulators of the cells response on apoptotic 
signals. 
- Proteins/proteases of the caspase/calpain families which can activate each other and cleave 
death substrates. Amongst them are upstream instigator caspases (caspase-8) which activate 
other caspases, named effector caspases. They are important regulators of postmitotic 
neuronal homeostasis. Downstream caspases like caspase-3 or -9 and their proteolytic 
products are recognized markers of apoptosis, their activation representing an irreversible step 
in the cell death cascade (“point of no return”). Cells expressing these enzymes are prone to 
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death. Once activated, many but not all of these enzymes induce proteolysis of specific 
cellular substructures and consequently amplify the death signal cascade (Hengartner, 2000).  
 
 
 
 
Figure 1: Schema of apoptotic pathways in mammalian cells  
Apoptosis can be induced by different pathways which result in caspase activation, cleavage 
of cellular substrates, DNA fragmentation and cell death. One pathway includes 
mitochondrial damage caused by proapoptotic Bcl-2 family members or other apoptotic 
stimuli. This triggers the release of apoptogenic proteins such as cytochrome c, Smac, AIF, 
and EndoG. Cytochrome c leads to caspase activation through Apaf-1, and Smac relieves IAP 
inhibition of caspases. AIF and EndoG cause chromatin condensation and fragmentation in a 
caspase-independent manner. Bcl-2 family members which can transduce apoptotic stimuli to 
mitochondria are pro-apoptotic members, such as Bad, Bim or Bax.  These signals, if not 
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neutralized by antiapoptotic proteins, such as Bcl-2 or Bcl-xL, are further transferred to the 
mitochondria by proapoptotic proteins such as Bax or Bak.  
Apoptosis can also be triggered via activation of death receptors such as Fas which leads to 
caspase activation and apoptosis. The steps studied in this thesis, modulation of oxidative 
stress by quantitative variation of scavenging enzymes SOD and the phosphorylation of Bad, 
are highlighted by coloured letters. 
(Modified from Wang, 2001)  
 
Activation of proteins which participate in the cell death cascade can either happen by 
cleavage of proforms, by increased protein expression or by reversible phosphorylation since 
the activity of many proteins and enzymes depends on their state of phosphorylation.  
The wide interest in especially mechanisms of programmed cell death is understandable: It is 
established that apoptosis can be inhibited or reversed at an early stage before the “point of no 
return”, and the elucidation of the apoptotic processes might provide targets for 
neuroprotection. However, since necrosis is a major component of acute neuronal damage as 
stroke or trauma, observation and elucidation of its mechanisms is important, as well. In this 
thesis, different models of neuronal cell death are applied to study specific factors involved in 
programmed cell death and necrosis. The two different “in vivo” models of neuronal damage, 
cold injury-induced brain trauma (CIBT) and intrastriatal injection of the toxin 3-
nitropropionic acid (3-NP) in mice, were employed to study the influence of quantitative 
modulation of superoxide dismutases (SODs) on brain damage. In addition, the role of the 
enzyme protein phosphatase type-2C (PP2C) which participates in the reversible 
phosphorylation of proteins during neuronal apoptosis was studied in cultured rat neurons. 
 
 
1.2. Role of SODs in neuronal damage  
1.2.1. Free radicals in brain injury 
Free radicals are produced in tissues under physiological as well as under pathological 
conditions. They are defined as molecules with free, unpaired electrons; a compound which 
contains oxygen with a single, unpaired electron in an outer orbital shell is called oxygen free 
radical. Oxygen free radicals, belong to a group of with reactive oxygen species (ROS) which 
can oxidize and damage cell structures like lipids, nucleic acids, proteins and saccharides 
(Lewen et al., 2000). Among potentially cytotoxic ROS are superoxide anion radicals (O2-.), 
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hydroperoxyl radicals (HO2.),  hydrogen peroxide (H2O2), hydroxyl radicals (HO.), lipid 
peroxide radicals (R-OO., R= lipid), singulet oxygen (1O2), nitric oxide (NO.) and 
peroxynitrite (ONO2-). Under physiological conditions, the electron chain of the mitochondria 
is a constant source of free radical production, about 2-5 % of oxygen is not fully utilized but 
transformed into ROS, preferentially superoxide anion radicals and hydrogen peroxide. The 
energy demand of the brain and its O2 consumption is especially high since its high 
metabolism rate is essential for pumping ions associated with synaptic communication. 
Although its weight is just 2 % of the total body weight, about 20 % of the body’s oxygen 
intake is used by the brain, mainly for the production of high energy molecules like 
adenosine-triphosphate (ATP). Its respiration rate is about 10 times higher than that of other 
body tissues and even under physiological conditions ROS production is high. Additionally, 
the brain is a likely source of reactive oxygen species since it contains high levels of iron and 
copper metals which can lead to the production of the especially aggressive hydroxyl radical 
by the Fenton reaction. Finally, the brain contains a high percentage of lipids and is therefore 
an easy target for oxidation and generation of free oxygen radicals. Unsaturated bonds of fatty 
acids in lipids and membrane cholesterol can react with free radicals and undergo 
peroxidation (Bast and Goris, 1989); each of the resulting peroxides is a potential free radical 
which can start an autocatalytic reaction that peroxidizes the neighbouring lipids and starts a 
cascade of free radical production. 
To protect themselves from oxidative stress created by a high metabolism rate, brain cells 
employ protective mechanisms which include superoxide dismutases (SODs), enzymes which 
are able to scavenge superoxide anion radicals, glutathione peroxidase, catalase, and 
antioxidative compounds like vitamin E, glutathione or ascorbic acid. Under pathological 
conditions, production of ROS can be strongly increased to a level which exceeds the 
capacities of the endogenous antioxidative defence and have deleterious effects to the cell 
leading to both apoptosis and necrosis. Superoxide anion radicals react with NO., constantly 
produced by the nitric oxide synthase, to peroxynitrite which degrades to aggressive hydroxyl 
radicals and nitrogen dioxide or leads to nitration of cellular tyrosines (Beckman et al., 1990). 
Especially the pathomechanism of neuronal necrosis has been shown to be closely associated 
with both free radical production and excitotoxicity. Free radicals can increase the 
extracellular concentration of excitatory neurotransmitters like glutamate by inhibiting its re-
uptake (Trotti et al., 1998). Intracellular Ca2+ overload is triggered via activation of glutamate 
receptors associated with Ca2+ ion channels (Carriedo et al., 1998). Destruction of the 
intracellular ion homeostasis leads to mitochondrial dysfunction resulting in a stop of ATP 
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production. As long as the cell is still supplied with oxygen, mitochondrial dysfunction causes 
ROS production, and without full detoxification from these free radicals the mitochondria 
themselves become targets of free radical attacks. This leads to the circulus vitiosus of further 
impairment of ATP generation causing energy depletion followed by enhanced free radical 
production (Hillered and Chan, 1988a) (Coyle and Puttfarcken, 1993). There are other free 
radical pathways activated by high Ca2+ levels, including the conversion of xanthine 
dehydrogenase to xanthine oxidase, nitric synthase and the phospholipase A2-cyclooxygenase 
pathways which, again, lead to the formation of superoxide anion radicals, hydrogen 
peroxide, nitric oxide and peroxynitrite (Lewen et al., 2000). By oxidation of cellular 
structures like lipids, DNA, and proteins, ROS destroy and alter their functions. Even high 
intracellular levels of ROS do not kill cells directly but through Ca2+ as demonstrated in 
previous studies revealing that even under high peroxide concentrations (level 100 times 
higher than under physiological conditions) neuronal cells survived if their Ca2+ intake was 
inhibited (Maher and Schubert, 2000). 
 
 
1.2.2. Superoxide dismutase family 
The SOD family, endogenous free radical scavengers, includes three well known members in 
mammalian cells: Copper/zinc-superoxide dismutase (SOD1, Cu,Zn-SOD) a homodimer 
constitutively expressed in the cytosol; inducible manganese-superoxide dismutase (Mn-SOD, 
SOD2) which is localized in the mitochondrial matrix as a homotetramer; high-molecular 
weight tetrameric glycosylated Cu,Zn- SOD which can be found in the extracellular space (E-
SOD, SOD3) and is present only in low levels in the brain (Fridovich, 1995). All of the SODs 
dismute superoxide anion radicals to hydrogen peroxide which is subsequently converted to 
molecular oxygen and water by catalase and selenium-dependent glutathione peroxidase. First 
experiments to understand the role of SODs in the functionality of the cells and their role in 
CNS damage revealed a protective effect of liposome-entrapped SOD1 in traumatic and 
ischemic injuries (Chan et al., 1987) (Imaizumi et al., 1990) (Michelson et al., 1988) (Phelan 
and Lange, 1991). Other investigators obtained various degrees of success (Wei et al., 1981) 
(Pigott et al., 1988; Liu et al., 1989) (Levasseur et al., 1989) (Zhang and Ellis, 1991) or failure  
(Forsman et al., 1988) (Haun et al., 1991) (Ikeda et al., 1989) (Ment et al., 1985) (Schurer et 
al., 1990) when using free, non-modified SOD or modified SOD (PEG-SOD) in various 
models of neuronal injury. SOD1’s short half life in circulating blood (6 min) and its inability 
to pass the blood brain barrier (BBB) explain, partly, the contradicting results about 
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neuroprotection by SODs. A more elegant approach to unveil the direct role of SODs in the 
pathogenesis of brain damage, however, is the use of genetically engineered animals in which 
the level of SOD expression has been altered by either “transgenically” increasing their level 
or decreasing the level by deletion or mutation of the genes in “knock-out” approaches. One 
has to be aware that by genetic modulation of protein expression cells possibly develop 
mechanisms to compensate or counteract the genetic change and therefore, in some cases, the 
physiology of genetically modified cells is different from normal cells. Still, knock-out and 
transgenic animals offer the great opportunity to examine underlying mechanisms of cell 
physiology and damage. In this thesis, three different strains of genetically engineered mice 
were used to test the effect of SOD in brain damage, heterozygous SOD2 knock-out (SOD2-
KO, het), homozygous SOD1 knock-out mice (SOD1-KO) and SOD1 transgenic mice 
(SOD1-TG) mice. 
 
 
1.2.3. SOD knock-out and transgenic mice used in this study 
1) SOD2-KO:  
In SOD2-KO mice Sod2 was mutated with a replacement type targeting vector that deleted 
exon 3 of the SOD2 gene which resulted in a shortened m-RNA and loss of enzymatic 
activity. Homozygous SOD2-KO mice showed a lethal phenotype, animals only survived 
until postnatal day 10, showed dilated cardiomyopathy and steatosis. Therefore, instead of 
homozygous animals, heterozygous mice were more suitable for brain injury experiments. At 
the age of 9 month, heterozygous animals revealed no discernible phenotypic difference 
compared to their wild-type littermates other than that their enzymatic SOD2 activity was 
reduced to 50 % (Li et al., 1995b). These mice have been tested in various models of brain 
and neuronal injury including traumatic brain injury (TBI) (Lewen et al., 2001), transient 
focal ischemia (Noshita et al., 2001) (Kim et al., 2002), permanent focal ischemia (Murakami 
et al., 1998b) (Fujimura et al., 1999b) subarrachnoid haemolysate exposure (Matz et al., 
2001), systemic 3-NP intoxication (Kim and Chan, 2002), and glutamate toxicity in neuronal 
culture (Li et al., 1998). The role of SOD2 as a neuroprotective enzyme was evident in all 
models since a decrease in protein level resulted in exacerbated damage, mostly correlating 
with increased cytochrome c release from the mitochondria. Not in all models an increase in 
apoptosis was associated with exacerbated brain injury in SOD2-KO mice, e.g. after TBI the 
number of apoptotic cells was reduced although the total number of damaged cells had 
increased, as had the cytochrome c release.  
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2) SOD1-TG:  
The second kind of genetically modified animals used in this study were SOD1-TG mice of 
the strain TgHs/SF-218 carrying the human CuZn-SOD (h-SOD-1) gene and being bred on a 
CD-1 background. The genome of this strain carried several copies of the h-SOD-1 gene, 
presumably in a tandem array and showed a threefold increase in SOD1 activity. There were 
no observable phenotypic differences between SOD1-TG mice and their non-transgenic 
littermates (Chan et al., 1991). SOD1 overexpression had revealed neuroprotective effects in a 
number of brain injury models including global and focal cerebral ischemia (Kinouchi et al., 
1991) (Kinouchi et al., 1998) (Yang et al., 1994) (Murakami et al., 1997) (Fujimura et al., 
1999a) (Fujimura et al., 2000), cold injury-induced brain trauma (Chan et al., 1991), 
neurotoxicity in neuronal culture (Chan et al., 1990b), methamphetamine neurotoxicity (Cadet 
et al., 1994), systemic 3-nitropropionic acid toxicity (Beal et al., 1995), photothrombotic 
ischemia (Kim et al., 2001), traumatic brain injury (Mikawa et al., 1996), subarrachnoid 
hemorrhage (Kamii et al., 1999) and spinal cord injury (Sugawara et al., 2002). However, not 
in all types of brain injury models SOD1 overexpression improved the outcome, as in a model 
of permanent focal ischemia the damage was not attenuated (Chan et al., 1993).  
 
3) SOD1-KO: 
The third strain of animals used for this study were SOD1-KO mice of the strain Sod1<tm1 
Cep>  created by a targeted deletion of the Sod1 gene in embryonic stem cells of 129/CD1 
mice using a positive-negative selection scheme that replaced all Sod1 coding sequences with 
a neomycin resistance gene. Homozygous knock-out mutants were bred on a CD1 
background for at least 8 generations, they showed 100 % reduction of SOD1 activity while 
their phenotype was not distinct from their wild-type littermates’. Although in a model of 
transient focal and global ischemia the damage was exacerbated in SOD1-KO mice (Kondo et 
al., 1997b) (Kawase et al., 1999) and the animals revealed increased neuronal damage induced 
by kainic acid (Kondo et al., 1997a), the reduction of SOD1 did not affect the infarction after 
permanent focal cerebral ischemia (Fujimura et al., 2001).  
 
 
1.2.4. Cold injury-induced brain trauma 
Cold injury-induced brain trauma (CIBT), synonymous with cryogenic injury, is a model for 
early development of vasogenic cerebral edema which is the most common form of brain 
edema observed after many brain injuries like trauma and stroke (Tanno et al., 1992) 
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(Baskaya et al., 1997) (Kogure et al., 1981). Characterized by increased brain water and 
sodium content, it is associated with increased permeability of the blood brain barrier (BBB) 
for macromolecules like serum proteins which is normally limited due to the tight barrier of 
capillary endothelial cells. Brain injuries concomitant with vasogenic edema can be explained 
by several pathophysiological mechanisms: Primary damage can be caused by swelling of the 
edematous tissue and brain herniation which can lead to critical conditions. Additionally, 
swelling of the injured tissue can increase the intracranial pressure leading to decreased 
cerebral perfusion and ischemia. Furthermore, the distance between cells and vessels gets 
extended by extravasation of fluid into the extracellular space, as gets the diffusion distance 
for oxygen and nutrition. Therefore, the edema forces the tissue into an ischemic state and 
leads to a declined ATP production. Furthermore, vasogenic edema has been shown to release 
arachidonic acid from membrane lipids, potentially inducing a cascade of free radical 
production and excitotoxicity (Chan et al., 1990a). Finally, humoral components extravasate 
from the vessels into the tissue and can possibly damage the cells, as well. 
CIBT induces trauma by application of low temperature on the exposed cortex and was first 
established in cats by Klatzo et al., 1958, then modified for rats and later developed for mice 
(Chan et al., 1991). In the latter modification, craniotomy is not necessary since the skull of 
mice is thin enough to allow damage of the underlying cortex; therefore this procedure is less 
invasive. The development and severity of the lesion after CIBT varies in different studies 
due to use of different protocols of CIBT induction and different experimental animals. In 
general, the vessels in the core of the lesion area are mechanically disrupted by freezing. 
Subsequently, capillaries in the lesion become permeable for molecules from the vascular 
compartment by secondary damage mechanisms. Thus, serum elements extravasate and 
spread by hydrostatic forces from the systemic circulation (Reulen et al., 1977). Cells, 
amongst them astrocytes, take up serum proteins after extensive extravasation (Maeda et al., 
1997). During the phase of early edema, massive cell death, both necrosis and apoptosis, 
occurs inside the lesion. After closure of the injured small vasculature, healing processes take 
place around the cold lesion with proliferation of the microvasculature, and edema fluids and 
serum proteins gradually disappear (Orita et al., 1988).  
The model of CIBT used in this study has been well established by Chan et al. (Chan et al., 
1991): Following CIBT, an early (1 to 4 hours) increase in water content in the injured 
hemisphere was demonstrated that reached its maximum level at 24 h and remained elevated 
for 3 days. BBB breakdown, while also acute, returned to baseline values by 24 h post-CIBT 
(Chan et al., 1991) (Murakami et al., 1998a) (Murakami et al., 1999). Apoptosis, 
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characterized by appearance of TUNEL-positive cells, was maximal at 72 h post-insult in the 
periphery of the injury and was thought to contribute to secondary brain damage and lesion 
expansion in both early and late phases after cold injury. Cytochrome c release from the 
mitochondria was demonstrated as well as caspase activation indicating that apoptosis, 
indeed, contributed to cell death after CIBT (Morita-Fujimura et al., 1999b) (Morita-Fujimura 
et al., 1999a).  
Oxidative stress seems to be a major component in CIBT damage: Liposome-entrapped SOD1 
reduced BBB breakdown, transgenic mice overexpressing copper-zinc (Cu/Zn) SOD (SOD1) 
revealed significant attenuation of brain edema, neurological deficits and a reduction of 
blood-brain barrier (BBB) permeability following CIBT (Chan et al., 1987; Chan et al., 1991) 
supporting the notion that ROS are implicated in traumatic brain injury development. Release 
of arachidonic acid occurring after CIBT has been associated with free radical production and 
subsequent excitotoxicity causing enhanced repeated ROS generation (Chan et al., 1988). 
Pathophysiology and biochemical sequelae of focal neuronal and glial damage after cold-
induced brain trauma are thought to be quite similar to traumatic brain injury (TBI) since 
vascular compartments are the major targets for free radical attack (Chan et al., 1983) (Chan 
et al., 1987) (Kontos, 1985). Therefore, findings from TBI can, with restrictions, be 
transferred to the CIBT model as well. Like in CIBT, experimental evidence has associated 
reactive oxygen species (ROS) formation as one of the various biochemical events leading to 
cell death with TBI (Lewen et al., 2000). Brain injury in cats has been reported to increase the 
production of superoxide anion which is normally scavenged by superoxide dismutase 
(Kontos and Wei, 1986; Patel et al., 1996) Several studies have demonstrated apoptotic cell 
death following TBI, and two major pathways have been identified in mammalian cells: the 
Fas/TNF-R receptor pathway and the mitochondrial pathway (Rink et al., 1995) (Clark et al., 
1997; Skoglosa et al., 1999). The mitochondrial electron transport chain is one of the many 
sources of ROS (Phillis, 1994) and plays a significant role in the pathogenesis of TBI. In 
general, release of cytochrome c from the mitochondrial inner membrane into the cytosol 
initiates the mitochondrial-dependent apoptosis pathway (Liu et al., 1996b) (Yang and 
Cortopassi, 1998). It has been shown that oxidative stress-dependent mechanisms after severe 
TBI result in the release and translocation of cytochrome c from the mitochondria to the 
cytosol 1 hour (Lewen et al., 2001) before DNA fragmentation. Manganese superoxide 
dismutase (SOD2)-deficient mice in particular, expose massive mitochondrial cytochrome c 
release after controlled cortical impact leading to large cortical lesions but less apoptotic cell 
death 4 and 24 hours after injury compared with  WT animals (Lewen et al., 2001). 
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Regarding the exacerbation of damage after TBI in SOD2-KO mice compared to WT animals 
and manifestation of increased secondary and delayed BBB breakdown at 72 h post-insult in a 
model of transient focal ischemia, it was hypothesized that SOD2-KO mice would be more 
susceptible to secondary brain damage and hemorrhage in CIBT, as well. In this thesis SOD2-
KO mice were subjected to CIBT to test the role SOD2 in the develoment of the lesion, 
especially focussing on the late effects and delayed BBB breakdown.  
 
 
1.2.5. Intrastriatal 3-NP model 
The mycotoxin 3-nitropropionic acid (3-NP, mildewed sugar cane toxin) is an irreversible 
inhibitor of succinate dehydrogenase, an electron transport enzyme in complex II of the 
mitochondria. By blocking both mitochondrial electron transport and Krebs Cycle, it leads to 
cellular depletion of adenosine triphosphate (ATP) (Ludolph et al., 1992). Therefore, hypoxic 
(energy-deficient) brain damage such as specific, striatal lesions is induced after chronic or 
subacute systemic treatment (Alston et al., 1977) (Palfi et al., 1996). 
3-NP intoxication provides an interesting model of CNS damage since it can produce 
selective striatal lesions resembling the histological, neurochemical, and clinical features of  
Huntington’s Disease (HD) (Palfi et al., 1996) (Borlongan et al., 1997; Brouillet et al., 1999). 
Huntington’s Disease is a progressive neurodegenerative disorder associated with severe 
degeneration of basal ganglia neurons, especially intrinsic neurons of the striatum and 
characterized by progressive dementia and involuntary abnormal choreioform movements 
(Martin and Gusella, 1986). The degeneration of basal ganglia is associated with a decrease of 
mitochondrial function most notable in the caudate nucleus (Brennan et al., 1985). The way of 
administering 3-NP seems to be a crucial aspect determining how closely the model reflects 
the features of HD: Chronic, systemic treatment with low doses of 3-NP, on the one hand, can 
produce selective striatal lesions sparing aspiny NADPH-diaphorase-positive neurons and 
replicating some features of HD (Beal et al., 1993b) (Brouillet et al., 1995) (Palfi et al., 1996). 
Apoptosis has been shown to be the most prominent type of cell death after this kind of 
treatment (Sato et al., 1997a).  
Acute systemic or intrastriatal treatment with 3-NP, on the other hand, does not closely 
correlate with HD (Beal et al., 1993b). Intrastriatal injection of 3-NP leads to degeneration of 
both intrinsic striatal neurons and the nigrostriatal dopaminergic system, suggesting that this 
lesion may provide an animal model of a form of multiple system atrophy rather than 
Huntington's disease (Nakao and Brundin, 1997). It is characterized by severe loss of 
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neuronal cell bodies and marked glial infiltration in the medial aspect of the striatum. In 
comparison with systemic chronic administration, it results in more profound hypoactivity, 
greater loss of passive avoidance retention, and more severe striatal damage (Koutouzis et al., 
1994) (Borlongan et al., 1997). Rapid cell death after intrastriatal injection may be due to 
excitotoxic necrosis as suggested by previous studies (Ankarcrona et al., 1995), however, 
apoptosis has been described as an underlying mechanism of cell death as well (Sato et al., 
1997b) (Sato et al., 1998).  
Investigations of cell death mechanisms in HD have identified energy depletion and increased 
sensitivity for excitatory amino acids (EAA, e.g. glutamate) as a primary cause of neuronal 
cell death (Zorumski and Olney, 1993). One hypothesis is that cells degenerate due to 
increased cellular vulnerability to glutamate excitotoxicity. This increased toxicity is caused 
by  deficits in mitochondrial energy production which are evident, too, after 3-NP intoxication 
(Albin and Greenamyre, 1992) (Ankarcrona et al., 1995) (Beal et al., 1993b). Energy 
depletion induced by 3-NP has been described to potentate the glutamatergic intoxication 
especially via NMDA receptors as well as non-NMDA receptors (Simpson and Isacson, 1993) 
(Beal et al., 1993b) (Hamilton and Gould, 1987), and blood brain barrier (BBB) dysfunction 
followed by serum proteinaceous deposits might modulate the severity of the lesion 
(Hamilton and Gould, 1987) (Nishino et al., 1995). Supporting the hypothesis that 3-NP 
neurotoxicity might be mediated by an overproduction of ROS, previous findings showed 
increased peroxynitrite production after 3-NP treatment (Schulz et al., 1996), in vivo protein 
oxidation in striatal synaptosomes (Fontaine et al., 2000), reduction of the striatal lesion after 
subacute, systemic treatment in SOD1-overexpressing animals, and increased vulnerability in 
heterozygous Mn-SOD knockout mice (Beal et al., 1995) (Andreassen et al., 2001) (Kim and 
Chan, 2002). Oxidative stress associated with 3-NP toxicity could possibly be produced via 
by three mechanisms:  
1) Enhanced ROS production by increased O2 flux from the electron chain in mitochondria; 2) 
induction of enhanced excitotoxicity; 3) inflammatory responses to neuronal degeneration. 3-
NP inhibition of succinate dehydrogenase of the Krebs cycle in the mitochondria increases the 
production of ROS via a direct mechanism by functional impairment of the electron transport 
chain. An excitotoxic mechanism of ROS production has been described to be mediated via 
NMDA receptor activation (Lafon-Cazal et al., 1993): Decreased ATP levels lead to the loss 
of membrane depolarisation (Riepe et al., 1992) which relieves the voltage dependant Mg2+ 
block of NMDA (N-methyl-D-aspartate) receptor ion channels (Henneberry et al., 1989). 
Unblocking these receptors allows ambient glutamate concentrations to push the intracellular 
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ion homeostasis out of balance, triggers Ca2+ influx which can not be counteracted by the cell 
due to energy depletion. At first, Ca2+ may be taken up by mitochondria and endoplasmatic 
reticulum, but when their capacity is exceeded, high intracellular Ca2+ concentrations further 
impair mitochondrial function, increase ROS production via mitochondrial and cytoplasmatic 
pathways and activate caspases, phospholipases, kinases and endonucleases (Brouillet et al., 
1999).  All these events ultimately lead to cell death through different pathways which are 
related to apoptosis or necrosis depending on cell type, severity of energy depletion and 
possible compensatory mechanisms.  
Oxidative stress can also occur in association with inflammatory response induced by 3-NP. 
Neutrophil infiltration, immunoreactivity to serum/immune complement factors like 
C3b/C4B4 have been observed after 3-NP intoxication suggesting inflammation taking place 
in the lesion (Nishino et al., 1995). Additionally, levels of pro-inflammatory cytokines, tumor 
necrosis factor alpha (TNF-α) (Geddes et al., 1996) and expression of inducible nitric oxide 
synthase (Nishino et al., 1996) have been found to be increased. 
Since increased excitotoxicity is just one of many pathways, thought to be involved in the 
pathogenesis of HD, neither systemic acute or chronic administration of 3-NP nor models of 
intrastriatal injection fully mimic HD-related cell death. However, they are well established 
models to study excitotoxic cell death after inhibition of mitochondrial ATP production. In 
the present study, a model of intrastriatal 3-NP injection was employed to study whether 
SOD1 influences the outcome of the lesion. Since overexpression of SOD1 decreases the 
lesion in a more moderate model of subacute systemic 3-NP treatment (Beal et al., 1995), we 
set out to determine whether in an acute model of intrastriatal 3-NP injection SOD1 might 
play a protective role as well, using SOD1-TG mice as well as SOD1-KO animals. 
 
 
1.3. Role of protein phosphatase type-2Cβ in neuronal cell death 
1.3.1 Phosphatases in cell function 
Reversible phosphorylation, the phosphorylation of proteins by protein kinases (PKs) and 
subsequent dephosphorylation by protein phosphatases (PPs), is an important cellular 
mechanism to regulate the function of proteins. This regulation includes modulation of 
enzymatic activities, marking proteins for destruction, enabling them to move from one 
cellular compartment to another or changing their association with other proteins. Kinases and 
phosphatases themselves are possible targets for reversible phosphorylation. By modulation 
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of kinase and phosphatase activities the cell can regulate different cellular pathways, 
including programmed cell death/apoptosis. A number of disorders have been implicated with 
mutations in protein kinases and phosphatases and deleterious effects of some naturally 
occurring toxins and pathogens can be explained by them altering protein phosphorylation. 
Understanding processes which are regulated by reversible phosphorylation will reveal new 
therapeutical targets for the treatment of various diseases. For example, progress has been 
made in developing specific inhibitors of protein kinases for the treatment of cancer and 
chronic inflammatory diseases (Cohen, 2001). 
About 600 kinases are known to be encoded by the human genome but only an estimated 
number of 200 phosphatases (Cohen, 2001). However, since single phosphatase catalytic units 
are often associated with several different regulatory or targeting subunits, it is believed that 
the number of functional phosphatase holoenzymes adds up to the number of protein kinases.  
Whereas, so far, the focus of research interest was predominantly on protein kinases, it is 
evident that protein phosphatases as their counterparts play an equally important role. There 
are 4 potential sites for phosphorylation and dephosphorylation in proteins: the amino acids 
serine, threonin and tyrosine which contain a free –OH residue whose phosphorylation leads 
to O-phosphates and histidine which can be phosphorylated at its -NH group creating N-
phosphoamidates. Thus, 3 different superfamilies of protein O-phosphatases exist: The 
protein tyrosine phosphatases (PTP) including members such as dual-specifity phosphatase 
and serine/threonine phosphatases which are grouped into members of the PPP family 
(phosphoprotein phosphatases) and PPM family (protein phosphatase Mg2+-dependent) which 
are defined by molecular structure and conserved amino acid sequences (Klumpp et al., 
2002). PP1, PP2A or PP2B belong to the family of PPPs whereas five PP2C isoforms and the 
pyruvate dehydrogenase with similar amino acid sequences are part of the PPM family 
(Ingebritsen and Cohen, 1983). Additionally, protein histidine phosphatases have been 
discovered which can dephosphorylate N-phospho-histidine. The nomenclature of 
serine/threonin phosphatases has been established according to their biochemical properties 
before gaining more knowledge about structural similarities: Type 1 enzymes were inhibited 
by heat-stable inhibitor proteins and preferentially dephosphorylated the ß-subunit of 
phosphorylase kinase. Type 2 protein phosphatases, on the contrary, were insensitive to these 
inhibitors and preferentially dephosphorylated the alpha unit of the phosphorylase kinase. 
Type 2 was divided in different subtypes which were activated under special conditions: 
While PP2A was spontaneously active, PP2B activity was Ca2+-dependent and PP2C Mg2+ -
dependent. An additional parameter by which phosphatases could be differentiated from each 
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other was their sensitivity to certain toxins, such as okadaic acid, a fatty acid derivative, or 
microcystein, a cyclic heptapeptide. Both natural toxins known to be potent inhibitors of most 
Ser/Thr phosphatases in different concentrations (Cohen et al., 1990). PP1, PP2A and PP2B 
activity could be inhibited by these toxins whereas PP2C as well as members of the PTP 
superfamily stayed unaffected.  
 
 
1.3.2. Connection of PP2C with Bad and neuronal death 
Protein phosphatase type 2C enzymes (PP2Cs), members of the PPM family, are monomeric 
molecules with a relative molecular weight (Mr) of 42,000- 48,000 Da. PP2Cα and PP2Cß are 
the two most prominent PP2C enzymes, produced from distinct genes, while each of them can 
be devided in several isoforms due to different splicing variants. Since full PP2C activity was 
detectable only in the presence of unphysiologically high concentrations of Mg2+-ions (10-20 
mM Mg2+ or Mn2+-ions) in vitro, for a long time the importance of PP2C was underestimated 
(Tsuiki et al., 1988). When Klumpp et al. discovered that certain unsaturated fatty acids like 
oleic acid or ginkgolic acids increased the activity of PP2C in vitro and that in the presence of 
these kinds of fatty acids much lower Mg2+ concentrations were sufficient for activation, the 
physiological role of PP2C had to be re-evaluated (Ahlemeyer et al., 2001) (Klumpp et al., 
1998). 
These fatty acids or derivatives which were able to activate PP2C had common chemical and 
structural features: They were unsaturated, lipophilic compounds with a minimum chain 
length of 15 C-atoms and had a negatively charged group. Interestingly, the same fatty acids 
which activated PP2C in vitro induced apoptosis in chick neuronal culture (Klumpp et al., 
2002). This astonishing finding gave reason to hypothesize that PP2C activation could play an 
important role in neuronal apoptosis.   
It is unresolved how the apoptotic pathway is influenced by PP2C, however, there is strong 
indication that the dephosphorylation of Bad (Bcl-2/Bcl-xL-antagonist, causing cell death) 
might be one of the underlying pro-apoptotic mechanisms (Klumpp and Krieglstein, 2002). 
Bad belongs to the Bcl-2 family which consists of pro- (Bax, Bid, Bad, Bak, Bcl-xS) and anti-
apoptotic members (Bcl-2, Bcl-xL) which control a critical intracellular checkpoint within an 
evolutionary preserved cell death pathway (Wang and Reed, 1998) (Fig. 1). They are key 
regulators of apoptosis whose function as cell death agonists or antagonists is modulated by 
transcriptional and posttranscriptional modifications. The relative ratio between anti- and pro-
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apoptotic members of this family determines the ultimate sensitivity to cell apoptotic signals 
(Oltvai et al., 1993). Many of the Bcl-2 family proteins are capable of interacting with each 
other by a shared sequence homology with Bcl-2 in the BH3 (Bcl-2 homology 3) domain, an 
amphipathic helix required to interact with other Bcl-2 family members (Huang and Strasser, 
2000). They are normally located in other cellular compartments and translocate to the 
mitochondria in response to apoptotic stimuli. Once translocated to the mitochondria, they 
interact with each other, causing mitochondrial damage and release of apoptogenic proteins 
possibly through the formation of a permeability transition pore in the mitochondrial 
membranes. Cytochrome c, one of the pro-apoptotic proteins released from mitochondria, 
forms a cytoplasmic complex including Apaf-1 and caspase-9. This results in caspase-9 
activation and subsequent caspase-3 activation which leads to cleavage of death substrates 
and apoptosis (Fig. 1). In order to avoid a suicidal fate by dimerisation of pro- and anti-
apoptotic members of this protein family, cells require continuous survival signals from their 
surface receptors to support cell survival. The mechanism of post-translational modification 
(e.g. phosphorylation) which inactivates pro-apoptotic members of the Bcl-2 family and 
prevents them from interacting with ant-iapoptotic members is supported by survival factors 
such as insulin-like growth factor, platelet-derived growth factor, nerve growth factor, and 
interleukin-3 (Datta et al., 1999).  
The proapoptotic molecule Bad is able to heterodimerize with a wide range of anti-apoptotic 
members like Bcl-xL in the outer mitochondrial membranes, neutralizing their anti-apoptotic 
activities, thereby promoting cell death (Yang et al., 1995) (Bae et al., 2001). This 
heterodimerization with Bcl-xL is regulated by its state of phosphorylation (Hirai and Wang, 
2001) (Fig. 2). So far at least five different phosphorylation sites of Bad have been discovered 
in the murine protein: Ser112, Ser136, Ser155, Ser170 and Ser128. While phosphorylation at Ser128 
seems to be a proapoptotic signal (Konishi et al., 2002), Ser112, Ser136, Ser155 and Ser170 
phosphorylations have been proposed to have anti-apoptotic functions. The mechanism by 
which phosphorylation inhibits binding of Bad to Bcl-xL has been closely examined of several 
groups (Zha et al., 1996) (Zha et al., 1997) (Datta et al., 2000) (Yaffe and Elia, 2001) 
(Masters et al., 2001):  According to a current model, unphosphorylated Bad forms a stable 
complex with Bcl-xL via its BH3 domain; this complex is localized on the outer surface of the 
mitochondrial membrane and functions as an apoptotic signal.  Ser155 as part of the BH3 
domain is unphosphorylated in this complex. Phosphorylation at sterically approachable 
Ser112/Ser136 by kinases allows binding of Bad to 14-3-3 ligants, dimeric alpha-helical 
pSer/Thr-binding proteins, via its phospho-serine-136 domain. Although Bad has a 
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substantially higher affinity to Bcl-xL, the binding to 14-3-3 protein weakens the Bad/Bcl-xL 
complex enough to allow phosphorylation at Ser155 which destroys the Bad/Bcl-xL complex 
by disrupting the interaction the hydrophobic face of the BH3 domain and the hydrophobic 
groove of Bcl-xL. Bad then translocates from the outer mitochondrial membrane to the 
cytoplasm where it forms a stable complex with 14-3-3 proteins. Dephosphorylation of Bad 
by phosphatases reverses this process, Bad dissociates from 14-3-3 proteins and translocates 
to the mitochondrial membrane where it can dimerize with Bcl-xL. (Fig. 2) 
 
Figure 2: 
Bad, unphosphorylated at Ser155, binds to 
anti-apoptotic Bcl-xL, causing the release of 
mitochondrial factors like cytochrome c into 
the cytosol which triggers caspase activation 
followed by apoptotic cell death. This 
mechanism is reversed by phosphorylation of 
Bad at Ser155 which opens the Bad/ Bcl-xL 
complex and allows Bad to diffuse into the 
cytosol where it can bind to 14-3-3 binding 
proteins if it is phosphorylated at Ser 136 and 
Ser112. 
   
 
 
 
 
 
 
Phosphorylation at Ser112, Ser136 and Ser155 is regulated by growth factors through activation 
of different survival kinases such as Raf-1 when targeted to mitochondria (Wang et al., 1999) 
(Wang et al., 1996) (Salomoni et al., 1998) (Neshat et al., 2000), Akt/proteine kinase B (Datta 
et al., 1997) (del Peso et al., 1997) (Blume-Jensen et al., 1998), protein kinase A (Harada et 
al., 1999) (Datta et al., 2000)  (Virdee et al., 2000) (Zhou et al., 2000) (Lizcano et al., 2000), 
the p21-activated kinases (Schurmann et al., 2000) or the mitogen-activated protein kinase 
Rsk (Lizcano et al., 2000) (Bonni et al., 1999). However, it is not fully resolved which protein 
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kinase phosphorylates which site of Bad in vivo. Although some published findings are 
conflicting, it is likely that phosphorylation of Bad Ser112, Ser136 and Ser155 is meditated by 
multiple pathways of kinase activation. In vivo, Ser112-phosphorylation by the MAP-kinase 
Rsk and protein kinase C has been described. Involvement of protein kinase A in Ser112-
phosphorylation is not fully understood since contrasting findings have been published. 
Reports about protein kinase B (PKB) involvement are equally contradictory (Harada et al., 
1999) (Tan et al., 1999) (del Peso et al., 1997) (Liu et al., 1996a). Phosphorylation of Ser136 is 
mediated mainly through either PKB (del Peso et al., 1997) or a so far unknown kinase 
(Lizcano et al., 2000) (Scheid and Duronio, 1998). Ser155 phosphorylation seems to 
predominantly performed by c-AMP-mediated protein kinase A (Lizcano et al., 2000). 
Different phosphatases like Ser/Thr-protein phosphatases type-1 (PP1), 2A (PP2A) and 2B 
(Calcineurin, PP2B) are responsible for the dephosphorylation of Bad at Ser112, Ser136 and 
Ser155. PP1, PP2A and PP2B have been shown to dephosphorylate Bad at phospho-serine-112 
and -136 (Wang et al., 1999) (Ayllon et al., 2000) (Chiang et al., 2001). Recently it has been 
observed that PP2C dephosphorylates Ser155 in vitro (Krieglstein, Klumpp, unpublished data) 
and that phospho-Bad-112 and -136 are substrates for PP2C as well. Thus, the underlying 
mechanisms by which PP2C could be involved in apoptosis could be that PP2C, after 
activation by unsaturated fatty acids, dephosphorylates Bad which unleashes Bad's 
proapoptotic properties.  
The aim of this part of this study was to elucidate the role of PP2C in neuronal apoptosis in 
vivo. Protocols were established to detect Bad, Bad-155P and PP2C proteins in primary 
neuronal culture and to induce damage and apoptosis in these neurons by treatment with 
unsaturated fatty acid like oleic acid or ginkgolic acids. With these tools changes in protein 
levels of Bad, Bad-155P and PP2C due to treatment were analyzed to search for possible 
changes in Bad-phosphorylation due to PP2C activation. 
 
 
1.4. Outline of the study 
The purpose of this study was to evaluate the involvement of specific enzymes, superoxide 
dismutases and PP2C, in neuronal cell death. To this end, different experimental models of 
neuronal damage were used. The role of superoxide dismutases (SODs), endogenous free 
radical scavengers, was tested in two in vivo models of neuronal damage, cold injury-induced 
brain trauma (CIBT) and intrastriatal injection of the toxin 3-nitropropionic acid in mice. The 
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function of enzyme protein phosphatase type 2Cß (PP2Cß) which participates in the 
reversible phosphorylation of proteins was studied during apoptosis in primary rat neuronal 
cultures induced by oleic acid and ginkgolic acids. 
 
 
1) A possible protective role of superoxide dismutases 
Influence of SOD2 downregulation on CIBT  
ROS have been shown to play a pivotal role in the development of CIBT, a traumatic model 
with vasogenic edema as the most obvious parameter. Since overexpression of cytosolic 
SOD1 could ameliorate the outcome of CIBT, one major aim of this thesis was to elucidate 
the role of mitochondrial SOD2 in CIBT by using SOD2-KO mice and compare their 
outcome of the lesion with that in wild-type littermates at 1, 3 and 7 days post-insult. 
Parameters to describe the development of the lesion were as follows: 
-  Lesion size as the percentage of damaged tissue measured up to 7 days post injury 
-  Edema formation as hemisphere enlargement up to 7 days after CIBT to examine BBB 
 breakdown 
-  Number and distribution of apoptotic cells by TUNEL-staining to reveal the severity 
 of the lesion  
-  Number and distribution of inflammatory cells, neutrophil infiltration following CIBT, 
 which are another major source for ROS, examination up to 7 days 
-  Grade and distribution of hemorrhagic transformations (HT) up to 7 days  
- In situ superoxide anion production by hydroethidine oxidation 2 hours following 
 CIBT to assess whether there were any differences in the level of ROS production in 
 both animal groups early in development of the tissue injury 
 
Role of SOD1 on intrastriatal damage after 3-NP injection 
The aim of the 3-NP experiments was to testing a possible influence of SOD1 in this 
intrastriatal 3-NP model using SOD1 transgenic and knockout mice. The model was 
established in mice inducing a middle-sized lesion within the borders of the striatum of wild 
type mice and the development of the lesion established. Parameters to define the lesion were  
-  Size of the lesion at 4 h, 24 h, 72 h and 7 days  
- Edema formation at the same time points as for measurement of lesion size  
-  Detection of apoptotic cells by TUNEL-staining to reveal the severity of the lesion and     
 define the predominant type of cell death 
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-  Immunohistochemistry of active caspase-3 and caspase-9 as biochemical markers for 
 apoptosis to confirm findings of TUNEL-staining 
After establishing the model, mice overexpressing SOD1 (SOD1-TG), wild type littermates 
and animals which had the SOD1 gene homozygously knocked out (SOD1-KO) were 
subjected to 3-NP injection, and the severity of their lesions was compared. Measured 
parameters were: 
-  Size of lesion  
-  Edema development 
-  Detection and quantification of apoptotic cells by TUNEL-staining 
 
 
2) PP2C, a potential target for prevention of apoptosis 
Since PP2C has been shown to be activated by certain toxic unsaturated fatty acids which also 
induce apoptosis, induction of PP2C enzymatic activity might play a pivotal role in 
mechanisms of apoptosis. The aim of this study was to elucidate the role of PP2C in neuronal 
apoptosis also focussing on Bad phosphorylation as possible target for PP2C in vivo. The 
study had the following tasks: 
-  To establish protocols to detect Bad, Bad-155P and PP2Cβ proteins in rat neuronal 
 culture by either Western blotting or immunohistochemistry and hence prove that 
 PP2Cβ and Bad are co-localized. 
-  To establish treatment conditions to induce cell damage, preferably apoptosis in 
 cultured neurons (neonatal hippocampal or embryonic cortical neurons) by 
 treatment with unsaturated fatty acid like oleic acid or ginkgolic acids. 
-  To detect possible changes in protein levels of Bad, Bad-155P and PP2Cβ after 
 treatment with oleic acid or ginkgolic acids in order to elucidate a possible role of 
 PP2C in neuronal apoptosis probably by involving Bad dephosphorylation. 
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2.  Material and Methods 
2.1. Antibodies 
Primary antibodies: 
Anti-active caspase-3, rabbit, polyclonal    1) Promega GmbH, Mannheim, 
        Germany  
        2) PharMingen International, San 
        Diego, CA, USA 
Anti-active caspase-9, p35, rabbit, polyclonal   Santa Cruz Biotechnology,  
        Santa Cruz, CA, USA  
Anti-Bad, rabbit, polyclonal     1) Cell Signaling/ New England 
        Biolabs, Frankfurt a.M., Germany 
        2) Santa Cruz Biotechnology, 
        Heidelberg, Germany 
Anti-Bad-155P, rabbit, polyclonal    Cell Signaling/ New England 
        Biolabs, Frankfurt a.M., Germany 
Anti-myeloperoxidase (MPO), rabbit, polyclonal  DAKO , Carpinteria, CA, USA 
Anti-PP2Cß, rabbit, polyclonal    Provided by Prof. Klumpp, 
        Münster, Germany 
 
Secondary antibodies: 
Biotinylated anti-mouse IgG (H+L)    1) Vector Laboratories,  
        Burlingame, CA, USA 
        2) Amersham, Braunschweig, 
        Germany 
Biotinylated anti-rabbit IgG (H+L)    1) Vector Laboratories,  
        Burlingame, CA, USA 
        2) Amersham, Braunschweig, 
        Germany 
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2.2. Chemicals and materials 
Acrylamide/ Bisacrylamide     Carl Roth GmbH & Co, Karlsruhe, 
        Germany 
Agarose       Sigma Aldrich, Milwaukee, WI,
        USA 
Amino-n-caproic acid     Sigma, Taufkirchen, Germany 
Ammonium persulfate, APS     AppliChem, Gatersleben,  
        Germany 
ATP        Sigma, Taufkirchen, Germany 
Axioplan 2 Imaging microscope/Axiovision software  Carl Zeiss MicroImaging,  
        Thornewood, NY, USA 
B-27 supplement, 50x,     Life Technologies, Karlsruhe, 
        Germany 
Betadine solution, 10 % povidone iodine   Purdue Frederick, Norwalk, CT, 
        USA  
Boric acid       Sigma, Taufkirchen, Germany 
Bovine serum albumin - fraction V, BSA   Sigma Aldrich, Milwaukee, WI
        USA 
Bromophenol blue      Sigma, Taufkirchen, Germany 
Calpain inhibitor      Sigma, Taufkirchen, Germany 
cA-PK        Sigma, Taufkirchen, Germany 
Citric acid       Sigma Aldrich, Milwaukee, WI, 
        USA 
Cresyl violet       Sigma Aldrich, Milwaukee, WI, 
        USA 
DAB-tablets, N-N’-Diaminobenzamidine   Sigma Aldrich, Milwaukee, WI, 
        USA 
Dihydroethidium, Hydroethidine    Molecular Probes, Eugene, OR, 
        USA 
Disodium hydrogenphosphate, Na2HPO4   Fluka Chemie AG, Neu Ulm, 
        Germany 
DNAse-/RNAse-free water     Sigma Aldrich, Milwaukee, WI, 
        USA 
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dNTPs  Roche diagnostics, Indianapolis, 
 IN, USA 
16-dUTP Roche diagnostics, Indianapolis, 
 IN, USA 
Dimethylformamide, DMF      Sigma Aldrich, Milwaukee, WI, 
        USA 
Dimethylsulfoxide, DMSO     Sigma, Taufkirchen, Germany 
 IN, USA 
Developer for Kodak films     Sigma, Taufkirchen, Germany 
EDTA        Sigma, Taufkirchen, Germany 
EGTA        Sigma, Taufkirchen, Germany 
Eosine dye Y       Sigma Aldrich, Milwaukee, WI, 
        USA 
Ethidium bromide      Sigma Aldrich, Milwaukee, WI, 
        USA 
Filter paper       Schleicher und Schüll,  Dassel, 
        Germany 
Fisherbrand Superfrost/Plus Microscope Slides,   Fisher Scientific, Tustin, CA, USA 
precleaned 
Fisher Histomatic Tissue Processor, Model 166   Fisher Scientific, Tustin, CA, USA 
Fixator for Kodakt films     Agfa Gevaert, Leverkusen,  
        Germany 
Fetal calf serum      PAA, Linz, Austria 
Fluorescence microscope, Axiovert 100    Zeiss, Göttingen, Germany 
Fmax fluorometer       Molecular Devices Corp.,  
        Sunnyvale, CA, USA 
Formaldehyde 37 %      Sigma Aldrich, Milwaukee, WI, 
        USA 
D-Glucose       Merck, Darmstadt, Germany 
Gentamycine       Sigma, Taufkirchen, Germany 
Glacial acetic acid      Sigma Aldrich, Milwaukee, WI, 
        USA 
Glycerol       Sigma, Taufkirchen, Germany 
Glycine       Sigma, Taufkirchen, Germany 
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Goat serum        Sigma, Taufkirchen, Germany 
Hamilton syringe, 5 µl     Hamilton, Reno, NV, USA 
Heparine Sodium injection, 1000 Units/ml   Pharmacia & Upjohn, Kalamazoo, 
        MI, USA 
HEPES       Sigma, Taufkirchen, Germany 
Homeothermic control unit      Harvard Instruments, Holliston, 
        Maine, USA 
Hoechst-33258 dye      Sigma, Taufkirchen, Germany 
Horse serum       PAN Biotechnologies GmbH, 
        Aidenbach, Germany 
Hydrochloric acid, HCl     Sigma, Taufkirchen, Germany 
Hydroethidine (= Dihydroethidium) 
Hydrogen peroxide 30 %, H2O2    Sigma Aldrich, Milwaukee, WI, 
        USA 
Isoflurane, AErrane®      Inhalon Pharmaceuticals Inc. 
        Lehigh Valley, PA, USA 
Image analysis system, MCID     Imaging Research Inc., Ontario, 
        Canada 
Kodak X-Omat film      Sigma, Taufkirchen, Germany 
L-Glutamine       Sigma, Taufkirchen, Germany 
Lithium carbonate, Li2CO3     Sigma Aldrich, Milwaukee, WI, 
        USA 
Laser scanning microscope, LSM 510   Zeiss, Göttingen, Germany 
Magnesium chloride,  MgCl2     Sigma Aldrich, Milwaukee, WI,  
        USA 
Magnesium sulfate, MgSO4,     Sigma Aldrich, Milwaukee, WI,  
        USA 
Mayer’s hematoxylin      Sigma Aldrich, Milwaukee, WI, 
        USA 
2-Mercaptoethanol      Sigma, Taufkirchen, Germany 
Methanol       Sigma, Taufkirchen, Germany 
Methyl green solution     Vector laboratories, Burlingame, 
        CA, USA 
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Microtome, 820 Spencer       VWR Scientific, West Chester, 
        PA, USA 
Milk powder, fat-free      Heirler Cenovis GmbH,  
        Radolszell, Germany 
Mineral oil       Sigma Aldrich, Milwaukee, WI, 
        USA 
Minimal essential medium (MEM)    Life Technologies, Karlsruhe, 
        Germany 
Micro BCA Protein Assay Reagents    Pierce, Rockford, USA 
Model 5000 Microinjection unit    David Kopf Instruments, 
        Tujungam, CA, USA 
MOPS        Sigma, Taufkirchen, Germany 
3-Nitropropionic acid (3-NP)     Sigma Aldrich, Milwaukee, WI, 
        USA 
Neurobasal medium      Life Technologies, Karlsruhe, 
        Germany 
Nickel sulfate, NiSO4      Sigma Aldrich, Milwaukee, WI, 
        USA 
Nile blue A       Sigma, Taufkirchen, Germany 
Nitro-blue tetrazolium (NBT)    Sigma Aldrich, Milwaukee, WI, 
        USA 
Nitrocellulose membrane, Hybond    Amersham, Braunschweig,  
        Germany 
Nitrogen dioxide, N2O     Praxair, Danbury, CT, USA 
Novex precast gel, Tris-Glycine gel 10 %    Invitrogen, Carlsbad, CA, USA 
NP-40        Sigma Aldrich, Milwaukee, WI, 
        USA 
Oxygen, O2        Praxair, Danbury, CT, USA 
Oleic acid       Sigma, Taufkirchen, Germany 
Papain        Sigma, Taufkirchen, Germany 
Pap pen, Kiyota      Sigma, Taufkirchen, Germany 
Parafilm M       Fisher Scientific, Tustin, CA, USA 
Paraffin, solid       Sigma, Taufkirchen, Germany 
PCR machine, Robocycler Gradient 40   Stratagene, La Jolla, CA, USA 
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PCR nucleotide mix      Invitrogen/Life Technologies, 
        Grand Island, NY, USA 
Penicillin/Streptomycin     PAA, Linz, Germany   
Permount       Fisher Scientific, Tustin, CA, USA 
Petri dishes (Ø 35 mm, 60 mm)/ 24-multiwells  Fisher Scientific, Schwerte,  
        Germany   
Phenol red       Sigma, Taufkirchen, Germany 
Phenylmethylsulfonyl fluoride (PMFS)    Sigma, Taufkirchen, Germany 
Polyethylenimine, PEI     Sigma, Taufkirchen, Germany 
Poly-L-lysine       Sigma, Taufkirchen, Germany 
Ponceau S red       Serva Feinbiochemica GmbH&Co, 
        Heidelberg, Germany 
Potassium chloride, KCl     Sigma Aldrich, Milwaukee, WI, 
        USA 
Potassium ferrocyanide     Sigma Aldrich, Milwaukee, WI, 
        USA 
Potassium phosphate      Sigma Aldrich, Milwaukee, WI, 
        USA 
Potassium dihydrogenphosphate, KH2PO4   Merk, Darmstadt, Germany  
Premium cover glass       Fisher Scientific, Tustin, CA, USA 
Proteinase K       DAKO Corporation, Carpinteria,
        CA, USA 
Pyruvate       Sigma Aldrich, Milwaukee, WI, 
        USA 
Riboflavin       Sigma Aldrich, Milwaukee, WI, 
        USA 
Silk suture, 6-0       Ethicon, Cornelia, GA, USA 
Small stereotactic frame     David Kopf Instruments,  
        Tujungam, CA, USA 
Sodium acetate      Sigma Aldrich, Milwaukee, WI, 
        USA 
Sodium azide, NaN3      Sigma Aldrich, Milwaukee, WI, 
        USA   
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Sodium chloride, NaCl     Sigma Aldrich, Milwaukee, WI, 
        USA  
Sodium dihydrogenphosphate, NaH2PO4   Sigma, Taufkirchen, Germany 
Sodium dodecylsulfate, SDS     Sigma, Taufkirchen, Germany 
Sodium hydrogencarbonate, NaHCO3   Sigma, Taufkirchen, Germany 
Sodium tetraborate      Sigma, Taufkirchen, Germany 
Staurosporine       Sigma, Taufkirchen, Germany 
Strepavidin Oregon Green     Molecular Probes, Oregon,  
        USA 
Taq DNA polymerase, recombinant    Invitrogen/Life Technologies, 
        Grand Island, NY, USA 
TEMED       Sigma, Taufkirchen, Germany 
TdT buffer       Invitrogen/Life Technologies, 
        Grand Island, NY, USA 
TdT, recombinant      Invitrogen/Life Technologies, 
        Grand Island, NY, USA 
Trichloroacetic acid      Sigma, Taufkirchen, Germany 
Tris-HCl       Sigma Aldrich, Milwaukee, WI, 
        USA 
Triton-X 100       Sigma, Taufkirchen, Germany 
Trypan blue        Sigma, Taufkirchen, Germany 
Trypsin       Sigma, Taufkirchen, Germany 
Trypsin inhibitor      Sigma, Taufkirchen, Germany 
Tween-20       Sigma, Taufkirchen, Germany 
Vectamount Mounting Medium     Vector Laboratories, Burlingame, 
        CA, USA 
Vectastain ABC- Kit  (with peroxidase)   Vector Laboratories, Burlingame, 
        CA, USA 
Vectastain ABC-AP Kit (with alkaline phosphatase) Vector Laboratories, Burlingame, 
        CA, USA 
Vector Red Alkaline Phosphatase Substrate Kit I  Vector Laboratories, Burlingame, 
        CA, USA 
Vector Vip Substrate Kit for Peroxidase   Vector Laboratories, Burlingame, 
        CA, USA 
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XCELL Surelock Electrophoresis Cell    Novex/Invitrogen, Carlsbad, CA, 
        USA 
Xylene       Sigma Aldrich, Milwaukee, WI, 
        USA 
Xylene cyanole      Sigma Aldrich, Milwaukee, WI, 
        USA 
 
 
 
2.3. Cold injury-induced brain trauma (CIBT) experiments 
2.3.1. Animals 
Heterozygous SOD2 knock-out mice with a CD1/SV129 background (Li et al., 1995) were 
used for the cold injury brain trauma (CIBT) experiments. They were backcrossed with CD-1 
mice for at least 5 generations and obtained from local stocks. In these animals mouse-SOD2 
was mutated with a replacement type targeting vector that had deleted exon 3 out of 5 exons. 
This resulted in the production of a shortened mRNA and loss of enzymatic activity. 
Heterozygous SOD2 knock-out (SOD2-KO) animals had a ~ 50 % reduction of SOD2 
expression in various tissues including brain tissue. No abnormalities in phenotype compared 
to their wild-type littermates could be observed in these animals up to 9 month.  Homozygous 
SOD2-KO showed high neonatal lethality, animals did not survive 2 weeks and could, 
therefore, not be used for CIBT experiments. Knock-out mice and their wild- type littermates 
(WT) with identical genetic background were kept under controlled conditions (12 h 
light/dark circle, 23 ± 1°C, 55 ± 5 % humidity) and had free access to food and water. 
 
 
2.3.2. Genotyping of the SOD2 knockout mice 
DNA Preparation: 
Animals were labelled with a numbered earring clip to allow identification. A sample of tail 
tissue (2-3 mm length) was obtained and transferred into a 1.5 ml Eppendorf tube. 20 µl of 
lysis buffer (working solution) was added and the tissue incubated for 1 h at 55°C.  
Afterwards samples were diluted with 180 µl of DNAse-/RNAse-free water, incubated at 100 
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°C for 10 min and centrifuged at 20,000 x g for 10 min. The supernatant was used for the 
polymerase chain reaction (PCR).  
Polymerase chain reaction: 
DNA-fragments were amplified by a hot start PCR protocol using a primer pair described by 
Li and colleagues (Li et al., 1995b).  In a 0.5 ml Eppendorf tube 19 µl of primer mixture and 
1 µl of sample supernatant were combined. After vortexing and short centrifugation, a drop of 
mineral oil was added to prevent a reduction of volume by evaporation. The sample tubes 
were placed in the PCR machine and the PCR was started. 
PCR was performed in a Robocycler (RoboCycler Gradient 40, Stratagene, La Jolla, CA, 
USA) as follows: 
 
 RoboCycler Gradient 40, Stratagene, Program #1, SOD2 KO PCR 
 Step 1  98°C, 5 min  80°C, 2 min    
   1 cycle 
 
After cooling down the probes to 80°C, the RoboCycler was stopped to allow an  addition of 5 
µl of hot start PCR solution in each tube and the PCR continued. 
 
 Step 2  94°C, 30 sec  62°C, 60 sec  75°C, 90 sec  
   1 cycle 
 
 Step 3  94°C, 30 sec  62°C, 60 sec  75°C, 90 sec  
   30 cycles 
 
 Step 4  75°C, 5 min  6°C, 10 min      
   1 cycle 
 
Genotype identification    
After PCR, the amplified fragments were separated on a 1 % agarose gel. For preparation of 
the gel 1 g agarose was mixed with 200 ml 1xTBE buffer and then cooked in a microwave for 
2 min. Afterwards, 7 µl ethidium bromide solution were added under laminar flow protection. 
The solution was poured in the gel chamber (Model H5, Horizontal Gel Electrophoresis 
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System, Life technologies, Grand Island, NY, USA), and allowed to solidify for 1 h. The gel 
was transferred to an electrophoresis tank and covered with 1xTBE buffer. 10 µl of amplified 
sample were added to 3 µl loading buffer and 10 µl of this mixture was loaded on the gel. The 
electrophoresis was performed at 140 V for approximately 1 h in 1x TBE buffer. The DNA 
bands were visualized under UV illumination and recorded on Polaroid (Fotodyne, Fototdyne 
Incorp., New Berlin, WI, USA) (Fig. 3). 
  
 
 
Figure 3:  Genotypic identification of SOD2-KO mice 
WT animals showed one band for multiplied mouse SOD2 DNA, heterozygous SOD2 knock-
out mice (SOD2-KO het) showed two bands, one for the mouse SOD2, another for the DNA-
fragment that disrupted the SOD2 gene. Homozygous SOD2 knock-out mice (SOD2-KO ho) 
show one band for the vector that disrupted the SOD2 gene. 
 
 
Solutions for PCR: 
 
 Hot start PCR solution          
  DNAse/RNAse free water   4.5 µl 
  10 mM dNTPs    0.5 µl 
   Taq polymerase (added just before use) 0.1 µl    
  
 Loading buffer         
  Bromophenol blue    2.5 g 
  Xylene cyanole    2.5 ml 
  Glycerol     3.0 ml 
  Sterile water     ad 10 ml  
 
  32
 10x lysis buffer (stock)      
  1 M Tris HCl pH 8.0     5 ml 
  0.5 M EDTA       0.2 ml 
  NaCl      117 mg   
  SDS      1 g  
  Sterile water     ad 100 ml  
  
 10x lysis buffer (working solution)    
  Proteinase K      21.4 ml 
  Lysis buffer (stock)    278.5 ml 
 
 10x PCR buffer         
  1 M Tris-HCl, pH 9.0    1 ml 
  1 M KCl in sterile water   0.5 ml  
  1 M MgSO4 in sterile water   0.5 ml    
  10 mg/ml BSA solution    0.5 ml 
  10 % Triton-X in sterile water  0.5 ml    
 DNAse-/RNAse-free water    1.85 ml 
  
 Primer cocktail        
  1. Primer A, Mn SOD-Exon3/Up 
  5’-TTA GGG CTC AGG TTT CAG AA,  
  200 µM          50 µl 
  2. Primer B, 1.7 Short/Down 
   5’-CGA GGG GCA TCT AGT GGA GAA, 
   200 µM         50 µl 
  3. Primer C, Pall/Up  
  5’-CAC ACA TCG GGA AAA TGG TTT G, 
  200 µM     50 µl 
  4. DNAse/RNAse free water   850 µl 
 
 Primer mixture         
 DNAse/RNAse-free water   14 µl 
  Primer cocktail    2.5 µl  
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  10x PCR buffer     2.5 µl 
  
 Proteinase K         
  in 10 mM Tris-HCl, pH 7.5   14.0 mg/ml 
  
 1x TBE buffer           
  5x TBE      200 ml  
   Sterile water      ad 1 l 
 
 1 M Tris HCl, pH 8.0      
  Tris      12.11 g 
  Sterile water     100 ml 
  adjust to pH 8.0 with 1 M HCl 
 
 1 M Tris HCl, pH 9.0      
  Tris      12.11 g 
  Sterile water     100 ml 
  adjust to pH 9.0 with 1 M HCl      
        
 
2.3.3. General principles of surgery 
Throughout the surgery, maximal asepsis was achieved by using autoclaved instruments and 
disinfecting the surgery place with 70 % ethanol before each use. In all performed surgeries 
mice were anesthetized with an initial inhalator mixture of 5 % isoflurane/30 % oxygen/70 % 
nitrogen dioxide and anesthesia was maintained with 2 % isoflurane/30 % oxygen/70 % 
nitrogen dioxide. Chan et al. had used chloral hydrate anesthesia during the surgery inducing 
CIBT (Chan et al., 1991). This modification allowed us to reduce the time of anesthesia from 
about 30 min after chloral hydrate anesthesia (35 mg/g bodymass). 
 
 
2.3.4. Performance of CIBT surgery 
The induction of CIBT in mice was performed according to a method described by Chan et al. 
(Chan et al., 1991). This procedure created a unilateral, highly reproducible lesion in the 
cortex that did not extend into the hippocampus. After inducing anaesthesia, the heads of the 
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mice were shaved with an electric shaver and disinfected with iodine. The animal’s heads 
were placed in a small stereotactic frame for mice (David Kopf Instruments) and they were 
kept under anaesthesia using a face mask. They rested on a heating pad throughout the 
surgery and were covered with a blanket. Rectal temperature was monitored throughout the 
surgery and maintained at 37 ± 0.5ºC. (Homeothermic control unit, Harvard instruments). 
After scalp incision on the midline, the skull was exposed and cleaned from tissue. A metal 
probe (100 g, 4 mm diameter, constantly cooled with powdered dry ice) (Fig. 4) applied on 
the right side of the bony skull for 30 seconds (Fig. 5).   
 
Figure 4:  Metal probe to induce CIBT 
The metal probe was constantly cooled with 
powdered dry ice; a weight was added on top to 
increase the total weight to 100 g. Placing this 
probe on the intact bony skull produced a lesion 
in the underlying cortex. 
 
 
 
 
 
 
 
 
 
Figure 5: Surface of skull with the spot of  
CIBT induction 
The center of the cold injury probe was placed 
2 mm posterior and 2 mm lateral to bregma 
(marked as a round spot). 
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The skin wound was closed by a suture (silk suture, 6-0), and the animals were kept on the 
heating pad until regaining consciousness. After surgery, they were kept in a clean cage under 
controlled conditions (12 h light/dark circle, 23 ± 1°C, 55 ± 5 % humidity) and had free 
access to food and water. 
 
 
2.3.5. Removal of brains and subsequent paraffin embedding  
At different time points up to 7 days after CIBT animals were sacrificed in deep isoflurane 
anaesthesia. Immediately after the respiration stopped, the thorax was opened allowing free 
access to the heart. After opening the right chamber of the heart with scissors, the mice were 
slowly transcardially perfused with 50 ml heparinized saline (10 Units/ml) to clear the vessels 
from blood and 50 ml 3.7 % formalin/PBS. After waiting 10 min to let the formalin harden 
the brain, the mice were decapitated with scissors. Their scalp was incised on the midline, the 
skin removed and the skull carefully opened with small scissors to allow the brain to be 
removed with a spatula. The brains were postfixed by storing them in 3.7 % formalin/PBS 
solution in glass vials for one week and afterwards paraffin-embedded using an automatic 
tissue processor (Fisher Histomatic Tissue Processor, Model 166). The paraffin-embedded 
brains were cut into 6 µm sections by microtome (820 Spencer Mictrotome); the brain 
sections were transferred onto glass slides (Fisherbrand Superfrost/Plus Microscope Slides, 
precleaned) in 150 µm intervals and used for histological assessment. Adjacent sections were 
used for haematoxylin and eosin staining, myeloperoxidase (MPO)-immunohistochemistry, 
Perl’s iron staining, and TUNEL staining. 
 
 Heparinized saline 10 Unit /ml 
 Heparine 1000 U/ml    10 ml 
 NaCl      9 g 
 Demineralized water    ad 1000 ml 
 
 3.7 % Formalin/PBS solution 
  Formaldehyde 37 %    100 ml 
  PBS-tablets     5 
  Demineralized water    ad 1000 ml  
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2.3.6. Histological assessment of infarct size and edema 
To assess the size of the lesion, hematoxylin and eosin (H&E) staining was performed on 9 
paraffin sections per animals in defined anatomical distances. H&E is a routine staining of 
purple color that allows the detection of lesion as a relatively pale area. Hematoxylin is a 
basic stain with deep purple or blue color; it stains basophilic structures such as chromatin 
(i.e. cell nuclei) and ribosomes. Eosin is an acidic stain with a red color and stains acidophilic 
cell structures and dead neurons. The glass slides containing the paraffin brain sections (-> 
2.3.5.) were placed in a slide holder and subjected to the following washing/staining steps: 
 
 3 min resting in 100 % xylene  
 3 min washing in 100 % xylene  
 3 min washing in 100 % xylene /100 % ethanol (1:1) 
 3 min washing in 100 % ethanol 
 3 min washing in 100 % ethanol 
 3 min washing in 95 % ethanol 
 3 min washing in 70 % ethanol 
 1 min washing under running tap water  
 5 min incubation in Mayer’s hematoxylin  
 12 dips in Demineralized water  
 1 quick dip in 1 % acid alcohol (1 % HCl in 70 % ethanol) 
 5 min washing under running water tap water (H2O) 
 5 dips in 1 % saturated lithium carbonate solution 
 5 sec brief dip in destilled water H2O 
 30 sec dip in 1 % saturated lithium carbonate solution 
 5 min washing under running tap water  
 1 quick dip in Eosin Y dye  
 12 dips in demineralized water  
 15 dips in 95 % ethanol 
 15 dips in 100 % ethanol 
 15 dips in 100 % ethanol 
 15 dips in 100 % ethanol 
 3 min washing in 100 % xylene /100 % ethanol (1:1) 
 5 min washing in 100 % xylene 
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 After the H&E staining, the sections were sealed with Permount and covered with glass 
coverslips (Premium Cover Glass, Fisher Scientific). Digital pictures of the stained sections 
were taken and printed out on paper. The area of traumatic injury was first defined by 
examining the stained sections under light microscopy and later outlined on the print outs. 
Ipsilateral hemisphere, contralateral hemisphere and cortical area of traumatic injury were 
measured on the printouts using an image analysis system (MCID). Lesion size was 
calculated as average % of ispsilateral hemisphere in 9 defined sections. The size of edema 
was evaluated as average hemisphere enlargement in 4 defined core sections. 
 
 
2.3.7. Hydroethidine assay 
 The production of superoxide anion radicals (O2-.) after CIBT was investigated by 
intravenously administering hydroethidine (HEt) which diffuses into the CNS parenchyma 
and is selectively oxidized by superoxide anion radicals (O2-.) to ethidium (Et). HEt has been 
shown to be a good tool to measure and detect free radical production in brain tissue after 
various insults (Murakami et al., 1998b). Ethidium shows red fluorescence at 590 nm when 
excited at 544 nm. Light- and air-sensitive hydroethidine was stored at -20°C in darkness 
under argon as a stock solution in dimethylsulfoxide. For the hydroethidine assay HEt-stock 
solution was freshly diluted 1:100 in PBS (working solution 1 mg/ml in PBS), sonicated until 
it was a milky, homogenous suspension and kept in darkness until use.  
Animals were anesthetized, their chests shaved with an electric shaver and disinfected with 
iodine. They were placed on a heating pad and anesthesia was maintained using a face mask. 
Rectal temperature was monitored throughout the surgery and maintained at 37 ± 0.5ºC. 
(Homeothermic control unit, Harvard instruments). A 1 cm long incision was made on the 
chest and the vena jugularis exposed. 0.2 ml HEt solution was injected 5 min before CIBT 
into the jugular vein through the overlying muscle to avoid bleeding. Administration of HEt 
before the induction of the CIBT was necessary to achieve a good distribution of the HEt 
throughout the brain. The skin wound on the chest was closed by a silk suture. After the 
injection HEt the animals were kept anesthetized and the CIBT was performed, as described 
previously (chapter 2.3.4.). Two hours after CIBT animals were sacrificed with an overdose 
of isoflurane. Immediately after the respiration stopped, the thorax was opened to access the 
heart which was still beating. The right heart chamber was opened and the mice were 
transcardially perfused through the left ventricle of the heart with 50 ml heparinized saline to 
clear the vessels from blood. Afterwards the mice were decapitated, their scalps incised on 
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the midline, the skin removed, the skull opened and the brain removed with a spatula. The 
brains were frozen on dry ice and tissue of lesion area and contralateral side was dissected by 
a sharp scalpel. Tissue of two animals (approximately 50 mg) was pooled, supplemented with 
dimethylformamide (DMF) (three times the volume of the tissue) and sonicated. After 20 min 
rest in darkness at room temperature the samples were centrifuged at 20,000 x g for 20 min at 
4°C, 100 µl of the supernatant transferred to a multiplate and fluorometrically measured by 
multiplate reader (Fmax fluorometer) at an excitation of 544 nm and emission of 590 nm. 
  
 Heparinized saline 10 U/ml 
 Heparine 1000 U/ml    10 ml 
 NaCl      9 g 
 Demineralized water    ad 1000 ml 
  
 HEt stock solution 
  Dihyroethidium (Hydroethidine)  100 mg 
  DMSO     1 ml 
 
 
2.3.8. Perl’s iron staining 
To examine hemorrhagic transformations in the damaged tissue, Perl’s iron staining was 
performed on brain sections following the protocol of Koeppen (Koeppen, 1995).  Perl’s iron 
staining is the classic method to demonstrate intracellular iron in tissues e.g. in hemoglobin or 
hemosiderin. Paraffin sections of 6 µM thickness on slides (->2.3.5.) were deparaffinized and 
hydrated by the following process: 
 
 3 min resting in 100 % xylene  
 3 min washing in 100 % xylene  
 3 min washing in100 % xylene /100 % ethanol (1:1) 
 3 min washing in 100 % ethanol 
 3 min washing in 100 % ethanol 
 3 min washing in 95 % ethanol 
 3 min washing in 70 % ethanol 
 1 min washing in demineralized water 
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Afterwards sections were incubated in Perl’s iron solution for 15 min on a shaker at room 
temperature. After 3 times washing with PBS they were incubated with DAB-solution for 15 
min at RT in the dark, washed 3 x 5 min with PBS, and counterstained with methyl green 
solution for 15 min. They were washed 3 x for 20-30 sec in demineralized water and 
dehydrated by immersing 3 x 20-30 sec in butanol 100 % and 3 x 5 min in xylene 100 %. 
Slides were sealed with Permount using a glass coverslip (Premium Cover Glass, Fisher 
Scientific). Digital pictures of the lesion area were taken with a light microscope (Axioplan 2 
Imaging microscope, Axiovision software), printed out and the hemorrhagic transformations 
graded by a “blinded” examiner (grade 0: no bleeding at all, grade 1: virtually no 
bleeding/restricted to some spot in < 25 % of sections of each animal, grade 2: some bleeding, 
restricted to traumatic region in 25-50 % of sections, grade 3: extensive bleeding 
encompassing entire traumatic region in 50-75 % of sections, grade 4: extensive 
bleeding/staining in core, penumbra and beyond in all sections).  
 
Perl’s iron solution 
 Potassium ferrocyanide   1 g 
 HCl, concentrated    1 ml 
 Demineralized water    ad 100 ml 
 
DAB solution 
 DAB-tablet     10 mg 
 PBS      50 ml 
 Tween 20     50 µl 
 H2O2 30 %     50 µl 
 
PBS 
 PBS tabs     5 pieces 
 Demineralized water    1000 ml 
 
 
2.3.9. MPO immunohistochemistry 
To assess the anatomical distribution of myeloperoxidase (MPO)-positive neutrophils taking 
part in the inflammatory process, immunohistochemistry was performed on paraffin sections 
of 6 µm thickness (-> 2.3.5.). Three sections of representative animals of each group were 
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stained. After deparaffinizing and hydration (as described in chapter 2.3.8.), paraffin sections 
were heated up in a microwave oven in 0.01 M citric acid in demineralized water at high 
power for 2 min and 50 % power for 20 min. Every 5 min the evaporated solution was 
replaced to prevent the slides from drying. The sections cooled down for 20 min and were 
washed 2 x 5 min with demineralized water. They were dried on a slide heater at 30°C for 5 
min and the sections circled with a PAP-pen. After blocking endogenous peroxidases with 
blocking solution for 30 min, sections were washed 3 x 5 min with PBS and incubated with 5 
% fat-free milk powder solution for 1 h. After removal of the milk solution each section was 
incubated with 50 µl 1:500 MPO-antibody (rabbit, polyclonal, in PBS) solution overnight at 
4˚C in a humid chamber to prevent the sections from drying out. The next day, sections were 
washed 3 x 10 min with PBS and the secondary antibody solution (biotinylated anti-rabbit 
IgG, 1:200 in PBS) was applied for 30 min at room temperature. Sections were washed again 
3 x 10 min with PBS and incubated with ABC solution (Vectastain ABC- Kit) for 30 min at 
room temperature to enhance the signal of the secondary antibody. After washing 2 x 5 min 
with PBS, visualisation was accomplished by incubation with Vector Vip solution for 15 min. 
Afterwards they were washed 3 x 5 min with PBS and counterstained with methyl green 
solution for 15 min. 
Sections were dehydrated (washed 3 x for 20-30 sec in demineralized water, 3 x for 20-30 sec 
in butanol 100 % and 3 x for 5 min xylene 100 %) and sealed with Permount using a glass 
coverslip (Premium Cover Glass, Fisher Scientific). MPO-positive cells were counted in four 
different areas of the lesion in two sections of each animal under high power magnification (x 
400). 
  
 ABC solution 
  Solution A     1 drop 
  Solution B      1 drop  
  PBS      5 ml 
  (Vortex solution A with PBS, add solution B, vortex, let it rest 30 min at R/T) 
  
Blocking solution     
 Sodium azide     0.33 g  
 Triton–X 100     0.1 ml 
  PBS      100 ml 
  Hydrogen peroxide, 30 %   0.33 ml 
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PBS 
 PBS tabs     5 pieces 
 Demineralized water    1000 ml 
  
 Vector Vip solution 
  PBS      5 ml 
  Reagent 1     3 drops 
  Reagent 2     3 drops 
  Reagent 3      3 drops 
  Hydrogen peroxide solution   3 drops 
  (Mix PBS and reagent 1, add reagent 2, mix well, add reagent 3, mix well, 
  add hydrogen peroxide solution, mix well, use within 15 min) 
 
   
2.3.10. Transferase-dUTP-Nick-End-Labelling (TUNEL-staining) 
DNA-fragmentation was examined by in-situ-labelling of fragmented DNA in the nucleus. 
DNA strand breaks are a typical feature of apoptosis and strong labelling of cells with 
condensed nuclei or fragmented allows detection of apoptotic cells and their distribution in 
brain tissue. Paraffin sections (6 µM thickness) were deparaffinized first using a protocol 
described previously (-> chapter 2.3.6.). Afterwards, the sections were circled by a Pap pen 
and dried on a 30 °C warm plate. Freshly diluted proteinase K (20 µg/ml in demineralized 
water) solution was applied for 15 min and later sections were washed two times with PBS. 
Endogenous peroxidases were quenched in 1.5 % H2O2 in PBS for 5 min at room 
temperature. After washing again 3 times with PBS, sections were incubated in TdT buffer 
for 15 min at room temperature. 
Afterwards, they were incubated with TdT/dUTP solution for 60 min at 37°C, followed by 3 
times 10 min washing with 2xTB buffer and 2 times for 15 min washing with 2 % BSA in 
PBS. 
They were washed 3 x 5 min with PBS and incubated with ABC solution (Vectastain ABC- 
Kit) for 30 min at room temperature. After washing with PBS once, sections were washed 
twice with 0.175 M sodium acetate solution for 10 min. The visualisation of the fragmented 
DNA was achieved by incubation with Ni-DAB for 10 min. Afterwards sections were washed 
3 x 5 min with PBS and stained with methyl green solution for 15 min. They were washed 3 x 
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20-30 sec in demineralized water, 3 x 20-30 sec in butanol and 3 x 5 min in xylene. 
Afterwards they were sealed with Permount using a glass coverslip (Premium Cover Glass, 
Fisher Scientific). 
 
 ABC solution 
  Solution A     1 drop 
  Solution B      1 drop  
  PBS      5 ml 
  (Vortex solution A with PBS, add solution B, vortex, let rest 30 min at room 
  temperature) 
 
 Ni-DAB solution  
  DAB tablet     10 mg 
  NiSO4      0.4 g 
  0.175 M Sodium acetate   40 ml 
  Hydrogen peroxide, 30 %   100 µl 
 (Dissolve DAB and 0.4 g Ni-sulfate in sodium acetate solution under stirring, 
  filtrate  solution, store in darkness, add H2O2 freshly before use) 
 
PBS 
 PBS tablet     5 pieces 
 Demineralized water    ad 1000 ml 
 
2xTB buffer  
  NaCl       1.7646 g 
  Sodium citrate    3.5064 g  
   Demineralized water    200 ml 
 
TdT/dUTP buffer (for 8 sections)  
 TdT, 25 µl/ml     7.5 µl 
  Biotinylated 16-dUTP (60 µl/ml)   18 µl    
 TdT buffer (1 x)    ad 300 µl  
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2.4. Experiments of intrastriatal 3-NP injection 
2.4.1. Animals 
Heterozygous SOD1 transgenic mice 1), their wild-type littermates and homozygous SOD1 
knock-out mice 2) were used to study neurodegeneration induced by intrastriatal injection of 
3-nitropropionic acid (3-NP)- model. They were obtained from local stocks, kept under 
controlled conditions (12 h light/dark circle, 23 ± 1°C, 55 ± 5 % humidity) and had free 
access to food and water. 
Ad 1) Heterozygous SOD1 transgenic mice (SOD1-TG) of the strain TgHS/SF-218, carrying 
the human CuZn-SOD (h-SOD1) gene in addition to their endogenous m-SOD1 genes, were 
bred on a CD-1 background. They had been created by Epstein and colleagues (Epstein et al., 
1987) and showed a ~3-fold increase in endogenous SOD1 activity (Chan et al., 1991). 
Ad 2) Homozygous SOD1 knock-out mice (SOD1 KO) of the strain 129/CD-1SOD1<tm1> 
were originally produced by Reaume and colleagues at Cephalon, Inc. (West Chester, PA, 
USA) (Reaume et al., 1996). These animals were bred on a CD-1 background. There were no 
differences in phenotypes between these mutants and their wild-type littermates. The knock-
out mice showed no SOD1 activity.  
 
 
2.4.2. Genotyping of SOD1 transgenic and knock-out mice 
The animals were typed by detecting SOD activity photochemically via its inhibition of 
nitroblue tetrazolium (NBT) reduction by superoxide anion radicals. When reactive oxygen 
species are formed, NBT is converted to a blue-colored formazan which shows an increased 
absorbance at 560 nm. In the presence of SOD which scavenges superoxide anion radicals, 
reduction of NBT is blocked. For phenotyping, soluble cellular protein samples are separated 
by gel electrophoresis and tested for SOD1 activity. SOD1 can be observed as unstained 
bands on the gel. SOD1 transgenic mice have an additional gene coding for human SOD and 
show one strong (homodimer of human SOD1) and one weak band (heterodimer of human 
SOD1 and mouse SOD1), homozygous SOD1-KO mice do not show any signal for SOD1 at 
all and can therefore be easily distinguished from wild type littermates which show one band 
(homodimer of mouse SOD1) (Fig. 6). 
For phenotyping, animals were labelled with a numbered earring clip to allow identification. 
A short piece of tail was cut off and a drop of blood from the wound transferred into a 1.5 ml 
Eppendorf tube containing 50 µl of lysis buffer. A XCELL Surelock Electrophoresis Cell 
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was set up with a 10 % Tris-Glycine gel (Novex precast gel), the electrophoresis apparatus 
filled with 1x running buffer. On a Parafilm strip 10 µl of 2x loading buffer and 10 µl lysated 
blood samples were mixed, and the samples loaded on the gel. Electrophoresis was 
performed for 45 min at 20 mA /gel. The gel was stained on a shaker with staining solution 
for 15 min and afterwards exposed to UV-light. After the reaction of NBT, the gel appeared 
blue, the areas of SOD activity remained white (Fig. 6). The results were recorded as 
photographic images. 
 
Figure 6: Detection of SOD1 after nitro-
blue tetrazolium/ staining. 
  
Lanes 1, 3, 7, and 8 show samples from wild- 
type animals, lanes 2+4 are samples from 
SOD1-KO mice, lanes 5+6 are samples from 
SOD1-TG mice. Active SOD1 can be detected 
as bright spots on the gel. 
 
 
  
 
 2x Loading buffer  
  Glycerol       1 ml 
  Bromophenol blue    1 mg 
  Upper gel buffer    1.25 ml 
  Demineralized water    6.75 ml 
 
Lysis buffer 
EDTA      1 mM 
NP-40      50 µg 
Demineralized water    ad 10 ml 
 
 1x Phosphate buffer 
  Potassium phosphate    62.6 g 
  Demineralized water    1000 ml 
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  Adjust to pH 7.8 
  
 1x Running buffer    
  Glycine     14.4 g 
  Tris       3.02 g 
  Demineralized water     1000 ml 
  
 Staining solution 
  Riboflavin     2 mg 
  0.5 M EDTA in demineralized water 20 µl 
  Nitro-blue tetrazolium (NBT)  16.4 g 
  TEMED     175 µl  
  Demineralized water    100 ml  
  
 Upper gel buffer  
  Tris      6.05 g 
  Demineralized water    100 ml 
  Adjust to pH 6.8 with 1 N HCl  
 
 
2.4.3. Intrastriatal 3-NP injection 
3-NP was freshly dissolved in saline (1 g in 28 ml) and the pH adjusted to 7.4 with 1 N 
NaOH. The solution was sterile-filtered and stored under argon until use. Throughout the 
surgery, maximal asepsis was achieved by using autoclaved instruments and disinfecting the 
surgery place with 70 % ethanol before each use. 
Mice (3 months, male, 35-40 g) were anesthetized with an initial dose of 5 % isoflurane/ 30 
% oxygen /70 % nitric dioxide and the anaesthesia was maintained with 2 % isoflurane/30 % 
oxygen/70 % nitric dioxide. After shaving their heads with an electric shaver and disinfection 
with iodine, the mice were placed in a small stereotactic frame and kept under anaesthesia 
using a face mask. They rested on a heating pad throughout the surgery and were covered 
with a blanket to avoid dropping of body temperature. Rectal temperature was monitored 
throughout the surgery and maintained at 37 ± 0.5ºC. After scalp incision on the midline, the 
skull was exposed and cleaned from tissue. Afterwards, a small piece of skull (Ø 1.5 mm) 
was removed by means of a hand-held drill and 3-NP was injected in the striatum (3.3 mm 
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deep, 2 mm lateral left, 0.5 mm anterior to the bregma) with a volume of 0.4 µl over a time 
of 4 min using a 5 µl Hamilton syringe fitted with a 30 gauge blunt-tipped needle which was 
held by a microinjection unit (Model 5000 Microinjection Unit, David Kopf Instruments). 
The needle was left in place for another 4 min before being removed. After the injection the 
drilled piece of skull bone was moved back into place, the skin wound was closed by a silk 
suture (6-0) and the animals kept on the heating pad until regaining consciousness.  
After surgery the animals were kept in a clean cage under controlled conditions (12 h 
light/dark circle, 23 ± 1°C, 55 ± 5 % humidity) and had free access to food and water. 
 
 
2.4.4. Removal of brains and subsequent paraffin-embedding  
3-NP treated animals were sacrificed with an overdose of isoflurane. Immediately after the 
respiration stopped, the thorax was opened allowing free access to the still beating heart. 
After opening the right atrium, the mice were transcardially perfused through the left 
ventricle of the heart with 50 ml heparinized saline (10 Units/ml) to clear the vessels from 
blood. For “floating” sections and paraffin-embedded tissue, animals were additionally 
perfused with 50 ml 3.7 % formalin in PBS. Animals were not perfused with formalin for 
preparation of frozen brain sections. Afterwards, the mice were decapitated with scissors, the 
skull opened and the brain removed with a spatula. Brains were differently processed 
afterwards for preparation of paraffin sections, frozen section or floating sections. 
For paraffin-embedding the brains were further processed as described in chapter 2.3.5., and 
6 µm sections in 150 µm intervals were prepared. Adjacent sections were used for 
myeloperoxidase (MPO)-immunohistochemistry and TUNEL staining. 
For immunohistochemistry brains were postfixed in 3.7 % formalin/PBS solution for 1 day, 
cut into 50 µM sections by vibratome (Vibratome 1000 Series, Technical Products 
International) and stored in PBS as “floating” sections. They were used for caspase-3 and 
caspase-9 immunohistochemistry. 
For frozen sections brains were rapidly frozen in –18°C methylbutane. By cryostat (Leica CM 
1800) they were cut into sections of 20 µM thickness in 300 µM intervals and transferred onto 
glass slides and used for assessment of the lesion after cresyl violet staining. 
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2.4.5. Cresyl violet staining of frozen sections and measurement of lesion size and edema 
Frozen sections were defrozen, air-dried at room temperature for 1 h, afterwards Nissl-stained 
with cresyl violet. The striatal lesions could be seen as pale, unstained area. For cresyl violet 
staining, sections were subjected to the following staining steps: 
 
Xylene 100 %  2 x 2 min 
Ethanol 100 %  2 x 1 min 
Ethanol 95 %  1 min 
Ethanol 70 %   1 min 
Demineralized water 2 x 3 min 
Cresyl violet solution 15 min 
Demineralized water 2 x 3 min 
Ethanol 70 %  30 sec 
Ethanol 90 %   1 min 
Ethanol 100 %  1 min  
Xylene 100 %  3 x 3 min 
 
After staining the sections were sealed with Permount and covered with coverslips. The area 
of injury was defined examining the stained sections under a light microscope and outlined on 
printouts. Ipsilateral hemisphere, contralateral hemisphere and area of striatal injury were 
measured on the printouts using an image analysis system (MCID). Lesion size was 
calculated as average % damage of ispsilateral hemisphere of 12 consecutive sections. The 
size of the edema was evaluated as average hemisphere enlargement in 4 defined core 
sections. 
 
 Cresyl violet solution: 
  Solution A:  Cresyl violet   0.15 g 
         Demineralized water  25 ml 
  Solution B:  Glacial acetic acid  1.69 ml 
    Demineralized water  150 ml 
  Solution C: Sodium acetate  2.72 g 
    Demineralized water  100 ml 
  (Combine solutions A, B and C) 
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2.4.6. Transferase-dUTP-Nick-End-Labelling (TUNEL-staining) 
The same protocol, as described in chapter 2.3.10., was used. 
 
 
2.4.7. Immunohistochemistry of caspase-3 and caspase-9 in floating sections 
Additionally to TUNEL-staining, immunohistochemistry of active caspase-3/9 enzymes was 
performed to detect apoptosis after 3-NP injection. Caspases are cystein proteases synthesized 
as inactive proforms and processed in cells undergoing apoptosis by self proteolysis or 
cleavage by another protease. The antibodies against active caspase-3 and caspase-9 used in 
this study had a 50-fold higher affinity towards the active forms than to the proforms. 
Formalin-fixed floating brain sections from 4 h, 24 h and 72 h time points were used for this 
staining. They were incubated with peroxidase block solution for 60 min and, afterwards,  
washed with PBS/0.1 % Triton-X -100 solution (PBS-TrX) 3 x 5 min, blocked with 20 % 
normal goat serum in PBS-TrX for 90 min and washed again 3 x 5 min with PBS-TrX. Brain 
sections were incubated with the primary antibody solution (1:100, polyclonal anti-caspase-3, 
active form, polyclonal anti-caspase-9, active form) in 0.5 % normal goat serum in PBS-TrX 
for 48 h at 4°C. Afterwards, the sections were washed 3 x 10 min with 1 % BSA /PBS-TrX 
and then incubated with the secondary antibody solution (1:300, biotinylated anti-rabbit IgG in 
1 % BSA/ PBS-TrX) for 1 h. After washing 3 x 10 min with 1 % BSA/PBS-TrX sections were 
incubated with ABC-AP solution (Vectastain ABC-AP Kit) for 30 min, washed 2 x 10 min 
with PBS and the labelling was visualized with Vector Red solution. The sections were 
washed twice with PBS, mounted on glass slides (Fisherbrand superfrost/Plus microscope 
slides, precleaned) and dried over night at room temperature. 
The next day, they were counterstained with methyl green for 5 min, dehydrated (washed 3 x 
20-30 sec in demineralized water, 3 x 20-30 sec in butanol 100 % and 3 x  5 min in xylene 100 
%) and sealed with Permount using glass coverslips. Sections were examined under light and 
fluorescence microscopy using a rhodamine filter (Axioplan 2 Imaging microscope, 
Axiovision software). Digital pictures of the lesion were taken. 
  
 ABC-AP solution 
  Solution A     2 drops 
  Solution B     2 drops 
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  PBS      10 ml 
 (Combine solution A and PBS, mix well, add solution B, mix well, incubate 30 
min before use)  
  
 Peroxidase block solution 
  Sodium azide      0.33 g 
  H2O2 30 % (freshly added)   0.33 ml 
  Triton-X 100     0.1 ml 
  PBS       ad 100 ml 
 
  Vector Red solution 
  Reagent 1     2 drops 
  Reagent 2     2 drops 
  Reagent 3     2 drops 
  100 mM Tris-HCl in demineralized  
  water, pH 8.2-8.5    5 ml 
 (Add reagent 1-3 to 5 ml of 100 mM Tris-HCl, pH 8.2 - 8.5 buffer and mix well 
after each step) 
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2.5. PP2C/Oleic acid experiments 
2.5.1. Animals 
Fischer-344-rats from domestic breeding were used for primary mixed hippocampal cultures 
from neonatal rats (day 1). Animals were held under controlled conditions (12 h light/dark 
circle, 23 ± 1°C, 55 ± 5 % humidity) and had free access to food (Altromin, Germany) and 
water. 
For establishment of primary embryonic cortical cultures, pregnant G18 Sprague-Dawley rats 
were obtained from Charles River (Charles River Wiga, Sulzfeld, Germany). Embryonic 
cortices were prepared from 18 days old embryos. 
 
 
2.5.2. Preparation and cultivation of embryonic cortical neurons 
All procedures were performed under sterile conditions. All instruments, trypsin and trypsin 
inhibitor were UV-sterilized; solutions were sterile-filtrated before use. All preparations were 
performed in a laminar flow hood. 
Pregnant rats were deeply-anesthetized with halothane and killed by dislocation of the neck. 
They were disinfected with 70 % ethanol, their abdomen opened with scissors and the uterus 
containing the embryos removed. The embryos’ skulls were opened with scissors, the brains 
gently removed with tweezers and kept in cold 1x HBSS. The cortices were dissected under a 
stereomicroscope and afterwards incubated in 1xHBSS supplemented with 1mg/ml trypsine 
for 15 min. Afterwards the supernatant was removed, the cortices incubated with 1mg/ml 
trypsin-inhibitor/HBSS 1x for 2 min. Then they were washed with 10 ml HBSS 1x and gently 
triturated 20 x in 4 ml HBSS 1x with a 10 ml glass pipette. After trituration, the cell 
suspension was diluted to 10 ml and transferred into a 50 ml falcon tube excluding bigger 
tissue fragments. The suspension was diluted 1:2 with HBSS 1x, centrifuged at 1000 
rounds/min for 5 min and the pellet dissolved in 20 ml HBSS medium. For preparation of 60 
mm dishes, this suspension was seeded at 4 * 104 cells/cm2 density in PEI-coated Petri dishes 
filled with 2 ml MEM+. For 35 mm diameter Petri dishes the suspension was diluted 1:2 with 
MEM+ and seeded at a 4 * 104 cells/cm2 density in PEI-coated Petri dishes filled with 2 ml 
MEM+. After 5 hours the medium was changed from MEM+ to Neurobasal medium pH 7.2 
washing the cells once with Neurobasal medium pH 7.2. At day 5 after seeding the medium 
was changed to fresh medium. Cultures from this preparation contained should contain over 
95 % neurons and less than 5 % astrocytes according to Mattson et al., 1993.  
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 HBSS stock 
  KCl      4 g 
  KH2PO4     0.06 g 
  NaCl      80 g 
  NaH2PO3     3.5 g 
  Na2HPO4     0.6 g  
  D-Glucose     10 g 
  Phenol red     0.1 g 
  Demineralized water    ad 1 l 
 
 HBSS,  pH 7.2 
  HBSS stock     50 ml 
 HEPES     1.2 g 
 B-27 supplement, 50x   10 ml 
 Gentamicin     5 mg 
 Demineralized water    ad 500 ml 
 
 Minimal Essential Medium pH 7.2 (MEM+) 
  MEM      4.695 g 
  HEPES     0.119 g 
  NaHCO3     1.1 g 
  Glucose     5.0 g 
  Fetal calf serum    50 ml 
  KCL      0.605 g 
  Pyruvate     0.06 g 
  L-Glutamine     0.088 g 
  Gentamicin     5 mg 
  Demineralized water    ad 500 ml 
 
 Neurobasalmedium pH 7.2 (for embryonic cortical neuronal culture) 
  Neurobasal     500 ml 
  HEPES     0.573 g 
  L-Glutamine     0.088 g 
  Gentamicin     5 mg 
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  B-27 supplement    10 ml 
 
 
PEI coating of Petri dishes 
Petri dishes were coated with PEI solution for 2 h at room temperature (Ø 35 mm: 1 ml; Ø 60 
mm: 2 ml). Afterwards they were washed thrice with 1.5-2 ml sterile, demineralized water. 
Dishes were opened and allowed to dry under UV light for 30 min in the laminar flow hood. 
They were filled with MEM+ (Ø 35 mm: 1 ml; Ø 60 mm: 2 ml) and incubated at 5 % CO2/ 
37°C over night. 
  
 Borate buffer 
  Boric acid     1.24 g 
  Sodium tetraborate    1.9 g 
  Demineralized water    ad 400 ml 
  Adjust to pH 8.4 
 
 PEI solution 
  PEI 5 %     0.4 ml 
  Borate buffer     400 ml 
 
 PEI 5 % 
  PEI 50 %      1:10 in demineralized water 
 
 
2.5.3. Primary mixed hippocampal cultures from neonatal rats 
Cultured hippocampal cells were prepared from neonatal (day 1) Fischer 344 rats as described 
previously (Sengpiel et al., 1998). Pups were disinfected with 70 % ethanol and decapitated 
with scissors. After opening the skull with small scissors, the brains were removed with a 
spatula and immediately placed into a Petri dish containing 37°C solution 1. Brains were 
dissected in a Petri dish coated with solid paraffin, the hippocampi were removed, cleaned 
from blood vessels and transferred into solution 2. They were incubated at 37°C in a water 
bath for 20 minutes and gently shaken. Afterwards, solution 2 was removed, the hippocampi 
were washed with cell culture medium and gently triturated 3 times with a fire-polished 
Pasteur pipette in 2 ml cell culture medium. After each trituration the triturated tissue was 
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allowed to sediment until the supernatant became free of visible pieces of tissue. The clear 
supernatants were combined by transferring them into solution 3. 
Solution 3 containing the cells was centrifuged at 1000 x g for 10 minutes and the pellet 
gently resuspended in cell culture medium. Cells were seeded in poly-L-lysine-coated Petri 
dishes with 35 mm diameter or 24-multiwell plates containing Neurobasal cell culture 
medium pH 7.2 to an approximate density of 2*104 cells/cm2. Cultures were incubted in a 
humidified 5 % CO2/95 % air atmosphere for one week, medium was changed to fresh 
Neurobasal cell culture medium at day 4 and cultures treated on day 7 or 8. The culture 
prepared after this protocol is expected to contain approximately 40 % astrocytes and 60 % 
neurons (Ravati, thesis, 2001). 
 
Media for preparation of neonatal hippocampal mixed culture: 
 
 Neurobasal medium pH 7.2 (for primary hippocampal mixed culture)   
 Neurobasal     100 ml 
 B27 supplement    2 ml 
 L-Glutamine (50 mM)   1 ml 
 Penicillin-streptomycin solution  5 ml 
       
 Solution 1     
 Bovine serum albumin   30 mg 
Neurobasal medium pH 7.2   150 ml 
 
Solution 2     
 Papain      30 mg 
 Bovine serum albumin   30 mg 
 Neurobasal medium pH 7.2   150 ml 
 
Solution 3      
Bovine serum albumin   500 mg 
Trypsin inhibitor    500 mg 
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Poly-L-lysine coating of Petri dishes 
The poly-L-lysine solution was sterile-filtrated, each Petri dish (35 mm diameter) filled with 2 
ml (1 ml for each well in 24-multiwell) solution and incubated over night at RT. The 
following day the dishes were washed 4 times with sterile demineralized water over a period 
of at least 5 hours and dried afterwards. Shortly before preparation the Petri dishes were 
loaded with 2 ml Neurobasal medium (1 ml Neurobasal cell culture medium for each of 24-
multiwell) and stored in an incubator at 37°C at 5 % CO2/95 % air atmosphere to let pH and 
temperature adjust. 
 
Poly-L-lysine solution 
 Poly-L-lysine (MG 300,000-700,000)  1 mg 
 Boric acid solution in demineralized  
 water (1.25 %)    5 ml 
 Sodium tetraborate solution in  
 demineralized water (1.91 %)  5 ml 
 
   
2.5.4. Trypan blue staining 
Viability of the cultured neurons was determined by Trypan blue staining. Trypan blue, a 
hydrophilic azo-dye can permeate cellular membranes; however, intact cells export the dye 
actively and remain unstained. Under damaging conditions cell membranes as protective 
barriers can become more permeable while the cells are not able to maintain the active 
removal of the dye which results in blue staining of the cytosol. Intact, unstained cells can be 
easily distinguished from damaged, blue-stained cells. 
The medium of the cell cultures was removed and replaced  by  50 %/50 % Trypan blue 
solution/ Neurobasal medium pH 7.2 which had been warmed up to 37°C. They were kept in 
the incubator at 37°C/5 % CO2 for 20 minutes, washed 3 times with PBS and fixed with 
formaldehyde-phosphate-buffer 4 % for 30 min. Afterwards they were washed with PBS 
twice and blue-stained/all cells were counted in 5 representative subregions per dish in at least 
4 dishes per group. Cell damage was expressed as percentage of Trypan blue-positive cells. 
The groups were compared statistically, ANOVA and Scheffé tests were performed, P-values 
≤ 0.05 were considered to be significant.  
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 Formaldehyde-phosphate-buffer 4 %     
 NaH2PO4     9.39 g 
  Na2HPO4     71.2 g 
  Formaldehyde 37 %    500 ml 
  Demineralized water     ad 5000 ml 
 
 PBS (Phosphate buffered saline) solution 
  NaH2PO4     9.39 g 
  Na2HPO4     71.2 g 
  Demineralized water    ad 5000 ml 
  
 Trypan blue solution 
  Trypan blue     400 mg 
  NaCl      810 mg 
  K2HPO4     60 mg 
  Demineralized water    100 ml 
 
 
2.5.5. Quantification of apoptosis in neuronal culture 
Hoechst-33258, a lipophilic, cationic dye permeates the cell membranes of intact and 
degenerated cells and stains nuclear DNA by binding to the minor groove of DNA at AT-rich 
sequences. This staining allows distinction between cells with intact nuclei and apoptotic cells 
with nuclei showing a clearly reduced size, chromatin condensation (visible as intensified 
fluorescence), and fragmentation. After washing the cells with ice-cold PBS once to remove 
the medium, they were fixed with ice cold 4 % formalin in PBS for 30 min at RT. Cells were 
observed under a light microscope to examine the cell morphology and representative 
photographs were taken. Afterwards, cells were incubated with a methanolic solution of 
Hoechst-33258 (10 µg/ml) for 30 minutes in darkness. They were washed with PBS once and 
stored in darkness until cell counting. Nuclear morphology of neurons was observed under a 
fluorescence microscope (Axiovert 100, Zeiss) or confocal laser scanning microscope (LSM, 
510, Zeiss) at an excitation wave length of 350 nm and an emission wavelength of 450 nm. 
Cells with shrunken nuclei, chromatin condensation (visible as intense blue fluorescence) and 
nuclear fragmentation were considered apoptotic. In each Petri dish 5 different representative 
subregions were chosen and in each field the number of neurons with apoptotic features as 
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well as the total number of neurons were recorded. Apoptosis was expressed as percentage of 
apoptotic cells. Statistical analysis was performed by using ANOVA followed by Scheffés 
post-hoc test. A P-value < 0.05 was considered significant. 
  
 PBS (Phosphate buffered saline) solution -> as in 2.5.4. 
 
 
2.5.6. Nile blue-staining of lipid droplets in neuronal culture 
Nile blue is a dye comprising two components: a red oxazone which dissolves in neutral 
lipids and a blue oxazine which is basic and reacts with phospholipids and free fatty acids. 
When dissolved in phospholipids/free fatty acids, the blue dye shows orange fluorescence at 
488/525 nm.  After fixation of the cell cultures with formalin for 30 min, they were washed 
with PBS and stained with 10 µg/ml solution Nile red solution/PBS for 2 h. After washing the 
cells 3 times with PBS, they were counterstained with water-based fluorochrome Hoechst 
33258 (10 µg/ml) solution for 30 min, washed 3 times with PBS and observed under laser 
scanning-microscope. (LSM, Zeiss). Representative pictures were taken. 
  
 Formaldehyde-phosphate-buffer 4% -> as in 2.5.4. 
 PBS (Phosphate buffered saline) solution -> as in 2.5.4 
 
 
2.5.7. Protein quantification 
Protein concentration of Western blotting samples was measured by the BCA kit (Micro BCA 
Protein Assay Reagents) for equal loading of gels. The principle of this protein quantification 
is the measurement of the absorption of the purple polypeptide-bichinchonic acid-Cu1+ 
complex. BSA standard solutions were prepared from a BSA stock (2 mg/ml) at 
concentrations of 1, 2, 3, 4, 5, 10, 20, and 40 µg/µl. Standards (5 µl) and samples (5 µl) and 
PBS were mixed with working solution of the BCA kit containing a mixture of 10 ml reagent 
A, 10 ml reagent B and 200 µl reagent C. After incubation for 1 hour at 60°C, 200 µl of each 
sample or standard was transferred onto a microtiter plate and the absorbance was measured 
at 562 nm using a photometric multiplate reader. The protein concentrations of the samples 
were calculated from the BSA standard curve.   
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Reagent A ®    
 Sodium carbonate 
Sodium bicarbonate 
 Sodium tartrate 
Sodium hydroxide    0.2 N 
 
 Reagent B®      
  Aqueous solution of Bichinchonic acid 0.4 % 
 
 Reagent C ®    
  Copper sulfate    4 % 
 
Albumin standard    
  Bovine serum albumin (BSA)  2 mg/ml 
  Sodium chloride    0.9 % 
  Sodium azide     0.05 % 
 
 
2.5.8. Western blotting analysis 
Cultured cells were washed with ice-cold PBS and collected with extraction buffer on ice. 
They were gently triturated through a 25G needle and kept on ice for 30 min before being 
stored at -80°C. By the high SDS concentration of the lysis buffer and the trituration through 
a needle the cells were lysed. The protein concentration of the lysates was measured using the 
BCA protein assay kit. Equally protein amounts of samples of lysates (ranging from 15-50 
µg/lane) were first incubated in sample buffer for 5 min at 95°C and, then, loaded and 
separated on a 15 % SDS-polyacrylamide gel. After electrophoresis, the gel as well as 4 filters 
and a nitrocellulose membrane were soaked in blotting buffer II for 5 min, 4 sheets of filter 
paper each in blotting buffer I and III. The filter papers, the gel, and the membrane were 
stacked on the blotter in the following order:  
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The proteins were blotted onto nitrocellulose membranes for 30 minutes at 250 mA. Uniform 
and complete protein transfer was monitored by staining of the membranes with Ponceau S 
solution for 5 min on a shaker. Afterwards, the membranes were washed with washing buffer 
until total removal of Ponceau S staining and blocked with blocking buffer for 1 hour at room 
temperature. After 3 times washing for 5 min with washing buffer, the membranes were 
incubated with primary antibody solutions overnight at 4°C. The next day, blots were washed 
three times for 5 min with washing buffer and incubated with secondary antibody solutions 
for 1 h at room temperature. Before the detection, the membranes were washed 3 times 15 
minutes with washing buffer, afterwards they were incubated in enhanced chemiluminescence 
solution for 1 min, put on a glass plate and covered with saran wrap. The blots were then 
exposed to a film. Exposure time varied depending on the intensity of the signals. The films 
were developed in developer solution until signals were visible. Afterwards, they were 
washed in tap water for 10 seconds, fixed in fixative solutions, washed in tap water, and dried. 
For detection of several proteins on the same blot, membranes were stripped, as follows, 
before incubation with a new primary antibody: Membranes were washed 3 x 10 min with 
washing buffer and incubated in stripping buffer for 30 min at 60 °C on a shaker and washed 
again 3 x 15 min. Then the stripped membrane could be used for a second detection starting 
with the blocking of the membrane. 
 
 Blocking buffer   
  BSA      2 g 
  Dry milk powder    5 g 
  Washing buffer pH 7.6   ad 100 ml 
 
 Blotting buffer I   
  Tris      18.17 g 
  Methanol     100 ml 
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  Demineralized water    ad 500 ml 
 
Blotting buffer II          
 Tris      1.82 g 
  Methanol     100 ml 
  Demineralized water    ad 500 ml 
 
 Blotting buffer III   
  Tris      1.51 g 
  Methanol     100 ml 
  Amino-n-caproic acid   2.62 g 
  Demineralized water    ad 500 ml 
  
 Collecting gel     
 Gel buffer 2     8 ml 
 Demineralized water    5 ml 
 Acrylamide/Bisacrylamide   3 ml 
 Ammonium persulfate 10 % in  
 demineralized water    30 µl 
 TEMED     60 µl 
  
 Electrophoresis buffer  
  Tris      3 g 
  Glycine     14.4 g 
  SDS      1 g 
  Demineralized water    ad 1 l 
 
 Extraction buffer   
 Glycerol      1 ml 
 SDS 10 % in demineralized water   3 ml 
 Tris 0.5 M, pH 6.8 in demineralized  
 water      2.5 ml 
 PMSF       1 mM 
 Calpain inhibitor    1 µM 
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 Trypsin inhibitor    7 µg/ml 
 Demineralized water    ad 10 ml 
 
 Gel buffer 1 
  Tris      72.8 g 
  SDS      1.6 g 
  Sodium azide 5 %    4 ml 
  Demineralized water    ad 400 ml 
  (adjust to pH 8.8 with 1 N HCl) 
 
 Gel buffer 2 
  Tris      12.1 g 
  SDS      0.8 g 
  Sodium azide 5 %    2 ml 
  Demineralized water    ad 200 ml 
  adjust to pH 6.8 with 1 N HCl 
 
 Loading buffer   
Glycerol      1 ml 
 SDS 10 % in demineralized water  3 ml 
 2-Mercaptoethanol    2.5 ml 
 Bromophenol blue 0.05 % in demineralized  
 water      2.5 ml 
 Tris 0.5 M, pH 6.8, in demineralized  
 water      2.5 ml 
 
 PBS (Phosphate buffered saline) solution -> as in 2.5.4. 
 
 Ponceau red solution   
  Ponceau S     0.4 g 
  Trichloracetic acid    3 g 
  Demineralized water    ad 200 ml  
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 Primary antibody solutions  
  1) Anti-Bad-155P (rabbit, polyclonal, Cell Signaling), 1:400 in 5 % BSA/ 
  washing buffer 
 2) Anti-Bad (rabbit, polyclonal, Cell Signaling), 1:400 in 5 % BSA/washing 
buffer 
 3) Anti-PP2Cβ (rabbit, polyclonal, Klumpp lab), 1:1000 in 0.1 % BSA/ 
 washing buffer 
 4) Anti-α-tubulin (mouse, monoclonal, Sigma), 1:10, 000 in blocking buffer 
 5) Anti-caspase-3 (rabbit, polyclonal, Promega), 1:400 in blocking buffer 
 
 15 % SDS-polyacrylamide gels (10 pieces)  
 Gel-buffer 1     15 ml 
Demineralized water    15 ml 
Acrylamide /Bisacrylamide   30 ml 
 Ammonium persulfate 10 % in  
 demineralized water    50 µl 
TEMED     100 µl 
 
Secondary antibody solutions 
  1) When using rabbit primary antibody solutions: horseradish-peroxidase-
  conjugated anti-rabbit IgG (Amersham or Promega), 1:2000 in blocking buffer 
  2) When using mouse antibody solutions: horseradish-peroxidase-conjugated 
  anti-mouse IgG (Amersham or Promega), 1:2000 in blocking buffer 
 
 Stripping buffer 
  SDS      8 g 
  Tris HCl     3.958 g 
  2-Mercaptoethanol    2.8 ml 
  Demineralized water    ad 400 ml 
 
 Washing buffer (pH 7.6)  
  Tween 20     1 ml 
  PBS      ad 1 l 
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2.5.9. Phosphorylation of Bad by cA-PK 
As a positive control for Bad-155P in Western blots and in order to facilitate the detection of 
Bad-155P bands in protein extracts of primary cultures, recombinant Bad-GST and samples 
of embryonic cortical neuronal cultures were phosphorylated in vitro.  
Bad-GST or samples were incubated with the phosphorylation solution for 30 min at 30 °C 
and stored at -20°C until use.  
 
 Phosphorylation solution added to 1 µl Bad-GST (3.4 µg/µl) 
  Buffer 1     1 µl 
  1 mM ATP     1 µl 
  150 mM MgCl2 in demineralized water  1 µl 
  cA-PK (1µg/µl)    1 µl 
  Demineralized water    5 µl 
 
 Phosphorylation solution added to 9 µl sample (4 µg/µl)   
  Buffer 1     1 µl 
  1 mM ATP     2 µl 
  150 mM MgCl2 in demineralized  water  1 µl 
  cA-PK (1µg/µl)    2 µl 
  
 Buffer 1 
  1 M MOPS in demineralized water, pH 7.2 80 µl 
  1M ß-Glycerophosphate in  
  demineralized water    100 µl 
  500 mM EGTA in demineralized water 40 µl 
  Mercaptoethanol    4 µl 
  Demineralized water    ad 1000 µl 
          
 
2.5.10. Immunohistochemistry of PP2Cβ in embryonic cortical neurons 
To explore the intracellular distribution of PP2Cβ in neurons, embryonic cortical neurons 
were immunocytochemically stained for PP2Cβ after counterstaining with Hoechst-33258 for 
nuclear localisation. Embryonic cortical neurons, cultured on 25 mm glass coverslips, were 
washed with ice-cold PBS once to remove the medium and then fixed with ice-cold 100 % 
  63
methanol for 30 min at RT. Afterwards, they were incubated with a methanolic solution of 
Hoechst-33258 (10 µg/ml) for another 30 minutes in darkness, washed 3 x 5 min with PBS 
and dried for 1 h at 60°C. The coverslips were circled by a Pap pen and the cells blocked with 
blocking buffer for 30 min to avoid unspecific binding. Over night the cells were incubated 
with the primary antibody solution at 4°C. The next day, they were washed 3 x 5 min with 
PBS and exposed to the secondary solution for 30 min at room temperature in the dark. Then 
they were washed again 3 x 5 min with PBS and Oregon green solution was applied for 1 h in 
darkness at RT.  Coverslips were washed 3 x 5 min with PBS, removed from the Petri dishes, 
turned over on a glass slide which was moistured with PBS and fixed with varnish. 
Immunostaining was evaluated using confocal laser scanning microscopy which allowed 
precise localisation of intracellular immunostaining. Cells were excited at 350 nm by an UV 
laser to detect Hoechst 33258 staining and an Argon laser to detect the Oregon green dye used 
for PP2Cβ immunohistochemistry. Data and images of stained neurons were analyzed by 
Zeiss Image Browser software. Negative controls without incubation with the primary 
antibody were used to evaluate the intensity of the staining. 
 
 Blocking Buffer 
  Goat serum     5 ml 
  PBS      ad 100 ml 
 
 Oregon green solution (90 µl per coverslip) 
  Streptavidin-Oregon green dye  6 µl 
  PBS      ad 1 ml 
 
 PBS (Phosphate buffered saline) solution -> as in 2.5.4 
 
 Primary antibody solution (70 µl per coverslip) 
  PP2Cβ antibody    1 µl 
  Goat serum     8 µl 
  PBS      ad 200 µl 
  
 Secondary antibody solution (70 µl per coverslip) 
  Biotinylated anti-rabbit IgG   1 µl 
  Goat serum     8 µl 
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  PBS      ad 200 µl 
 
 
2.5.11. Drug treatment of rat primary cultures  
The damaging effect of oleic acid, elaidic acid (“trans-oleic acid”), and ginkgolic acids was 
examined in primary cultures of embryonic cortical and neonatal hippocampal neurons. Since 
the damaging properties of oleic acid varied depending on the composition of the culture 
medium, three different culture media were tested:  
 
a)  Neurobasal without B27 supplement (NB-B27) 
 b)  Neurobasal with B27 supplement (NB+B27)  
 c)  Neurobasal with B27 without antioxidants (AO) supplement (NB+B27 –AO) 
    
 Neurobasal (NB) culture medium for embryonic cortical culture  
  Neurobasal®     500 ml 
  HEPES     0.5725 g 
  Glutamine     0.088 g 
  Gentamicin sulfate    0.0125 g 
 …. .………………………………………………………............ 
  alternatively added: 
  - in NB-B27:             none 0 ml 
  - in NB+B27:   +B27 supplement  10 ml 
  - in NB +B27-AO: +B27-AO supplement 10 ml 
 
 
 Neurobasal culture medium for neonatal  hippocampal culture 
  Neurobasal®     100 ml 
  L-Glutamine (50 mM)   1 ml 
  Penicillin-Streptomycin   5 ml 
 ………………………………………………………………… 
  alternately added: 
  in NB-B27:             none 0 ml 
  in NB+B27:   +B27 supplement  2 ml 
  in NB +B27-AO: +B27-AO supplement 2 ml 
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B27 supplement         B27-AO supplement 
  Biotin      Biotin     
  BSA fraction V    BSA fraction V 
  Catalase     L-carnithine 
  L-carnithine     Corticosterone 
  Corticosterone    Ethanolamine 
  Ethanolamine     D-Galactose 
  D-Galactose     Insulin, recombinant, human 
  Insulin, recombinant, human   Progesterone 
  Linolic acid     Putrescine 
  Linolenic acid     T-3 Albumin 
  Progesterone     Transferrin 
  Putrescine 
  Sodium selenite 
  Superoxide dismutase 
  T-3 albumin 
  DL-Tocopherol 
  DL-Tocopherol acetate 
  Transferrin 
  Vitamin-A acetate 
 
 
1) Treatment of primary cultures with oleic acid/DMSO  
Oleic acid, an unsaturated C-18 fatty acid (18:1 cis-∆9), is a light- and oxygen-sensitive oily 
liquid. It was stored in frozen aliquots at -70°C under a mixture of nitrogen/CO2 to avoid 
oxidation of the substance during storage. For each treatment a fresh aliquot was thawed. 
Since oleic acid is highly lipophilic, almost insoluble in water, it had to be dissolved in 
DMSO to increase solubility before adding it to the culture medium. The amount of DMSO in 
the culture medium was kept constant at a final concentration of 0.1 % (V/V) to avoid effects 
caused by DMSO which is known to have radical scavenging properties while the 
concentration of oleic acid varied from 1 µM to 150 µM. 
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In all experiments d7/8 primary embryonic cultures of cortical neurons or d7/8 primary 
hippocampal mixed cultures were used. They were washed with 37°C Neurobasal culture 
medium (either NB+ B27, NB-B27 or NB+B27-AO).  
Oleic acid was dissolved in DMSO, vortexed thoroughly, and immediately diluted in 37°C 
Neurobasal culture medium to a final concentration of 0.1 % DMSO. Despite the use of 
DMSO as a detergent and vortexing for 1 min, oleic acid was not fully soluble in culture 
media at concentrations higher than 100 µM (Neurobasal with B27) or 50 µM (Neurobasal 
without B27, with B27 without AO). The medium was removed from the cultures and the 
oleic acid/medium solution put on the cells. At different time points ranging from 1 h to 72 h 
the incubation was stopped either to stain the cells (-> Hoechst-33258 staining, Trypan blue 
staining, Nile blue staining) or to harvest the cells for protein extraction.  
 
2) Treatment of cell cultures with oleic acid/β-cyclodextrin  
Since oleic acid was not entirely soluble in cell culture media at 100 µM/0.1 % DMSO and 
known to be light- and oxygen-sensitive, β-cyclodextrin was employed overcome problems of 
stability and solubility. β-Cyclodextrin is a cyclic oligosaccharide consisting of 7 
glucopyranose units. It is doughnut-shaped and contains an electron-rich, hydrophobic cavity 
(Fig. 7). Hydrophobic molecules, like oleic acid, are incorporated into the cavity of 
cyclodextrins by displacing water. This reaction is favored by the repulsion of the 
hydrophobic molecule by water. This effectively encapsulates the molecule within β-
cyclodextrin, rendering it water-soluble. When the water soluble complex is diluted in a much 
larger volume of aqueous solvent, like the cell culture medium, the process is reversed, 
thereby releasing oleic acid. Incorporated in β-cyclodextrin, oleic acid is stable against 
oxidation when stored at 4°C. 
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Figure 7:  Structure of β-cyclodextrin 
 
Sterile-filtered stock solution of 0.1 M oleic acid/ 9.3 % β-cyclodextrin in demineralized 
water was diluted in Neurobasal culture medium with B27 to working concentrations ranging 
from 10 µM to 200 µM oleic acid. β-cyclodextrin stock solution (9.3 %) was used as a 
control. The culture medium replaced by this solution, and at different time points the 
incubation was stopped either to stain the cells (with Hoechst 33258) or for protein extraction. 
 
 
3) Treatment with elaidic acid (“trans-oleic acid”) 
Elaidic acid, an unsaturated C-18 fatty acid (18:1 trans-∆9) and, therefore, the trans-isomer of 
oleic acid, is a solid substance known to be light- and air-sensitive. It was stored in the dark at 
– 20°C. This substance was applied to primary cultures of embryonic cortical neurons at a 
working concentration of 150 µM elaidic acid/0.1 % DMSO. Almost insoluble in water like 
oleic acid, it was freshly dissolved in pure DMSO to a 0.15 M stock solution this stock later 
dissolved 1:1000 in Neurobasal culture medium without B27 (NB-B27). Like oleic acid, it 
was not fully soluble in NB-B27 at this concentration. The cells were washed with NB-B27 
once before treatment with elaidic acid. After treatment for twenty-four hours the cells were 
stained with Hoechst 33258 to detect neuronal apoptosis and, in addition, morphologically 
examined using a light microscope. 
 
 
4) Treatment with ginkgolic acids 
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Ginkgolic acids, isolated from Ginkgo biloba leaves and seeds, are long-chain benzoic 
derivatives. We used ginkgolic acids composed of 4 different salicylic acid derivatives which 
had the following alkyl residues: C13:0 (11 %), C15:0 (4 %), C15:1 (43 %), C17:1 (39 %). 
These ginkgolic acids had a mean molecular weight of 347 g/mol. Before treatment, fresh 
stock solutions of ginkgolic acids in pure DMSO were prepared and dissolved 1:1000 in 
Neurobasal medium with B27. The end concentration of DMSO was 0.1 % while ginkgolic 
acids ranged from 10 µM - 250 µM.  After removal of the old medium the cultures were 
treated with the cell culture medium containing ginkgolic acids. At different time points the 
treatment was stopped, either to extract proteins for Western blots, or to perform Hoechst-
33258 or Trypan blue staining. 
 
5) Treatment with Staurosporine  
As a control for induction of neuronal apoptosis, we used staurosporine, a non-selective 
protein kinase inhibitor that has been shown to induce apoptosis in cultured neurons. 
We treated primary cultures with 200 nM staurosporine/0.1 % DMSO in Neurobasal medium 
with B27 or in Neurobasal medium without B27. Staurosporine was stored as a 1 mM stock 
solution in DMSO at -20°C; aliquots were diluted to 1:5 in DMSO to a concentration of 200 
mM staurosporine and this solution dissolved 1:1000 in culture medium to an end 
concentration of 200 nM staurosporine/0.1 % DMSO. Eight or twenty-four hours later the 
treatment was stopped and Nile blue staining or Hoechst-33258 staining performed on the 
cells. 
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2.6. Statistics 
Statistically analyses of the results were performed as follows: 
1) CIBT experiments: 
Infarct areas, edema levels and O2-. production were analysed using one way analysis of 
variance (ANOVA) followed by Student t-test. All data were expressed as mean ± standard 
error of the mean (SEM); a P value < 0.05 was considered significant. Three stars (***) in 
graphs indicate a significance level of P < 0.001, two stars (**) a significance of P < 0.01, one 
star (*) a significance of P < 0.05. The TUNEL and MPO data were analysed using 
generalized linear models for nested factorial design. The analysis was run using SAS 
software (v 8., SAS Institute, Cary, NC, USA). Model main effects were animal type, time 
and area. The hemorrhage data were analysed using a non-parametric method for ranked data.  
 
2) 3-NP experiments and PP2C experiments 
For all data of lesion areas and edema levels in 3-NP experiments and data of cell damage and 
apoptotic cell counts in PP2C experiments one way analysis of variance (ANOVA) with 
subsequent Scheffé (*) or Duncan (+) test was employed. Statistics were performed using 
Microsoft Excel and WinSTAT. All results are expressed as mean ± standard error of the 
mean (SEM) (3-NP experiments) or ± standard deviation (SD) (PP2C/oleic acid experiments). 
Significant differences between groups were considered significant at values P < 0.05 
(indicated as * or +), P < 0.01 (** or ++) and P < 0.001 (*** or +++). 
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3. Results 
3.1. Effect of SOD2-reduction on cold injury-induced brain trauma 
3.1.1. Lesion size and edema development in SOD2-KO mice and wild-type animals 
Edema formation correlating with blood brain barrier (BBB) breakdown in the lesion and 
lesion size indicating the expansion of the lesion into the cortex are two parameters which 
reflect the degree of tissue damage after induction of cold injury brain trauma. To detect 
possible differences in these parameters, brain sections of SOD2-KO animals and their wild- 
type littermates following CIBT (as described in chapter 2.3.4.) were stained with 
hematoxylin & eosin (H&E) which allowed detection of damaged tissue as a pale area when 
compared to undamaged tissue. The lesion area was determined on printouts of recorded 
photomicrographs. Percentage hemisphere enlargement (= edema formation) and percentage 
damage ipsilateral hemisphere were calculated (lesion size). A total number of 8-11 animals 
per group were analyzed. There was no difference in lesion size between SOD2 KO animals 
and wild-type (WT) mice at any of the time points 24 h, 72 h and 7 days (Fig. 8A). Lesion 
size remained constant between 1 and 3 days post-CIBT followed by a significant decrease at 
7 days due to tissue loss. There were also no significant differences in edema formation 
between WT and SOD2-KO mice at the time points examined. In both groups edema 
gradually decreased from 1 day to 7 days (Fig. 8B).  
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Figure 8A+B: Lesion size and edema formation in SOD2-KO mice and WT animals 
A) Percentage area of damage (lesion size) for the affected hemisphere in wildtype (WT) and 
Mn-superoxide dismutase knockout mice (SOD2-KO) was calculated at 1, 3 and 7 days 
following cold injury-induced brain trauma (CIBT). By 7 days post-CIBT, both WT and 
SOD2-KO showed a significant reduction in lesion size compared to 1 and 3 days. 
B) Edema formation was significantly reduced in both animal groups by 3 and 7 days 
compared with 1 day. 
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3.1.2. Hemorrhagic transformations followed the same pattern in WT and SOD2-KO 
mice 
Hemorrhagic transformations were used as an indicator for alterations of the blood brain 
barrier which have been described to appear after CIBT. Both grade and distribution of 
hemorrhagic transformation were examined at 24 h, 72 h and 7 days in CIBT-treated SOD2-
KO mice and WT littermates using Perl’s Iron staining (-> 2.3.8.).  
 
A) Comparison of grade of hemorrhagic transformation in WT and SOD2-KO mice 
Hemorrhagic transformations in the cold injury-induced lesions were detected by Perl’s Iron 
staining in SOD2-KO and WT animals and degree of hemorrhagic transformations graded 
(Table 1).  
   
  Score  0 1 2 3  4 
 
          Number of animals 
 
  WT  
 1 d 3 4 1 0 0 
 3 d 0 0 0 5 3 
 7 d 0 0 0    5    4 
  
  SOD2-KO 
1 d 5 3 1 2 0 
 3 d 0 0 0 5 6 
 7 d 0 0 0 4 4 
 
Table 1. Hemorrhage scores in SOD2-KO and WT mice after CIBT 
Scores: Grade 0, no bleeding; grade 1, very minor Perl iron staining restricted to a small 
area in <25 % of all sections examined; grade 2, some staining restricted to the injured area 
in 26-50 % of sections; grade 3, extensive staining encompassing entire injured region in 51-
75 % of sections; grade 4, extensive staining within and outside of the injured area in more 
than 76 % of sections. 
 
A non-parametric method for ranked data was used for statistical analysis of the score results. 
The statistical analysis revealed that there was no significant difference in hemorrhagic 
transformation between the two groups, WT and SOD2-KO mice, however, significant (p < 
0.0001) changes were found when comparing different time points; the interaction of animal 
type and time was not significant. Pair wise comparisons of the ranks then showed that 
hemorrhage score for one day was different (lower) compared to days 3 and 7 which were not 
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different from each other (p < 0.0001 for 1 day vs. 3 days and for 1 day vs. 7 days). Results 
were consistent using Kruskall Wallis non-parametric tests for time stratified by type as well 
as for type stratified by time. 
 
 
B) Distribution of hemorrhagic transformation in WT and SOD2-KO mice 
In both SOD2-KO and WT mice hemorrhagic transformations followed a characteristic 
temporal pattern (Fig. 9)  
 
 
 
Figure 9: Hemorrhagic transformations in SOD2-KO and WT mice 
Representative photomicrographs of Perl’s Iron-stained sections show hemorrhagic 
transformations at 1 day (1, 2), 3 days (3, 4) and 7 days (5, 6) after CIBT. There were no 
differences in the rate of hemorrhagic transformations between WT (1, 3, 5) and SOD2-KO 
animals (2, 4, 6). Insets show iron-positive red blood cells (1-4C) and inflammatory cells (3B, 
4B, 5B, 6B) in the affected tissue. 
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One day after CIBT (Fig 9.1A, 9.2A) little or no red blood cells could be observed in the 
lesion area (Fig: 9.1B, 9.2B). At this early time point bleeding was caused by mechanical 
destruction of vessels due to freezing. At 3 days (Fig. 9.3A, 9.4A) extensive bleeding could be 
observed in both SOD2-KO and WT mice. Both red blood cells (Fig. 9.3C, 9.4C) and 
inflammatory cells (Fig. 9.3B, 9.4B) could be easily discerned. Since these hemorrhagic 
transformations were not observed at earlier time points, one can assume that they were 
caused by secondary damage including gradual damage of the blood brain barrier by free 
oxygen radicals or digestion of the vessels basal laminar matrix by MMPs (matrix 
metalloproteinases) which have been described to be activated after induction of CIBT 
(Morita-Fujimura et al., 2000). Iron-uptake by inflammatory cells had already started and was 
increased at 7 days. At 7 days (Fig. 9.5A, 9.6A) only a few RBCs could be observed whereas 
iron-positive inflammatory cells were detected throughout the lesion core and perimeter (Fig. 
9.5B, 9.6B).  
 
 
3.1.3. Inflammatory response after CIBT in WT and SOD2-KO mice 
To detect inflammatory response after CIBT, brain sections were stained for myeloperoxidase 
(MPO) to detect MPO-positive neutrophils. Neutrophil invasion was used as a parameter to 
quantify the inflammatory response by comparing the amount of MPO-positive cells in the 
lesion in WT and SOD2-KO mice. To elucidate the pattern of inflammatory response in the 
lesion the local distribution of MPO-positive cells was observed in both groups. 
 
A) MPO cell count after CIBT in WT and SOD2-KO mice 
In 4 different areas of the lesion (A = left corner lesion, B = right corner lesion, C = penumbra 
under lesion, D = middle core lesion) cell counts of MPO-positive cells were performed. They 
showed no differences between WT and SOD2-KO animals at any time point examined 
(Table 2). 
The only factor for which MPO counts differed was time (p > 0.001). MPO counts did not 
differ by animal type, by type crossed by (X) time, by type X area, by time X area or by type 
time X area. Pair-wise comparison of adjusted least square means is valid only for those 
factors that are significant in the model and was based on a-priory hypothesis. Adjusted mean 
MPO counts were significantly different between all times (p > 0.0001 for all comparisons) 
with 3 days > 1 day > 7 day.  
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Table 2: MPO-positive cell counts 
Least square mean (LSM) MPO counts and associated standard error (SE) adjusted for the 
other factors in the model (main factors: animal type, time in days, area). Two measurements 
were taken from each area for each animal within each time and animal type (5 different 
animals for the WT/1 day, and KO/1 day groups; 4 different animals for each of the other 
type/time combinations). 
*In the nested analysis mean MPO cell counts were significantly different by time (p < 
0.0001). 
  
Factors LSM SE 
   
Animal type   
   Wild type (WT) 12.6 .65 
   SOD2-KO (KO) 11.7 .65 
   
 Time in days*   
      1 11.5 .74 
      3 20.2 .83 
      7 4.8 .83 
   
Area   
      A 12.6 .92 
      B  11.0 .92 
      C 11.2 .92 
      D 13.9 .92 
   
Animal/Time groups   
      WT- 1 d 11.7 1.0 
      WT- 3 d 20.7 1.2 
      WT- 7 d 5.5 1.2 
      KO- 1 d 11.2 1.0 
      KO- 3 d 19.7 1.2 
      KO- 7 d 4.2 1.2 
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B) Distribution of MPO-positive cells after CIBT in WT and SOD2-KO mice 
Neutrophil infiltration was evident in animals at 1 day post-insult, peaked at 3 days, and was 
reduced at 7 days after CIBT (Fig. 10). Hemorrhagic transformations and MPO-positive cells 
were co-localized.  
 
 
Figure 10. Co-localisation of MPO-positive cells and hemorrhagic transformations 
Representative photomicrographs show co-localization of hemorrhage (Perl’s iron staining) 
and MPO-positive cells in adjacent sections from the same animals.  There were very few 
MPO-positive cells and little or no hemorrhage at 24 h post-insult in both WT and SOD2-KO 
animals (1A+B, 2A+B). By 3 days after CIBT there was a significant increase in MPO-
positive cells and in Perl’s iron staining in both animal groups (3A+B, 4A+B). At 7 days 
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post-insult the grade of hemorrhagic transformation was equally high in both WT and SOD2-
KO animals while the number of MPO-positive cells was equally reduced in both groups 
(5A+B, 6A+B). Bar = 50 µm. 
 
 
3.1.4. TUNE-labelling in SOD2-KO and WT mice  
DNA-fragmentation as a typical feature of apoptosis was examined by in-situ labelling of 
fragmented DNA (TUNEL-staining) in the nucleus. Both apoptosis and necrosis have been 
described in this model (Murakami, Neuroscience, 1997); morphologically, they can be 
differentiated since apoptotic cells show typical features like condensed or fragmented nuclei 
which are more intensely labelled. Necrotic cells are fainter labelled and their nuclei appear 
enlarged. The amount of apoptotic cells as well as their distribution was compared between 
SOD2-KO mice and WT animals. 
 
A) Similar numbers of apoptotic cells in WT and SOD2-KO animals 
TUNEL-positive cells were counted in 4 different areas of the lesion (A = left corner lesion, B 
= right corner lesion, C = penumbra under lesion, D = middle core lesion) and the results 
statistically analyzed. Only strongly labelled cells were counted as positive. The results are 
shown in Table 3. Comparison of least square means for factors significant in the model 
showed that  adjusted mean cell counts for 1 day and 7 days were significantly different from 
the value obtained for to 3 days (p = 0.04 and p = 0.009, respectively), but not different from 
each other. TUNEL-positive cells could be found predominantly in the corner region of the 
lesion and less in the core or penumbra under lesion, however, this tendency was not 
significant due to high variation within the groups. 
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Table 3: TUNEL-Positive Cell Counts 
Least square mean (LSM) counts of TUNEL-positive cells and associated standard error (SE) 
adjusted for the other factors in the model (main factors: animal type, time in days, area).  
Three measurements were taken from each area for each animal within each time and animal 
type (3 different animals for each type/time combination). 
*In the nested analysis mean TUNEL- positive cell counts were significantly different by time 
(p=0.046). 
 
 
B) Similar distribution of TUNEL-positive cells 
Cells with intensely labeled nuclei could be observed at all time points examined (Fig. 11, 1-
6B). Aside from TUNEL-positivity, several cells showed the characteristic morphological 
features of apoptosis, including cell shrinkage, blebbing of the nucleus and apoptotic bodies 
  
Factors LSM SE 
   
Animal type   
   Wild type (WT) 14.6 .57 
   SOD2-KO (KO) 14.4 .57 
   
Time in days*   
      1 15.0 .70 
      3 12.9 .70 
      7 15.5 .70 
   
Area   
      A 18.5 .80 
      B  20.0 .80 
      C 7.9 .80 
      D 11.5 .80 
   
Animal/Time groups   
      WT- 1 d 14.2 .98 
      WT- 3 d 13.9 .98 
      WT- 7 d 15.6 .98 
      KO- 1 d 15.7 .98 
      KO- 3 d 12.0 .98 
      KO- 7 d 15.5 .98 
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(Fig. 11, 1-6B, arrows). However, a large number of TUNEL-positive cells (with weaker, 
diffuse brown staining) could not be identified as apoptotic by morphologic criteria, 
particularly at 7 days post-CIBT. These cells were considered necrotic, and were not included 
in the cell count. 
 
 
Figure 11: TUNEL-positive cells after CIBT 
Representative photomicrographs of TUNEL-stained sections show distribution of TUNEL-
positive cells at 1 day (1, 2), 3 days (3, 4) and 7 days after CIBT (5, 6). No differences in 
spatial distribution or number of TUNEL positive cells could be observed between wild-type 
(1, 3, 5) and SOD2-KO animals (2, 4, 6). High magnification insets show TUNEL-positive 
cells (1 - 6B).  TUNEL-(+) cells with characteristic apoptotic features are highlighted by 
arrows. 
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3.1.5. Hydroethidine oxidation showed no significant difference in superoxide anion 
production 
Measurement of hydroethidine oxidation in the injured hemisphere showed no significant 
differences in ROS production between SOD2-KO animals and their WT counterparts 
(WT/SOD2-KO: 1.3 ± 0.5/1.2 ± 0.2) 2 hours following CIBT (Fig. 12).  
 
 
 
Figure 12: ROS production measured by hydroethidine assay of SOD2-KO and WT mice 
after CIBT  
Measurements of oxygen radical generation 2 hours after CIBT in the affected ipsilateral 
hemisphere (Ipsi) and on the contralateral (Contra) side by recording the emission by 
ethidium in 8 animals per group showed a significant increase in superoxide anion 
production in the ipsilateral hemisphere of both WT and SOD2-KO animals compared with 
the contralateral hemisphere. Data are expressed as mean ± SEM 
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3.2. The influence of the SOD1 level on intrastriatal 3-NP lesion 
3.2.1. Establishment of the model in wildtype animals 
Since the aim of this study was to test the influence of SOD1 levels on the outcome of the 
intrastriatal 3-NP lesion, it was crucial to create a lesion which did not exceed the striatum 
and allowed to detect an increase as well as decrease of the lesion. Using a protocol of 
intrastriatal 3-NP injection in mice invented by Kim et al. (Kim, unpublished data) did not 
seem practicable since the created lesion was too severe for the purpose of this study since the 
lesion expanded in hippocampus and cortex. Therefore the dose was reduced on 0.4 µl 3-NP 
solution (1 g/14 ml saline) (-> 2.4.3.) to create a reproducible, medium-sized lesion which 
within the striatum (Fig. 13). Control animals receiving saline injection revealed no lesion as 
determined after cresyl violet staining. 
 
  
Figure 13:  Striatal damage after 3-NP injection 
Cresyl violet staining of frozen brain sections the lesion was identified as a pale area 
(outlined with arrows) within the striatum. The photomicrograph shows a lesion at 24 h after 
the injection of 0.4 µl 3-NP solution (1 g/14 ml saline).  
 
To define the development of the lesion, lesion size and edema formation were examined after 
3-NP injection. Lesion size in CD-1 WT animals(n=5-6)  was not significantly different 
between 4 h, 24 h, 72 h after injection but decreased significantly from 72 h to 7 days. (4 h: 
30.80 ± 2.67, 24 h: 33.83 ± 4.60, 72 h: 28.64 ± 2.88, 7 days: 8.83 ± 2.61) (Fig.14A): The 
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edema, measured as hemisphere enlargement, peaked at 24 h after injection and was still 
evident at 7 days. (4h: 14.98 ± 2.77, 24h: 25.72 ± 4.41, 72h: 14.77 ± 1.71, 7days: 7.74 ± 6.53) 
(Fig.14B).  
 
 
 
 
Figure 14A: Lesion size after 3-NP injection in wild-type animals 
Size of lesion in CD-1 wild-type animals was measured from 4 h to 7 days post injury.  At day 
7 the size of the lesion was significantly decreased (P-value < 0.001 compared with 24 h time 
point, P-value ≤  0.01 compared with 4 h and 72 h, Scheffé) compared to all other time points. 
 
 
  83
Figure 14B: Edema development after 3-NP injection in wild-type animals 
Edema development was measured in CD-1 wild-type animals from 4 h to 7 days post injury 
Edema peaked at 24 h after 3-NP injection and was evident from 4 h to 7 days. From 24 h to 
7 days edema was significantly reduced (P-value < 0.05, Duncan). 
 
3.2.2. Detection of apoptosis in WT animals 
Since necrosis as well as apoptosis have been found after intrastriatal injection of 3-NP 
(Ankarcrona et al., 1995) (Sato et al., 1997a; Sato et al., 1998), TUNEL-staining was 
performed to detect apoptotic cells after intrastriatal 3-NP injection. TUNEL-staining was 
performed on paraffin sections of CD-1 mice at 4 h, 24 h, 72 h and 7 days after injury. At all 
time points, TUNEL-stained cells could be detected throughout the lesion (Fig. 15). However, 
this staining was relatively weak and the majority of stained cells did not reveal typical 
morphological features of apoptosis such as condensed nuclei, formation of apoptotic bodies. 
Only in the needle track area positively stained cells with apoptotic morphology could be 
detected (Fig. 16).  
In addition, caspase-3 and caspase-9 immunohistochemistry were performed on floating 
sections in wild-type animals at 4 h, 24 h and 72 h time points to detect whether caspases as 
typical markers for the apoptotic pathway were activated. No specific staining could be 
achieved inside the lesion at any time point. However, at 4 h (but not at 24 h or 72 h after 
injection) caspase-3- (Fig. 17) and caspase-9-positive cells (Fig. 18) could be detected in the 
needle track and, thus, served as a positive control for the staining. Control sections without 
primary antibody remained unstained. 
TUNEL-staining sections of SOD1-TG mice at all these points showed the same staining as 
observed in WT animals. In both groups the cells within the lesion predominantly showed 
necrotic features.  
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Figure 15: Representative TUNEL-staining in WT animals 
At 4 h (A), 24 h (B), 3 days (C) and 7 days (D, unspecific TUNEL-staining could be detected 
in the lesion area inside the striatum. The staining is weak and indicates the labelled cells to 
be necrotic since apoptotic cells would reveal intensely labelled nuclei. 
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Figure 16: Difference morphology of TUNE-labelled cells in needle track area and inside 
the lesion 
Representative photomicrographs of the needle track area (A, C, E) and striatal lesion area 
(B, D, F, G) show TUNEL-positive cells with apoptotic morphology only around the needle 
track. Few intensely labelled, condensed or fragmented nuclei (pointed out by white arrows) 
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could be observed while the vast majority of stained cell in the lesion area had faintly stained 
nuclei with increased size (black arrows) suggesting necrosis. This pattern could be observed 
at all time points 4 h (A+B), 24 h (C+D) and 72 h (E+F). At 7 days post injury the needle 
track area could not be distinguished from the rest of the lesion. (Scale bar = 0.1 mm) 
 
 
Figure 17: Caspase-3 immunohistochemistry 
Caspase-3-positive cells could be detected in the damaged cortical needle track area under 
light microscopy (A) and fluorescence microscopy (B) after caspase-3 immunohistochemistry 
in floating sections. Nuclei were counter-stained by methyl green. 
 
 
 
 
Figure 18: Caspase-9 immunohistochemistry 
Mechanically damaged cortex shows caspase-9 positive cells by immunohistochemistry under 
light microscopy (A) and fluorescence microscopy (B) at 4 h after 3-NP injection. Nuclei 
appear green by methyl green counter-staining. 
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3.2.3 Size of lesion and edema formation in SOD1-TG mice, their wild-type littermates 
and SOD1-KO mice. 
At 24 h after 3-NP injection, SOD1-TG mice showed a significantly smaller size of lesion and 
edema formation than wild-type animals. On the other hand, SOD1-KO mice did not have a 
significantly different lesion size compared with the WT animals (Fig. 19A). At 24 h, the 
edema was also significantly smaller in SOD1-TG mice compared to wildtype animals. A 
significant increase in edema was found in SOD1-KO animals compared to wild-type animals 
and SOD1-TG mice (Fig. 19B). At 72h, the lesion size remained significantly smaller in 
SOD1-TG animals compared to wild-type animals, edema formation, however, was not 
significantly different between wild-type animals and SOD1-TG. (Fig. 19A+B) 
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Figure 19 A+B: Size of lesion and edema formation at 24 h and 72 h after 3-NP injection 
in SOD1-TG mice, wild-type littermates and SOD1-KO mice 
A) Lesion size as % ispilateral hemisphere enlargement was significantly reduced in SOD1- 
TG mice compared to WT or SOD1-KO at 24 h after injection and stayed significantly 
decreased at 72 h (P-values < 0.01). B) The edema as % hemisphere enlargement was 
significantly different in SOD1-KO animals compared to wild-type and SOD1-TG animals (P-
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value < 0.01) and in SOD1-TG animals compared to their wild-type littermates ( P-value < 
0.05). At 72 h, edema showed no significant difference between wild-type animals and SOD1-
TG animals. (n=7-10). 
 
 
3.3. Search for PP2Cβ activation after induction of damage in cultured neurons  
3.3.1. Detection of Bad and Bad-155P and PP2Cβ in cultured rat neurons 
In this study, the hypothesis was tested that oleic acid treatment of cultured neurons activates 
PP2Cβ which contributes to apoptosis by dephosphorylation of Bad especially at Ser155. First, 
it was demonstrated that all enzymes were expressed in the cultured neurons (rat embryonic 
cortical and rat neonatal hippocampal) and co-localized in the same cellular compartment 
which is a precondition for their interaction. Western blot protocols for detection of Bad, Bad-
155P and PP2Cβ proteins were established, optimized and all proteins detected in both rat 
primary cultures. PP2Cβ´s cellular distribution in neurons was elucidated by 
immunocytochemistry. Bad or Bad-155P immunocytochemistry could not be performed since 
the available primary antibodies were too unspecific. 
 
3.3.1.1. Detection of Bad/ Bad-155P by Western blotting in embryonic cortical neurons 
To identify specific Bad bands by Western blotting, two polyclonal peptide antibodies were 
tested which were designed to detect different peptide sequences of Bad. The Bad-antibody 
produced by Cell Signaling Inc. (CS) detected amino acids of the N-terminal end of Bad, the 
Bad-antibody by Santa Cruz Inc. (SC) was designed to detect an amino acid sequence at the 
C-terminal end. The Bad-155P antibody (CS) used in these experiments was designed to 
detect an amino acid sequence including phospho-Ser155. Bad antibodies were used on 
untreated samples of rat embryonic cortical neuronal cultures (CC) (18 µg/lane), for Bad-
155P detection CC samples were used, as well. Additionally, CC samples were 
phosphorylated with the catalytic unit of protein kinase A (cA-PK) before detecting Bad-155P 
(CC+P, 18 µg/lane) in order to increase the intensity of the phospho-Bad band. (Fig. 21A). As 
controls, 0.1 µg purified recombinant Bad-GST (provided by Dr. P.Cohen, Dundee; Scotland) 
or cA-PK-phosphorylated Bad-GST (Bad-GST+P) were applied. On all blots two bands (23 
kDa and 27 kDa) were revealed in CC by the different Bad-antibodies. These observations are 
compatible with the two protein variants derived from two splicing products of Bad which 
have been described in rat tissue (Datta et al., 2002) (Datta et al., 2000) (Hamner et al., 2001): 
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Bad-β/BADS and Bad-α/BadL. These isoforms differ in length and amino acid sequence at 
their carboxy-terminal regions (Bad-β is 15 amino acids longer) but both still interact with 
anti-apoptotic members of the Bcl-2 family and therefore have proapoptotic qualities.   
Additionally, “clean” blots without strong background and clear bands showed that the higher 
band (Bad-α orBadL) was split into two separate bands with ~1 kDa difference (Fig. 20C). It 
has been argued that hyperphosphorylation of Bad leads to a mobility shift and results in two 
bands (Zha et al., 1996). The upper one was described as a hyperphosphorylated form of Bad, 
the lower was thought to be composed of unphosphorylated as well as phosphorylated Bad. In 
untreated embryonic cortical neuronal culture samples the upper band was very weak. 
Bad-GST was detected by all Bad antibodies at 47 kDa, Bad-GST+P by the phospho-Bad-155 
antibody at the same molecular weight. Although all Bad antibodies were able to detect Bad, 
their quality and specifity for Bad varied: Not only did the use of different primary antibodies 
influence the quality of the Western blots, the choice of secondary antibody (HRP-conjugated 
anti-rabbit antibody, Promega or Amersham) was of equal importance: 
A) The Santa Cruz Bad-antibody combined with any secondary antibody always resulted in 
blots with many strong unspecific bands indicating a high unspecificy of the primary antibody 
(Fig. 20 A). 
B) The Cell Signaling Bad or Bad-155P-antibodies produced markedly less unspecific bands 
than the Santa Cruz antibody when combined with the Promega secondary antibody (Fig. 
20A+B, 21A), and hardly any unspecific bands with the Amersham 2ndary antibody (Fig.  
20C, 21B). 
In conclusion, Bad or Bad-155P primary antibodies from Cell Signaling combined with 
secondary antibodies from Amersham allowed optimal detection of Bad/Bad-155P by 
Western blot. 
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Figure 20A: Comparison of Bad antibodies for 
Western blotting 
Proteins extracted from CC were separated 
electrophoretically (->2.5.8.) and analyzed with 
primary antibodies from Santa Cruz and Cell Signaling, 
respectively. Secondary antibodies were from Promega. 
Arrows indicate the bands expected to represent 
isoforms of Bad according to their molecular weight. 
       
    
 
Figure 20B: Unspecific bands by Promega 2ndary 
antibody on Bad Western blot 
Proteins from CC or recombinant Bad-GST were 
analysed by Western blotting with or without primary 
antibody (1. AB) from Cell Signaling and secondary 
antibody from Promega. In CC the secondary antibody  
produced a ladder of unspecific bands. The position of 
specific bands is indicated by arrows. 
 
     
 
Figure 20C: Optimized Western blot detecting Bad in 
cultured embryonic cortical neurons  
The combination of the primary Cell Signaling 
antibody and the secondary antibody from Amersham 
allowed detection of Bad without unspecific bands. 
Bad migrated as 2 bands, potentially representing 
splicing products at 23/27 kDa (arrows). The larger 
band was split in two, possibly one hyper-
phosphorylated and one unphosphorylated/partly-
phosphorylated band. 
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A            
Figure 21A+B: Detection of Bad-155P by Western 
blotting in primary cultures of embryonic cortical 
neurons 
A) Bad-155P antibodies indicated an increased band at 
27 kDa (arrow, left) in phosphorylated samples of 
embryonic cortical neurons (CC+P) compared to the 
unphosphorylated sample (CC). Phosphorylated Bad-
GST was used as a control and detected a band at 47 
kDa (arrow, right). The secondary antibody from 
Promega resulted in additional unspecific bands. 
 
 
B 
 
B) Western blot on Bad-155P (Cell Signaling antibody 
in combination with the secondary antibody from 
Amersham) showed two bands detectable at 23/27 kDa 
in samples of embryonic cortical neurons (CC) as 
indicated by large arrows. The combination with the 
secondary antibody by Amersham did only produce one 
unspecific band at about 40 kDa (small arrow). 
 
 
 
  
 
 
3.3.1.2. Detection of PP2Cβ in cultured neurons 
PP2Cβ is one isoform of the enzyme protein phosphatase 2C. It is a Mg2+-dependent serine 
phosphatase and can be activated by unsaturated fatty acids like oleic acid. Since the 
hypothesis was that PP2C activation by oleic acid contributed to apoptosis, it was necessary 
to show that PP2C, as well as Bad, could be detected in cultured neurons by Western blotting. 
Since so far PP2C´s cellular localization had not been established in cultured neurons, 
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immunocytochemistry was performed in cultured embryonic cortical neurons using a novel 
PP2Cβ antibody produced and kindly provided by Prof. S. Klumpp, Münster, which proved to 
be highly specific and useful for both Western blot detection and immunocytochemistry of 
PP2Cβ.  
 
A) Western blotting on PP2Cβ in embryonic cortical neurons 
In combination with the secondary antibody produced by Amersham PP2Cβ could be detected 
on Western blots of protein extracts from cultured embryonic cortical neurons without 
additional unspecific bands (Fig. 22). PP2Cβ migrated as a single band of ~ 45 kDa. In 
contrast, the secondary antibody from Promega produced faint unspecific bands. 
 
 
Figure 22: Western blotting of embryonic cortical 
neurons to detect PP2Cβ 
In embryonic cortical neuronal culture PP2Cβ was 
detected as a single band migrating at ~45 kDa 
molecular weight. Using the 2ndary antibody from 
Amersham allowed detection of a single specific band 
without generation of unspecific bands. Respectively, 
controls without the 1. AB were performed on the same 
blots as used for incubation with the 1. AB. 
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B) Immunocytochemistry on PP2Cβ in embryonic cortical neurons 
PP2Cβ immunocytochemistry revealed that PP2Cβ was localized in the cytosol but not in the 
nucleus (Fig. 23). Since Bad has been described to be localized in the cytosol, as well, these 
two enzymes could very possibly interact with each other. 
 
 
Figure 23: Detection of PP2Cβ in embryonic cortical 
neurons by immunocytochemistry   
Embryonic cortical neurons growing in cell culture 
were immuno-stained with (A) and without (B) primary 
antibody. PP2Cβ is localized in the cytosol of neurons 
and not in the nucleus (stained by Hoechst 33258).  
 
 
 
 
 
 
 
 
 
 
3.3.2. Treatment of cultured rat neurons with oleic acid 
3.3.2.1. Influence of B27 supplement on damaging effects of oleic acid  
Oleic acid has been shown to induce apoptosis in cultured chick neurons in a dose-dependent 
manner; treating chick neurons with oleic acid in Dulbecco´s Eagle medium without serum in 
concentrations ≥ 100 µM has been shown to significantly increase the number of apoptotic 
neurons in culture (Klumpp et al., 2002). In this study, when treating either rat embryonic 
cortical or neonatal hippocampal neurons with oleic acid/0.1 % DMSO in Neurobasal culture 
medium with B27 in concentrations up to 200 µM, neither could any morphological damage 
be observed under light microscopy nor a significant increase in apoptotic nuclei of neurons 
under fluorescence microscopy (Fig. 24, 25 26A). By using fresh aliquots of oleic acid which 
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had been stored under nitrogen/CO2 at -70°C, the possibility was excluded that light- and air-
sensitive oleic acid was deteriorated before use. Therefore, the lack of damage by oleic acid 
on cultured rat neurons could not be explained by the instability and oxidizability of oleic 
acid.  
To identify components of the culture medium which might inhibit the damaging effect of 
oleic acid, three different culture media were tested which had the same basic Neurobasal 
media composition but differed in the added supplements. The established protocol of 
culturing neurons suggested growing them in Neurobasal medium enriched with B27 
supplement (NB+B27). This supplement contained, among other components, antioxidants 
and bovine serum albumin (BSA). In a modified protocol cultured neurons were treated with 
150 µM oleic acid/0.1 % DMSO in Neurobasal medium without B27 (NB-B27) or 
Neurobasal medium with B27 without antioxidants supplement (NB+B27-AO) and compared 
to the NB+B27 group (Fig. 24, 25, 26A+B). Hoechst-33258 staining for apoptotic nuclei 
revealed that oleic acid in NB-B27 treatment led to a significant dose-dependent increase in 
apoptotic neurons at 24 h after treatment compared to the untreated control group. The 
number of apoptotic cells doubled after treatment with 150 µM oleic acid/0.1 % DMSO in 
NB-B27. Morphologically, all treated cells had damaged dendrites and showed “droplets” in 
the cytoplasm (Fig. 26B+C). Oleic acid treatment in NB+B27 and NB+B27-AO did neither 
lead to morphological damage nor increased numbers of apoptotic neurons. These numbers 
were not significantly different from control levels of ~ 15 % apoptotic cells in neonatal 
hippocampal and 20 % in embryonic cortical neurons.  
In all variations of Neurobasal cell culture medium oleic acid revealed solubility problems. In 
NB+B27 oleic acid was soluble in concentrations up to 100 µM, in NB-B27 or NB+N27-AO 
up to 50 µM. However, even if oleic acid was less soluble in NB-B27 compared to NB+B27, 
it damaged the cell significantly. Increased solubility did not correlate with increase in 
apoptosis.  
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Figure 24: The influence of B27 supplement on the induction of apoptosis by oleic acid in 
neonatal hippocampal neurons 
Treatment of primary hippocampal cultures with oleic acid/DMSO in NB-B27 led to a 
concentration-dependent increase in apoptotic neurons detected by nuclear staining. This 
damage was prevented when B27 was added to the culture medium. Staurosporine was used 
as a control apoptosis-inducing agent. (n=4) 
 
 
 
Figure 25: Effect of B27-AO supplement on the induction of apoptosis by oleic acid in 
neonatal hippocampal neurons 
Treatment of primary hippocampal cultures with oleic acid/DMSO in NB–B27 led to a 
concentration-dependent increase of apoptotic neurons detected by Hoechst 33258-staining. 
When B27-AO was added to the culture medium, this damage was prevented even at high 
concentrations of oleic acid. (n=4) 
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Figure 26A: Effect of B27 and B27-AO supplement on the induction of apoptosis by oleic 
acid in embryonic cortical neurons 
A significant increase in apoptotic neurons, detected by Hoechst-33258-staining, was induced 
in primary cultures of embryonic cortical neurons at 24 h after treatment with oleic 
acid/DMSO in NBl–B27. When B27-AO or B27 were added to the culture medium, this 
damage was inhibited. (n=2-4) 
 
 
 
Figure 26B: Effect of B27 and B27-AO supplement on morphological damage by oleic acid 
in embryonic cortical neurons 
At 24 h after treatment with oleic acid/DMSO in NB–B27, 100 % of embryonic cortical 
neurons showed features of damage. This damage was prevented by B27-AO or B27 
supplements in the culture medium. Only neurons with both destroyed dendrites and droplets 
in the cytosol were counted damaged cells. (n=2-4) 
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Figure 26C: Morphology of embryonic cortical neurons after oleic acid treatment: Effect of 
B27 and B27-AO on damage by oleic acid 
At 24h after treatment with oleic acid/DMSO in NB–B27, embryonic cortical neurons showed 
features of damage like destroyed dendrites and droplets in the cytosol (C). This damage was 
prevented when B27-AO or B27 was added to the culture medium (B, D) and could not be 
found in the control group either (A).  
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3.3.2.2 Influence of BSA or β-cyclodextrin on solubility of oleic acid and its damaging 
effect 
Oleic acid was soluble in Neurobasal without B27 in concentrations up to 50 µM/0.1 % 
DMSO. Higher concentrations revealed visible particles of oleic acid in the culture medium. 
Although oleic acid significantly damaged neurons while it was not fully solved, approaches 
were made to increase the solubility of oleic acid in order to have a defined concentration of 
oleic acid in the culture medium. The options were to either increase the concentration of 
DMSO or to add some ingredient to improve the solubility of oleic acid. Since DMSO was 
known to have antioxidative properties which might affect the damage by oleic acid, the 
DMSO concentration of 0.1 % was not to be altered. Therefore, two different substances were 
tested improve the solubility of oleic acid: 
a) BSA, which is known to bind oleic acid and, thus, to increase its solubility and  
b) β-cyclodextrin, which is able to hold oleic acid in its hydrophobic cavity and, 
 therefore, allows keeping very high concentrations of oleic acid in solution. 
 
a) Treatment with oleic acid + BSA 
BSA, bovine serum albumin, was dissolved in NB-B27 to concentrations of 0.01 %, 0.1 % 
and 1 %. These media were used to prepare solutions of 100 µM oleic acid/ 0.1% DMSO. 
Although the damage by 100 µM oleic acid was not as severe as after treatment with 150 µM 
oleic acid which had been chosen as the optimal concentration, 100 µM oleic acid was used 
for this experiment to potentially allow a full solution of oleic acid. The media were examined 
under a light microscope which revealed that oleic acid was only fully soluble in the medium 
containing 1 % BSA. At lower concentrations of BSA or in medium without BSA, particles of 
insoluble oleic acid were evident in the media.  
Neonatal hippocampal and embryonic cortical neurons were treated with 100 µM oleic 
acid/0.1 % DMSO in NB-B27 containing different concentrations of BSA. After 24 h, 
neurons were morphologically examined and stained with Hoechst-33258 to detect apoptotic 
nuclei. In medium containing BSA concentrations higher than 0.1 %, neither was neuronal 
damage by oleic acid observed morphologically (Fig. 28), nor did the number of apoptotic 
neurons increase significantly (Fig. 27A+B). It was not possible to find a concentration of 
BSA that would fully dissolve 100 µM oleic acid/0.1 % DMSO and yet allow it to damage the 
neurons. 
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Figures 27A+B: Effect of BSA on the induction of apoptosis by oleic acid in cultured 
neurons 
Increasing concentrations of BSA in culture medium blocked the apoptosis-inducing effect of oleic 
acid. The effect was lost at BSA-concentrations >0.1 %. An increase in solubility correlated with a 
loss of damage in neurons of primary neonatal hippocampal (A, n=4) or embryonic cortical cultures 
(B, n=5). 
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Figure 28: Morphology of cultured embryonic cortical neurons showing the effect of BSA 
on neuronal damage by oleic acid  
BSA concentrations > 0.1 % blocked morphologically detectable damage induced by 100 µM 
oleic acid/0.1 % DMSO in NB-B27 (E, F). An increase in solubility correlated with a loss of 
damage in embryonic cortical neurons. Neurons display features of damage like destruction 
of dendrites and ”lipid droplets” in the cytosol after treatment with oleic acid/DMSO in 
medium without BSA or 0.01 % BSA (C, D).  DMSO-treated controls in medium with or 
without BSA (A, B) and neurons treated with oleic acid/DMSO in medium containing either 
0.1 % BSA or 1 % BSA appear undamaged.  
 
 
c) Treatment with oleic acid in β-cyclodextrin 
The application of oleic acid in cyclodextrin provided the advantage that oleic acid was 
soluble at higher concentrations than when the increase of solubility was mediated by DMSO. 
Embryonic cortical and primary hippocampal neurons growing in primary cultures were 
treated with oleic acid/β-cyclodextrin adding various amounts of a stock solution to NB+B27 
(->2.5.11). By adding cyclodextrin the same concentration of cyclodextrine as in the group 
with the highest concentration of oleic acid / β-cyclodextrin was maintained in all groups. The 
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ratio of oleic acid to cyclodextrin in the stock remained unaltered at 10 mg oleic acid in 330 
mg β-cyclodextrin as provided by the supplier.  
Concentrations lower than 100 µM oleic acid/0.0093 % cyclodextrin than did not damage 
embryonic cortical neurons as shown by Hoechst-33258 staining and even this concentration 
did only allow induction of apoptosis to a percentage of ~35 % (Fig. 29). Repetitions of this 
experiment showed that reproducible, significant induction of apoptosis in neurons was not 
possible with 100 µM oleic acid. Since there were no solubility restrictions for oleic acid, a 
higher concentration of oleic acid (200 µM) was used to increase the damage which resulted 
in a correlating cyclodextrin concentration of 0.0186 %. Unfortunately, increasing the 
concentration to 0.0186 % cyclodextrin induced apoptosis in cultured neurons. This damage 
proved to be independent of its combination with oleic acid (Fig. 30). Apoptosis was 
confirmed by correlating increase in activation of caspase-3.  
The same effect was seen in neonatal hippocampal neurons: There was no significant 
difference between the percentage of apoptotic neurons after 200 µM oleic acid /0.0186 % 
cyclodextrin treatment and the percentage after treatment with 0.0186 % cyclodextrin (Fig. 
31A). Both induced apoptosis in a time-dependent manner as detected by Hoechst-33258 
staining of cell nuclei and Western blotting of caspase-3 (Fig. 32). The number of apoptotic 
neurons did not significantly increase with increasing concentrations of oleic acid. However, 
the total number of neurons gradually decreased (Fig. 31B); damaged cells were floating in 
the medium and were therefore not countable. It could not be determined how many of these 
floating cells were apoptotic.  
In both primary cultures the dramatic increase in apoptotic neurons occured between 18 h and 
24 h after treatment (Fig. 30, 33). Since high concentrations of cyclodextrin revealed a toxic 
effect of its own and because weak induction of apoptosis at lower concentrations of oleic 
acid/cyclodextrin revealed no advantages in comparison with oleic acid/DMSO treatment, 
cyclodextrin experiments were not further continued. β-Cyclodextrin, in concentrations 
associated with the amount of oleic acid necessary to induce apoptosis itself, induced 
apoptosis in embryonic cortical and neonatal hippocampal neurons. 
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Figure 29: Effect of oleic acid/cyclodextrin embryonic cortical neurons 
At 24 h, the number of apoptotic neurons was only significantly increased after treatment with 
100 µM oleic acid/0.0093 % cyclodextrin or higher concentrations. When the concentration 
of oleic acid/cyclodextrin was doubled to 200 µM /0.0186 %, a dramatic increase in 
apoptotic cells could be observed. (n=8) 
 
 
Figure 30: Effect of cyclodextrin on embryonic cortical neurons 
At 24 h after treatment, cyclodextrin treatment alone induced the same dramatic increase in 
apoptotic neurons as treatment with oleic acid /cyclodextrin. There was no significant 
difference in the induction of apoptosis between these two groups. (n=5) 
 
  104
 
 
Figure 31A: Effect of cyclodextrin on neonatal hippocampal neurons 
24 h treatment with 0.0186 % cyclodextrin increased the number of apoptotic neurons significantly. 
The combination with oleic acid did not further exacerbate the damage. (n=4) 
 
 
 
Figure 31B: Effect of oleic acid/cyclodextrin on neonatal hippocampal neurons 
Increasing concentrations of oleic acid in combination with cyclodextrin reduced the number of 
remaining neurons growing in the Petri dishes. Cyclodextrin alone did not significantly reduce the 
number. (n=4) 
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Figure 32: Western blot showing activation of caspase-3 in samples of primary 
hippocampal cultures after treatment with oleic acid/cyclodextrin and cyclodextrin alone 
Treatment with 200 µM oleic acid/ 0.0186 % cyclodextrin and 0.0186 % cyclodextrin alone 
both induced the cleavage of caspase-3 into its active form (at ~ 20 kDa). The total amount of 
caspase-3 protein remained constant (not shown), while active caspase-3 increased in a time- 
dependent fashion in both oleic acid/cyclodextrin treated and cyclodextrine treated cells. 
 
 
 
 
 
 
Figure 33: Time-dependent induction of apoptosis by oleic acid/cyclodextrin and 
cyclodextrin in neonatal hippocampal neurons  
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Apoptotic nuclei count after Hoechst-33258 staining revealed the deleterious effect of both ß-
cyclodextrin and oleic acid/ β-cyclodextrin. At 24 h and 48 h, there was a significant increase 
in apoptotic neurons compared to the 0 h control group. (n=5) 
 
 
3.3.2.3. Characterisation of neuronal damage after treatment of primary cultures with oleic 
acid/ DMSO in NB-B27 
After establishing oleic acid treatment in neurobasal medium without B27 which significantly 
induced apoptosis in neuronal culture (->2.3.2.2.), and after clarifying that neither BSA nor ß-
cyclodextrin were the appropriate tools to dissolve oleic acid in the cell culture medium, 
concentration- and time-dependent induction of apoptosis were examined in cultured neonatal 
hippocampal and embryonic cortical neurons. In both primary cultures it was observed that 
oleic acid treatment increased the number of apoptotic neurons in a concentration- (Fig. 34A, 
36A) and time-dependant manner (Fig. 35A, 36B). Oleic acid 150 µM/DMSO 0.1 % led to an 
increased of apoptotic neurons from control level of 10-20 % (DMSO-treated cultures) to 35-
40 % after 24 h treatment and up to 80 % after 48 h treatment. In embryonic cortical neurons 
time- and concentration-dependant the morphological changes of neurons were examined, as 
well. While the formation of “lipid droplets” could be observed as early as 3 h after onset of 
treatment with 150 µM oleic acid/0.1 % DMSO, destroyed dendrites and a significant 
increase in apoptotic nuclei could be observed as early as 12 h (Fig. 35B). At 24 h after 
treatment with different concentrations of oleic acid, cortical neurons showed the formation of 
vesicles in the cytosol at concentrations of 10 µM; at 100 µM oleic the dendrites were 
severely damaged (Fig. 34B). 
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Figure 34A+B: Concentration-dependency of damage to embryonic cortical neurons by 
oleic acid/0.1 % DMSO in Neurobasal medium without B27. 
At 24 h, oleic acid in concentrations higher than 50 µM /0.1 % DMSO significantly induced 
apoptosis as shown by Hoechst-33258 staining (A). Morphological observation under light 
microscope (B) revealed lipid droplets in the cytosol at much lower concentrations (10 µM 
oleic acid) (c); at concentrations of 100 µM oleic acid and higher, all neurons additionally 
showed loss of dendrites. (d, e). Neurons treated with 0.1 % DMSO showed healthy, 
undamaged neurons (b) like non-treated neurons (a). (n=5) 
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Figure 35A+B: Time-dependency of damage by oleic acid/0.1 % DMSO in Neurobasal 
without B27 medium in embryonic cortical neurons 
Treatment with 150 µM oleic acid/ 0.1 % DMSO significantly induced apoptosis in cortical 
neurons, as detected nuclear staining, as early as 24 h (A, n=4). Morphological observations 
under a light microscope showed vesicles in the cytosol of cortical neurons as early as 3 h 
after treatment (B). At 12 h, some neurons showed loss of dendrites (f) which increased up to 
24 h when most of the dendrites were fragmented or dissolved (g). Until 48 h after treatment, 
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DMSO-treated controls neither showed a significant increase in apoptotic neurons nor did 
they look morphologically damaged (a-c). 
 
A 
 
B 
 
 
Figure 36A: Concentration-dependent induction of apoptosis in neonatal hippocampal 
neurons by oleic acid in NB-B27 (n=4-6) 
Figure 36B: Time-dependent induction of apoptosis in neonatal hippocampal neurons by 
oleic acid in NB-B27 (n=6) 
  110
3.3.3. Nile blue staining of embryonic cortical neurons after oleic acid treatment 
Nile blue staining revealed that the droplets which could be observed after treatment with 150 
µM oleic acid/ 0.1 % DMSO in NB-B27 contained free fatty acids. Under a fluorescent 
microscope the droplets showed strong, red fluorescence. Neither DMSO- nor staurosporine-
treated neurons showed these fatty acids-filled vesicles/droplets (Fig. 37). Both oleic acid and 
staurosporine showed apoptotic features after Hoechst-33258 staining as fragmented, 
shrunken nuclei and intense Hoechst-labelling. Droplets appeared 3 h after onset o f 
treatment, much earlier than apoptotic nuclei, and could be observed in oleic acid treated cells 
only.    
 
 
Figure 37: Nile blue staining of embryonic cortical neurons after staurosporine and oleic 
acid treatment 
  111
Eight hours after treatment with 150 µM oleic acid/0.1 % DMSO only few neurons showed 
apoptotic nuclei but all displayed lipid droplets in the cytoplasm (D).  At 24 h, about 50 % of 
the oleic acid-treated neurons had apoptotic nuclei but 100 % revealed droplets and fully 
destroyed dendrites (E). Apoptosis, induced by 200 nM staurosporine/0.1 % DMSO, followed 
a different pattern: It was observed at 8 h (F) and 24 h (G) after treatment, while the neurons 
did not display lipid droplets at any time point. DMSO treatment did not induce apoptosis nor 
did it alter the morphology of neurons at 8 h (B) or 24 h (C) after treatment when compared 
with the 0 h control group (A). 
 
 
3.3.4. Western blotting on Bad, Bad-155P and PP2Cβ after oleic acid treatment in 
embryonic cortical and hippocampal cultures 
Cell extracts were prepared for Western blotting after treatment with 150 µM oleic acid/ 0.1 
% DMSO in NB-B27. Significant induction of neuronal apoptosis (~40 %) was controlled by 
nuclear staining of treated sister cultures. Protein samples were used for detection of Bad, 
Bad-155P and PP2Cβ. In primary hippocampal cultures one blot each was prepared for the 
detection of proteins. Afterwards equal protein loading was controlled by a-tubulin detection. 
In embryonic cortical neuronal cultures the same blot was used for all detections: Bad-155P 
was detected first, followed by Bad detection after stripping of the membrane. PP2Cβ 
detection and alpha-tubulin detection, as a control, followed using the same membrane 
without stripping since the remaining Bad band did not interfere with PP2Cβ or alpha-tubulin 
due to different molecular weights. In both primary cultures, Bad-155P protein was elevated 
as early as 1 h after onset of treatment, and decreased to below control level at later time 
points. Bad protein was slightly increased up to 3-4 h (Fig. 38, 39), however, this increase 
was not as pronounced as the one observed with Bad-155P. PP2Cβ protein level was not 
altered throughout the treatment. 
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Figure 38: Western blot detecting Bad-155P, Bad, PP2Cβ and alpha-tubulin after 
treatment with 150 µM oleic acid/0.1 % DMSO in samples of primary hippocampal mixed 
cultures 
At 1 h after treatment of primary hippocampal cultures with 150 µM oleic acid/0.1 % DMSO 
in NB-B27, by Western blotting Bad-155P protein was observed to be strongly increased 
compared to 0 h control and decreased gradually, afterwards, until it fell under control level 
at 24 h. Bad was slightly increased at 1 h and 4 h, PP2Cβ remained unaltered at all time 
points. Bad-155P, as well as Bad, slightly increased up to 24 h in cell extracts treated with 
0.1 % DMSO in NB-B27 as controls. PP2Cβ protein level remained constant in all treated 
and untreated cells at all time points. 
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Figure 39: Western blot detecting Bad-155P, Bad, PP2Cβ, and alpha-tubulin in protein 
extracts of cultured embryonic cortical neurons after treatment with 150 µM oleic acid/0.1 
% DMSO  
In embryonic cortical culture, Bad-155P protein was increased at 1 h compared to 0 h 
control after treatment with 150 µM oleic acid/0.1 % DMSO in NB-B27 and gradually 
decreased under control level from 1 h to 12 h.  Bad protein was slightly increased at 1 h and 
3 h after treatment and returned to control level at 12 h. PP2Cβ protein remained unaffected 
by the treatment at all time points. Bad-155P, as well as Bad and PP2Cβ proteins levels 
remained constant in cell extracts treated with 0.1 % DMSO in NB-B27 as control at all time 
points. 
 
 
3.3.5. Apoptotic effect of ginkgolic acids in rat neuronal cultures 
Ginkgolic acids, a composition of esters of ginkgolic acids, have been shown to increase 
PP2C activity in vitro and to induce apoptosis in cultured chick neurons at concentrations of 
100 µM after 24 h treatment (Ahlemeyer et al., 2001). Therefore, they fulfilled the same 
criteria as oleic acid to serve as a tool for the induction of apoptosis while activating PP2C 
which subsequently might influence Bad's phosphorylation state and therefore contribute to 
apoptosis. After establishing protocols to reproducibly induce apoptosis in rat embryonic 
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cortical and neonatal hippocampal neurons by treatment with ginkgolic acids, protein levels 
of Bad-155P, Bad and PP2Cβ were examined by Western blotting in protein extracts of 
treated and untreated  primary cultures to detect changes. 
 
 
3.3.5.1. Induction of apoptosis in rat neuronal cultures by ginkgolic acids 
Like oleic acid, ginkgolic acids proved to be almost insoluble in culture medium and had to 
be dissolved into a stock solution in DMSO. However, when mixing stock solution with 
Neurobasal culture medium with B27, concentrations of 250 µM ginkgolic acids /0.1 % 
DMSO were not fully soluble.  
Testing concentration-dependent induction of apoptosis by ginkgolic acids in either cultured 
embryonic cortical or neonatal hippocampal neurons, only concentrations ≥ 250 µM ginkgolic 
acids/0.1 % DMSO were found to significantly increase the percentage of neurons with 
apoptotic nuclei at 24 h (Fig. 40, 42). Apoptotic damage could be detected as early as 24 h in 
both primary cultures while the DMSO-treated neurons remained at control level of ~15 % 
damage (Fig. 41, 43). While neurons appeared overall damaged under light microscope, the 
percentage of apoptotic cells after treatment with 250 µM ginkgolic acids /0.1 % DMSO was 
unexpectedly low with 30 % in both lines of cultured neurons (Fig. 40, 42). 
This raised the question whether another type of cell death like necrosis which can not be 
detected by nuclear staining might contribute to neuronal damage, as well. Therefore, Trypan 
blue staining (TB) was performed in embryonic cortical neurons, in addition to Hoechst-
33258 staining, in order to examine whether apoptosis or necrosis was the predominant form 
of cell death after ginkgolic acids treatment. Sister cultures were used for these experiments 
since it was not possible to double-stain neurons with Trypan blue and Hoechst-33258. 
Neurons having picked up Trypan blue dye did not allow further nuclear Hoechst staining and 
Hoechst staining denaturized the cells which did inhibit further TB staining. At 24 h after 
treatment with 250 µM ginkgolic acids/0.1 % DMSO three times more Trypan blue-positive 
neurons were found in embryonic cortical cultures than neurons with apoptotic nuclei were 
detected by Hoechst staining (Fig. 41). While between 0 h and 24 h the percentage of 
apoptotic neurons remained unchanged (10 %) in the DMSO-treated control group, the value 
of damaged neurons doubled (18 %) as detected by Trypan blue staining. The ginkgolic 
treated group revealed an increase of apoptotic neurons to 32 % at 24 h while this increase 
could not be detected at earlier time points (6 h). The drastic increase of Trypan blue positive 
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neurons after ginkgolic acids treatment could already be observed at early time points and 
remained at this level (6 h: 84 %, 24 h: 86 %). 
 
 
 
Figure 40: Concentration-dependent induction of apoptosis in neonatal hippocampal 
neurons after ginkgolic acids treatment 
At 24 h hours after treatment of neonatal hippocampal neurons, significant induction of 
neuronal apoptosis was only observed at a concentration ≥ 250 µM ginkgolic acids/0.1 % 
DMSO. Treatment with lower concentrations of ginkgolic acids did not significantly increase 
the percentage apoptotic neurons compared to the DMSO-treated control group. (n=4) 
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Figure 41: Comparison of necrotic and apoptotic cell death in neonatal hippocampal 
neurons after ginkgolic acids treatment  
While only at 24 h after treatment with 250 µM ginkgolic acids the number of apoptotic 
nuclei was increased, Trypan blue (TB)-positive neurons were evident as early as 6 h in 
hippocampal neurons. The number of TB-stained neurons did not significantly increase from 
6 h to 24 h indicating that the necrotic damage developed at early time points. (n=3-4) 
 
 
Figure 42: Concentration-dependent induction of apoptosis after ginkgolic acids treatment 
in embryonic cortical neurons 
In embryonic cortical cultured neurons only treatment with 250 µM ginkgolic acids/0.1% 
DMSO significantly induced apoptosis at 24 h compared with DMSO-treated neurons. At 
lower ginkgolic acids concentrations the percentage of apoptotic neurons did not significantly 
differ from the percentage of DMSO-treated neurons. (n=5) 
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Figure 43: Time-dependent induction of apoptosis after ginkgolic acids treatment in 
embryonic cortical neurons 
In embryonic cortical neurons a significant increase of apoptosis was induced as early as 24 
h after treatment with 250 µM ginkgolic acids/ 0.1 % DMSO. (n=4-5) 
 
 
3.3.5.2. Detection of Bad, Bad-155P and PP2Cß protein levels by Western blotting after 
ginkgolic acids treatment of primary cultures 
To examine a possible regulation of the protein levels of Bad, Bad-155P or PP2Cβ after 
induction of apoptosis by ginkgolic acids treatment, primary embryonic cortical or 
hippocampal cultures were treated with 250 µM ginkgolic acid/0.1 % DMSO. Cell lysates 
prepared after various intervals of treatment were tested in Western blots for Bad, Bad-155P 
or PP2Cβ.  The same blots were used for detection of Bad-155P and Bad. After Bad-155P 
detection, the membranes were stripped and reincubated with the Bad antibody. PP2Cβ was 
detected on a separate blot. None of these proteins appeared to be strongly regulated after 
ginkgolic acids treatment at any time point in either embryonic cortical (Fig. 44) or neonatal 
hippocampal culture. There was a slight increase in Bad-155P and Bad protein level at 3 h 
after  treatment with 250 µM ginkgolic acids, which decreased at 6 h and fell under 0 h 
control level at 24 h.  
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Figure 44: Western blots detecting Bad-155P, Bad and PP2Cβ in cultured embryonic 
cortical neurons after treatment with 250 µM ginkgolic acids/0.1 % DMSO 
After treatment of embryonic cortical neurons with 250 µM ginkgolic acids/0.1 % DMSO 
Bad-155P, Bad and PP2Cβ protein levels were detected in protein extracts by Western 
blotting. Bad and PP2Cβ proteins were not altered after ginkgolic acids/DMSO treatment, the 
Bad-155P protein level was slightly increased at 3 h, fell back on control level at 6 h and 
below the 0 h control at 24 h. The amounts of all detected proteins were not changed in the 
DMSO-treated neurons any time points up to 24 h.  
 
 
3.3.6. Treatment of embryonic cortical culture with elaidic acid 
Elaidic acid (“trans-oleic acid”) is known to neither activate PP2C in vitro nor induce 
apoptosis in cultured chick neurons in contrast to oleic acid (Klumpp et al., 2002). To verify 
that elaidic acid does not induce apoptosis in cultured rat neurons, either, we searched for 
apoptotic effects of elaidic acid in primary cultures of embryonic cortical neurons. Treatment 
with 150 µM elaidic acid/0.1 % DMSO in NB-B27, applied up to 48 h, did neither 
significantly induce apoptosis (Fig. 45A) nor did it increase the number of morphologically 
damaged neurons (Fig. 45B). Up to 48 h, numbers of apoptotic cells remained on control 
niveau while the neurons showed a healthy morphology. No damaged dendrites or formation 
of lipid droplets in the cytosol were evident in contrast to neurons treated with 150 µM oleic 
acid/0.1 % DMSO (Fig. 45B). 
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Figure 45A+B: Comparison of damaging effects of oleic acid and elaidic acid (“trans-oleic 
acid”) on embryonic cortical neurons 
In contrast to oleic acid, its trans-isomer elaidic acid did not induce apoptosis in embryonic 
cortical neurons. There was no significant increase in apoptotic nuclei (A, n=4) at 48 h after 
treatment with 150 µM elaidic acid/0.1 % DMSO. Morphologically (B), neurons looked 
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healthy at 48 h after treatment with elaidic acid, their dendrites were intact (b) while the 
same concentration of oleic acid made the neurons shrink, destroyed their dendrites and 
made them display vesicles in their cytoplasm (c). Control neurons treated with 0.1 % DMSO 
looked healthy at 48 h, their dendrites were intact. 
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4. Discussion 
Cell death is involved a variety of biological events including embryogenesis, morphogenesis, 
differentiation, as well as cell and tissue homeostasis. In the mammalian nervous system, 
naturally occurring programmed cell death is required to form and refine the neuronal circuit 
(Raff et al., 1993). Following the emergence of functional neural networks, sustenance for 
neurons is required in order to maintain the nervous system because most mature neurons 
cannot proliferate. Inappropriate neuronal cell death results in dysfunction of the nervous 
system, as observed in neurodegenerative diseases, trauma, or stroke. Since the numbers of 
patients with neurodegenerative diseases and stroke are increasing in Western societies, the 
need for understanding the molecular machinery of cell death in order to find therapeutical 
targets to treat these diseases is great. In this thesis, the involvement of specific factors, the 
enzymes superoxide dismutases (SODs) and PP2C, in neuronal cell death was investigated by 
their modulation in different models of neurodegeneration. The roles of superoxide 
dismutases which function as endogenous free radical scavengers were tested in vivo in a 
model of cold injury-induced brain trauma (CIBT) and after intrastriatal injection of the toxin 
3-nitropropionic acid in mice. The function of protein phosphatase type 2C (PP2C) in 
neuronal apoptosis was examined by measuring changes in Bad phosphorylation after 
treatment of rat neuronal cultures with oleic acid or ginkgolic acids, activators of PP2C. 
 
 
4.1. Neuroprotective effect of SOD1 in a model of intrastriatal 3-nitropropionic 
acid injection 
One aim of this thesis was to examine the role of SOD1 in a model of intrastriatal 3-
nitropropionic acid (3-NP) injection. Mycotoxin 3-NP has been shown to irreversibly inhibit 
the enzyme succinate dehydrogenase which is part the electron transport chain in the 
mitochondria and to lead to cellular depletion of adenosine triphosphate (ATP) (Ludolph et 
al., 1992). Both chronic or subacute systemic intoxication with 3-NP induces specific striatal 
brain damage (Alston et al., 1977) (Palfi et al., 1996). Chronic systemic treatment with low 
doses of 3-NP has been demonstrated to produce selective striatal lesions sparing aspiny 
NADPH-diaphorase-positive neurons and thus replicating some features of Huntington’s 
disease (HD), a progressive neurodegenerative disorder associated with severe degeneration 
of basal ganglia neurons, especially of intrinsic neurons of the striatum (Martin and Gusella, 
1986) (Brouillet et al., 1999) (Beal et al., 1993b) (Palfi et al., 1996) (Borlongan et al., 1997). 
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After subacute systemic and intrastriatal injection, however, both intrinsic striatal neurons and 
the nigrostriatal dopaminergic system degenerate, suggesting that this lesion may provide an 
animal model of multiple system atrophy rather than Huntington's disease (Nakao and 
Brundin, 1997). Though the origin for striatal lesion is different for HD and 3-NP 
intoxication, in both cases energy depletion leads to neuronal cell death. Investigations of cell 
death mechanisms in Huntington’s disease have evolved around energy depletion and 
increased sensitivity for excitatory amino acids (EAA, i.e. glutamate) as a primary cause of 
neuronal cell death (Zorumski and Olney, 1993). Likewise, excitotoxicity seems to be a major 
factor in the pathogenesis of 3-NP lesions after both systemic and intrastriatal treatment and is 
required for the occurrence of striatal damage. Elimination of excitatory signals by removal of 
the cortex attenuates the lesion after acute systemic and intrastriatal treatment alike (Kim et 
al., 2000) (Beal et al., 1993a).  The activation of NMDA and non-NMDA receptors has been 
implicated after energy depletion in 3-NP toxicity, but it remained unclear which type of 
receptor plays a pivotal role in which treatment regimen: Beal and co-workers proposed that 
chronic systemic administration of 3-NP with mild energy impairment leads to selective 
NMDA receptor activation by postsynaptic mechanisms which can be blocked by NMDA-
antagonists like MK801. Damage by intrastriatal 3-NP injection was only blocked by a 
combination of both NMDA- and non-NMDA-antagonists indicating that a non-NMDA 
mechanism might be involved (Beal et al., 1993b). Opposite results have been described by 
Ikonomidou and colleagues: Slow progression of neuronal death induced by systemic 
treatment with 3-NP was enhanced by NMDA-antagonists but ameliorated by AMPA-(non-
NMDA)-antagonists while rapidly progressing neuronal death induced by intrastriatal 
treatment with 3-NP was prevented by NMDA antagonists (Ikonomidou et al., 2000). These 
authors concluded that glutamate could determine the fate of neurons by saving them through 
activation of NMDA receptors or inducing neuronal cell death by activating AMPA/kainate 
receptors. Even though there is no full agreement about the precise mechanisms of receptor 
activation and modulation, all previous publications strongly suggest profound differences in 
morphological, biochemical and behavioural outcome between chronic systemic treatment of 
low doses 3-NP, acute/subacute systemic treatment and intrastriatal injection of 3-NP. 
In this thesis, the role of cytosolic SOD1, an endogenous free radical scavenger, in the 
development of lesion after intrastriatal 3-NP injection was elucidated by testing whether 
changes in SOD1 levels affect the outcome of the lesion. Excitotoxicity induced by 3-NP, a 
prerequisite for striatal lesion (Schulz et al., 1996) (Kim et al., 2000), has been linked to free 
radical production (Coyle and Puttfarcken, 1993) causing lipid peroxidation, protein oxidation 
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and DNA damage. Mechanisms of free radical production due to 3-NP intoxication and 
subsequent excitotoxicity have been elucidated: By inhibition of the succinate dehydrogenase, 
ROS are produced in the dysfunctional mitochondria due to incomplete utilisation of oxygen. 
Additionally, inhibition of the succinate dehydrogenase stops the mitochondrial ATP 
production. Energy depletion leads to loss of membrane potential, activation of glutamate 
receptors and  generation of toxic superoxide radicals in vitro (Lafon-Cazal et al., 1993). 
Opening glutamate receptor-associated Ca2+-channels triggers Ca2+ influx into the cell and 
disrupts the intracellular Ca2+ homeostasis. This further enhances mitochondrial dysfunction 
and ROS production in the mitochondria. Free oxygen radicals themselves can target and 
damage mitochondria and further reduce their function (Wullner et al., 1994). In vivo, it has 
been shown by increased protein oxidation following administration of 3-NP to rats that 
oxidative stress precedes the formation of striatal lesions (Fontaine et al., 2000). Endogenous 
and exogenous antioxidants affect the outcome of the 3-NP lesion as well as endogenous free 
radical scavengers like members of the superoxide dismutase family (Nakao et al., 1996) 
(Fontaine et al., 2000) (Beal et al., 1995). Both cytosolic SOD1 (copper-zinc-superoxide 
dismutase, Cu-Zn-SOD) and mitochondrial SOD2 (manganese-superoxide dismutase, Mn-
SOD) have been shown to contribute to cellular defense mechanisms counteracting the 
deleterious effects of ROS generated after systemic 3-NP intoxication. SOD1 had 
neuroprotective effects after subacute systemic injection of 3-NP into SOD1-TG mice (Beal et 
al., 1995). Knock-out mice with a partial deficiency of SOD2 showed an increased neuronal 
vulnerability to 3-NP intoxication after subacute systemic injection (Andreassen et al., 2001). 
All these findings indicated that ROS production plays an important role in 3-NP intoxication, 
but so far it has not been examined whether cytosolic SOD1 could be protective in a model of 
intrastriatal injection of 3-NP.  In this study, SOD1-TG transgenic animals with a three-fold 
increase of cytosolic SOD1 and homozygous SOD1-KO mice that totally lacked SOD1 were 
used as tools to modulate SOD1 levels. The established protocol of intrastriatal 3-NP injection 
in wild type mice allowed creating a reproducible, medium-sized lesion within the striatum 
that did not extend into damage of hippocampus or cortex. The lesion size of ~ 30 % of the 
striatum did not significantly change between 4 h and 72 h after injection but decreased 
significantly from 72 h to 7 days. Edema measured as hemisphere enlargement was evident at 
all time points, peaked at 24 h, and decreased afterwards. Since both necrosis and apoptosis 
have been reported to occur after acute 3-NP intoxication (Ankarcrona et al., 1995) (Sato et 
al., 1997a; Sato et al., 1998), it was necessary to define the type of cell death by in-situ-
labelling of fragmented DNA (TUNEL-staining). Strongly labelled cells with features like 
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blebbing, shrinking or fragmentation of the nucleus would indicate apoptosis. However, the 3-
NP dose chosen in this study did not induce apoptosis. The majority of damaged cells were 
neither shrunk, nor did they have condensed, strongly labelled nuclei. On the contrary, the 
nuclei of damaged cells were increased in size compared to healthy ones in the contralateral 
hemisphere. Some apoptotic cells could be observed in the needle track area, but they were 
presumably the result of mechanical damage induced by the needle. Since the majority of 
dying cells did not show apoptotic morphology, biochemical markers of apoptosis such as 
active caspase-3 or caspase-9 were investigated by immunohistochemistry. These experiments 
revealed that, indeed, immunoreactivity occurred only in the needle track area but not in the 
3-NP-damaged cells of the striatum, supporting the notion that necrosis and not apoptosis was 
the predominating cell death mechanism in this model. 
After establishing parameters of this model such as development of lesion, edema formation 
and type of cell death in WT animals, the influence of SOD1-dosage on the outcome of 
intrastriatal 3-NP injection was examined. Since edema peaked at 24 h after injection in wild 
type animals, this time point was chosen to measure differences between SOD1-TG mice, 
their wild type littermates and SOD1-KO animals. At 24 h after 3-NP injection, SOD1-TG 
mice showed a significant decrease in both lesion size and edema formation compared to their 
WT littermates. SOD1 proved to be neuroprotective after this acute 3-NP treatment which 
supports the hypothesis that free radical production is a major factor in the pathogenesis of 
this intoxication.  At 72 h, lesion size was still significantly smaller in SOD1-TG mice 
compared to the WT animals whereas the difference in edema had vanished at this time point.  
SOD1-KO mice failed to reveal a significant increase of lesion size at 24 h after injection 
when compared with WT animals while showing a significant increase in edema formation. 
That SOD1 overexpression, a 3-fold increase in SOD1, affected both lesion size and edema 
development while complete loss of SOD1 did only affect the edema formation can be 
explained as follows: Edema formation, on the one hand, is associated with BBB breakdown 
after damage of endothelial cells of the vessels, while lesion size, on the other hand, reflects 
the overall damage of brain tissue including astrocytes and neurons. SOD1 reduction could 
have increased the level of free oxygen radicals after 3-NP intoxication but the damage on 
neurons and astrocytes might have been already too high in WT animals to be exacerbated in 
SOD1-KO mice.  In the more robust endothelial cells, however, the maximum damage by 
ROS and subsequent BBB breakdown was not reached in WT animals and therefore could be 
enhanced by reduction of SOD1. A reduction of ROS levels by SOD1 overexpression, on the 
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other hand, improved the conditions for both brain tissue and endothelial cells and therefore 
affected both lesion size and edema formation. 
In conclusion, intrastriatal 3-NP treatment of mice proved to be a model of necrotic cell death 
in which ROS production contributed to the development of the lesion. Overexpression of 
cytosolic free radical scavenger SOD1 could reduce lesion and edema after BBB breakdown 
by decreasing the level of free radicals after 3-NP injection. SOD1 reduction did not 
significantly exacerbate of the size of the lesion, however, it enhanced edema formation and 
blood brain barrier breakdown. Thus, this study confirms that oxidative stress plays an 
important role in 3-NP toxicity. 
 
 
4.2. Effect of SOD2 reduction on cold injury-induced brain trauma 
Using animals deficient in SOD2 (SOD2-KO mice), the role of the inducible mitochondrial 
antioxidative enzyme SOD2 in the development of secondary brain damage following severe 
traumatic injury was examined. Traumatic brain injury involves immediate neuronal cell 
death in the primary lesion site, disruption of blood-brain barrier integrity and cerebral edema.  
This process is accompanied by secondary damage being believed to be mediated by free 
radicals and leads to progressive extinction of brain parenchyma. Experimental evidence from 
various brain trauma models had shown that focal tissue necrosis following a traumatic insult 
is caused, to a large extent, by oxygen radical-mediated oxidation of lipids, proteins, and 
nucleic acids, which can critically alter cellular function (Lewen et al., 2000). Since cerebral 
edema is one of the most important prognostic factors in traumatic brain injury, a non-
invasive model of cold injury-induced brain trauma was used that results in vasogenic edema 
and allows reproducible cortical damage without the pathophysiological complexity of 
mechanical injury (Chan et al., 1991). The parameters compared between SOD2-KO animals 
and their wild type littermates (WT) were lesion size, edema development, number and 
distribution of apoptotic cells, as well as MPO-positive neutrophils and hemorrhagic 
transformations at time points from 24 h up to 7 days. Additionally, superoxide anion radical 
production in the injured cortex was measured in the first two hours after CIBT. The results of 
this study revealed that in the CIBT model a 50 % reduction in SOD2 activity did not alter the 
injury response according to the parameters measured. This lack of an effect of SOD2-
deficiency in this study is puzzling, particularly since SOD2-KO animals showed 
exacerbation of the lesion following global ischemia, permanent and transient focal ischemia, 
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traumatic brain injury (TBI) and subarachnoid hemorrhage (Matz et al., 2001) (Maier, 
Tannous, 2002) (Fujimura et al., 1999b) (Murakami et al., 1998b) (Noshita et al., 2001).  
In the present study, total superoxide anion production during the first 2 hours after CIBT was 
increased in the injured hemisphere as compared to the contralateral side. However, this 
increase in ROS formation in the injured brain hemisphere was not different between SOD2-
KO mice and WT animals. ROS increase in the injured hemisphere demonstrates that free 
oxygen radicals were, indeed, produced in the lesion after CIBT and supports the hypothesis 
of ROS production as a key event in the damage of CIBT. Chan et al. had uncovered the role 
of ROS in CIBT, showing that overexpression of SOD1 and exogenous administration of 
liposome entrapped SOD were neuroprotective and reduced brain edema after CIBT (Chan et 
al., 1991) (Chan et al., 1987). Previous work by Vagnozzi and colleagues in a closed head 
injury rodent model had shown that the lipid peroxidation level in the injured brain which was 
already present 1 minute after trauma, reached maximal values by 2 hours, and decreased 
progressively thereafter (Vagnozzi et al., 1999). These authors indicated that significant ROS 
production takes place in a very early phase of traumatic injury processes.  
In this study, a decrease of SOD2 levels did not increase the total amount of free oxygen 
radicals after CIBT nor did it influence any other parameter for measuring the effect of 
trauma. Two explanations might be invoked: either the production of free radicals did not co-
localize with SOD2 in the mitochondria in which case SOD2 could not have an influence on 
the ROS level, or the levels of ROS were already too deleterious in wild type animals to allow 
a further increase after reduction of SOD2. 
If the mitochondria were not the main source of ROS production in this model but the cytosol 
via mechanisms like the arachidonic acid cascade (Hillered and Chan, 1988b), mitochondrial 
SOD2 could influence the burst of ROS production less than cytosolic SOD1 whose 
overexpression has been shown to be neuroprotective after CIBT (Chan et al., 1991). 
Evidence for site-specific protection of SODs has been demonstrated previously: 
Overexpression of SOD1 did not prevent neonatal lethality in SOD2 knockout mice (Copin et 
al., 2000) implicating that not only the total amount of SODs but rather their localisation in 
the cell is important for their protective function. In previous studies SOD2-KO mice showed 
an exacerbation of the infarct in a model of permanent focal cerebral ischemia (Murakami et 
al., 1998b) while in the same model overexpression of SOD1 was not neuroprotective 
(Fujimura et al., 2001). This indicated that SOD2 modulation mainly affects models in which 
mitochondrial ROS production follows reperfusion of ischemic brain tissue. Such reperfusion 
may not occur after CIBT due to edema-induced ischemia which lasts for at least 72 h. Due to 
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edema and blood flow reduction, O2 supply might be permanently lowered leading to a drop 
of oxygen utilisation in the mitochondria which would, in turn, result in a reduced production 
of mitochondrial ROS. 
A different reason why reduced SOD2 levels did not influence the outcome of the lesion 
might be a devastating amount of superoxide anions formed in the injured cells following 
CIBT. The endogenous antioxidant systems might be completely overrun already in WT 
animals, making differences in ROS levels between WT and SOD2-KO mice undetectable. 
This explanation is attractive considering the severity of damage revealed by in-situ labelling 
of DNA-strand breaks (TUNEL-staining). After CIBT, cells inside the lesion area showed 
predominantly morphological features of necrosis. Though quite a few cells were strongly 
labelled, very few had condensed nuclei or were fragmented. Only a small number of 
TUNEL-positive cells met the morphologic criteria of apoptosis, suggesting that this type of 
cell death was not involved in the expansion of the lesion. This finding is in line with a 
previous report defining necrosis as the predominant form of cell death after CIBT (Stoffel et 
al., 2001). Other groups had stressed a role for apoptosis as a cause for cell death after CIBT 
as indicated by TUNEL-staining, detection of “DNA-laddering”, cytochrome C release from 
the mitochondria, and activation of caspases (Murakami et al., 1998a) (Murakami et al., 1999) 
(Morita-Fujimura et al., 1999b) (Morita-Fujimura et al., 1999a). Yet none of these methods 
allowed quantitative comparison of apoptosis versus necrotic cell death. In contrast to these 
studies, in this thesis TUNEL-staining was performed on paraffin sections being much thinner 
and allowing detailed analysis of individual cells.  
Lesion size did not significantly increase from 24 h to 3 days post injury, rather, due to tissue 
loss in the affected area the lesion appeared to be decreased by 1 week. This finding is 
corroborated by the observation of Murakami and colleagues that the lesion did not 
significantly increase between 30 min and 3 days after CIBT. The distribution of apoptotic 
cells found in our study was similar to previous findings (Murakami et al., 1998a) (Murakami 
et al., 1999): Apoptotic cells could be observed in the outer layer (penumbra) rather than in 
the core of the lesion. If significant apoptosis would have ocurred there at any timepoint, a 
progressive enlargement of the damaged area would have been observed. In other, probably 
milder models of traumatic injury, a significant number of apoptotic cells have been described 
to contribute to the development of secondary brain damage (Lewen et al., 2000). In the 
approach followed in this thesis, however, the core of the lesion was probably too severely 
damaged by permanent ischemia and mechanical damage to allow a programmed cell death.    
  128
This study was also designed to study edema formation in WT-animals at later time points 
after CIBT, as well as hemorrhagic transformations after BBB breakdown, inflammatory 
response, and the role of SOD2 in these processes. CIBT has been described to be a model for 
vasogenic edema (Chan et al., 1983), therefore, edema formation was followed up to 7 days 
after CIBT by measuring enlargement of the affected hemisphere. Significantly higher 
swelling was found in the injured hemisphere of all animals up to 7 days compared with the 
contralateral side, indicating occurrence of BBB breakdown and vasogenic edema, and 
confirming the results of previous studies regarding the effects of experimental CIBT on brain 
edema (Unterberg et al., 1994) (Ikeda et al., 1994) (Erdincler et al., 2002). Murakami and 
colleagues described vasogenic edema, visualized by Evans blue extravasation, peaking as 
early as 30 min after CIBT and returning to control levels at 24 h while the measured water 
content of the injured hemisphere remained increased up to 72 h (Murakami et al., 1998a).  
In this study, edema formation measured as hemisphere enlargement decreased between 1 and 
7 days in all animals, while the appearance of hemorrhagic transformations increased 
significantly at 3 days post insult, particularly in the periphery of the lesion. By 7 days no new 
hemorrhagic transformations could be observed. Staining for neutrophils and microglial cell 
activation showed that a significant amount of inflammatory cells was already present in the 
injured hemisphere at 24 h post CIBT. Neutrophil infiltration and microglial activation 
peaked at 3 days post insult and was at this time point found at the same site as the 
hemorrhagic transformations. Obviously, the inflammatory response correlated with 
hemorrhagic transformations but none of both correlated with the edema formation. This 
observation raises the question whether inflammatory cells are actively involved in delayed 
BBB breakdown. A biphasic BBB breakdown after CIBT is considered to be a likely 
mechanism, the first phase describing the acute breakdown within 24 h after the insult by 
primary freezing damage followed by BBB opening due to secondary damage, the second 
phase, at 3 days, featuring hemorrhagic transformations caused by inflammatory response but 
not generalized vasogenic edema. Biphasic opening of the BBB has also been observed after 
controlled cortical impact, where the second opening of the BBB at 3 days post insult did not 
contribute to further increases in edema formation either (Baskaya et al., 1997). In the present 
study, neutrophils might have contributed to secondary BBB breakdown after CIBT by 
different mechanisms. By secreting lysosomal enzymes or cytokines they may damage the 
BBB. In addition, phagocytes such as neutrophils and macrophages have been described to 
produce reactive oxygen species (ROS) during phagocytosis (Forman and Torres, 2002). 
Finding leukocyte recruitment only in regions of BBB disruption, Soares and colleagues 
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implicated inflammatory cells in BBB breakdown in a model of traumatic brain injury (Soares 
et al., 1995). Inducible nitric oxide synthase (iNOS) expression and nitric oxide production by 
polymorph nuclear leukocytes and macrophages has also been observed after CIBT (Nag et 
al., 2001) and may also contribute to the BBB breakdown. In that study, BBB breakdown was 
immediate in lesional vessels but was delayed in perilesional vessels that showed maximal 
BBB breakdown between 2-4 days, with complete restoration by 6 days post-lesion.  
We did not observe any differences in HT rates between WT and SOD2-KO animals at any 
time point up to 7 days. Again, if lysosomal enzymes as cytokines, extracellular ROS 
produced by phagocytes or nitric oxide production lead to this BBB breakdown, decreased 
SOD2 levels in the mitochondria would hardly affect this process.  
Our observations suggest, that two different phases of damage occur after CIBT, a) an acute 
one which is defined by physical destruction of the tissue (freezing) resulting in necrosis and 
b) a delayed one, secondary damage, which at earlier time points is characterized by 
vasogenic edema, free radical production, and predominant induction of necrosis rather than 
apoptosis and at later time points by hemorrhagic transformations and inflammatory 
processes. In the acute phase, the cold injury-inducing probe freezes the cortical tissue 
underneath the skull leading to necrosis, destroying cortical brain tissue, neurons, astrocytes 
and vessels alike, in the core of the lesion. A temperature gradient can be assumed throughout 
the lesion, therefore, cells with more distance to the core are less affected by cold injury. In 
the core of the lesion the blood brain barrier is disrupted by mechanical destruction of frozen 
vessels. Additionally, successive BBB breakdown of perilesional vessels can be observed, 
possibly due to mechanisms that include a) release of mediators such as arachidonic acid-
analogues and other polyunsaturated fatty acids (PUFA) that are produced by phospholipid 
degradation of the membranes, free radicals, bradykinin, vascular endothelial growth factor 
and b) activation of enzymes of the matrix metalloproteinase family (MMPs) (Chan et al., 
1983) (Hillered and Chan, 1988a) (Nag et al., 1997) (Morita-Fujimura et al., 2000). The BBB 
becomes permeable for electrolytes and serum proteins which results in vasogenic edema 
observable almost immediately after the insult (Murakami et al., 1998a). Secondary damage is 
initiated when the tissue of the lesion becomes ischemic due to edema formation and when 
free radicals are formed around the edema which result in lipid peroxidation of the cellular 
membranes and increases in intracellular calcium, thus aggravating vasogenic edema 
(Erdincler et al., 2002). Among their many deleterious effects ROS increase the extracellular 
concentration of excitatory amino acids (e.g. glutamate) by inhibiting their re-uptake (Trotti et 
al., 1998). Glutamate mediated increase of the intracellular Ca2+ concentration results in both 
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dysfunction of the mitochondria being unable to further produce ATP, and the increase of 
intracellular ROS production via activation of the xanthin oxidase pathway, nitric oxide 
synthase, and phospholipase A cyclooxygenase. ROS, again, peroxidize lipids of cellular 
membranes, proteins, DNA (Lewen et al., 2000). The damaged cells run out of energy and 
undergo necrosis, burst and release their intracellular components. Although free radicals 
contribute to this pathological event of necrosis, mitochondrial ROS production does not play 
an important role: Due to immediately occurring edema and destruction of vessel in the lesion 
site the supply with oxygen is strongly reduced and the metabolic rate and utilisation of 
oxygen is decreased due to hypothermia in the tissue. Oxygen is absolutely necessary for the 
production of ROS in the mitochondria, however, vasogenic edema is evident for at least 3 
days and during that time perfusion of the damaged tissue can only be found in the outer 
layers of the lesion. In this “penumbra” supply with oxygen is restored which leads to a burst 
of ROS in the damaged mitochondria of the cells. If these cells have enough energy left they 
undergo apoptosis, if not they die via necrosis. This process should be comparable to cell 
death occurring during reperfusion after transient focal ischemia, however, the percentage of 
necrotic cells in this area was too high in wild type animals to allow a further increase due to 
the reduction of SOD2 in KO-animals.  
At 24 h the expansion of the lesion reaches its maximum. As a sign of inflammatory 
processes, neutrophils invade the lesion, astrocytes get activated, and microglial cells 
transform into monocytes and easily intrude into edematous tissue. These cells clean the 
tissue from debris and microglia cells and astrocytes resorb edema fluid. Moreover, after 
closure of the injured small vasculature a healing process takes place around the cold lesion 
characterized by proliferation of microvasculature (Orita et al., 1988).   
In summary, these data show that CIBT provides a good model to follow the biphasic 
progress of BBB breakdown and development of the vasogenic edema. However, this model 
is not well suited to study the effect of SOD2 reduction in brain injury. Either the damage in 
this model is already too severe in wild type animals to allow the detection of an exacerbated 
injury as a consequence of a decreased amount of SOD2 in KO animals or the preferred site 
of free radical production after CIBT is not in the mitochondria and, therefore, cannot be 
influenced by the amount of SOD2. 
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4.3. Role of PP2C in neuronal apoptosis 
Reversible phosphorylation of proteins by protein kinases and phosphatases is an important 
mechanism to regulate cellular functions including signal transduction, cell division or control 
of cell death pathways. While the protein kinases involved in these processes have been 
widely examined for many years, the importance of protein phosphatases has been recognized 
only very recently. One of the less examined phosphatases is protein phosphatase 2C (PP2C). 
It is a member of the magnesium-dependent protein phosphatase family (PPM) and requires 
Mg2+ (or Mn2+) -ions for its activation. A possible role of PP2C in cell physiology was 
previously underestimated because unphysiologically high concentrations of Mg2+ were 
known to be required for full PP2C activation in vitro. Recently, Klumpp and colleagues 
exposed that unsaturated fatty acids, such as oleic acid, linoleic acid and arachidonic acid, can 
activate PP2C, probably by affecting its response to divalent cations (Klumpp et al., 1998), 
which implicates that in the presence of these fatty acids PP2C could be active under 
physiological Mg2+ concentrations. All chemical compounds, mostly fatty acids, which were 
found to activate PP2C had in common that they were lipophilic, unsaturated molecules with 
a negatively charged group while trans-isomers and esterified derivatives of fatty acids like 
oleic acid were found to be inactive.  
An astonishing correlation between PP2C activation by these compounds and their ability to 
induce apoptosis has been observed in chick neuronal culture (Klumpp et al., 2002) hinting at 
PP2C as an important player in neuronal apoptosis. How the apoptotic pathway is influenced 
by PP2C, however, is unresolved so far. Various endogenous substrates of PP2C have been 
identified in protozoan and mammalian cells such as Bad, translation elongation factor 1ß 
(Mamoun and Goldberg, 2001), cyclin-dependent kinases (Cheng et al., 1999) and a number 
of stress-activated MAP kinases (Hanada et al., 1998) (Hanada et al., 2001) (Nguyen and 
Shiozaki, 1999). There is strong indication that dephosphorylation of Bad by PP2C might be 
one major underlying pro-apoptotic mechanism (Klumpp and Krieglstein, 2002):  Bad, a 
member of the Bcl-2 family consisting of anti- and proapoptotic members which control a 
critical intracellular checkpoint within an evolutionary preserved cell death pathway (Wang 
and Reed, 1998), is dephosphorylated by PP2C at Ser112, Ser136, and preferably at Ser155  “ in 
vitro”  (Krieglstein, Klumpp, unpublished data). Dephosphorylation has been shown to 
unleash Bad's proapoptotic properties by triggering heterodimerization of Bad with Bcl-xL 
whose protective function in the mitochondrial membrane is, thereby, ameliorated. 
Phosphorylation of Bad at Ser155 inhibits Bad/Bcl-xL dimerisation and prevents Bad-induced 
apoptosis, moreover, phosphorylation at Ser112 and Ser136 allows Bad to bind to 14-3-3 
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proteins in the cytosol. So far it has not been demonstrated whether PP2C dephosphorylates 
Bad in vivo and, thereby, induces apoptosis. One aim of this thesis was to elucidate the 
proapoptotic role of PP2C in rat neuronal cultures after treatment with PP2C-activating 
compounds and to define apoptotic pathways regulated by PP2C in vivo. 
As a first step to show Bad dephosphorylation after PP2C activation, it was investigated 
whether Bad and PP2C proteins, possibly involved in a PP2C-related pathway of neuronal 
apoptosis, were expressed in rat neuronal cultures and co-localized in the same cellular 
compartment which is a precondition for their interaction. In this study, Bad, phospho-Bad-
155 and PP2Cβ proteins were detectable in both rat embryonic cortical (CC) and neonatal 
hippocampal (HC) neuronal cultures by Western blotting analysis. Cellular PP2Cβ protein 
distribution was examined by immunocytochemistry (ICC) in CC and PP2Cβ was found 
being localized in the cytosol but not in the nucleus. Since Bad has been described to be 
localized in the cytosol and at the outer mitochondrial matrix (Zha et al., 1997) an interaction 
between PP2Cβ and Bad “in vivo” could be hypothesized.  
Afterwards, oleic acid treatment was optimized in both rat neuronal cultures to induce 
apoptosis which had been observed in cultured chick neurons at oleic acid concentrations 
≥100 µM (Klumpp et al., 2002). In this study, significant damage could be achieved by 
treating the cell cultures for 24 h with 150 µM oleic acid while excluding serum proteins from 
the cell culture medium. In the presence of serum proteins, such as bovine serum albumin 
(BSA), the apoptotic effect was diminished in a dose dependant manner. While increasing the 
solubility of oleic acid in cell culture medium, BSA presumably bound oleic acid, thus, 
lowered the concentration of free oleic acid in the cell culture medium and prevented cellular 
damage. No ratio of oleic acid and BSA could be found which allowed full solubility of oleic 
acid and simultaneously induced apoptosis in rat neuronal cell culture. Therefore, not only 
BSA was inappropriate as a tool to dissolve oleic acid, but also B27 supplement, a component 
of the Neurobasal medium, had to be excluded since it contained BSA.  
Since oleic acid was not fully soluble in the culture medium at 150 µM/0.1 % DMSO, and 
lower doses did not reproducibly induce apoptosis in rat neuronal culture, β-cyclodextrin was 
tested as a solvent mediator to achieve higher concentrations of oleic acid. Although, β-
cyclodextrin allowed dissolving oleic acid to considerably high concentrations in cell culture 
medium, it proved to be ill-suited for treatment of rat embryonic cortical and neonatal 
hippocampal neuronal culture due to toxic effects of its own. In high concentrations, 
cyclodextrin induced apoptosis in cultured neurons being demonstrated by nuclear staining 
and confirmed by detection of active caspase-3, a biochemical marker for apoptosis, by 
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Western blot analysis. Since, for technical reasons, it was impossible to reduce the 
concentration of β-cyclodextrin without reducing oleic acid’s concentration, β-cyclodextrin, 
too, was not useful to study the influence of oleic acid on PP2C. 
Because neither ß-cyclodextrin nor BSA could be used to increase oleic acid solubility, high 
concentrations of oleic acid were prepared in NB-B27 even if oleic acid was not fully 
dissolved. Interestingly, the concentration of dissolved oleic acid seemed to be less important 
for induction of apoptotic damage than the total amount of oleic acid in culture medium 
including non-dissolved parts. This can be explained by the finding that fatty acids, 
assumingly oleic acid, were found in the cytosol in “lipid droplets”. Under light microscopy, 
neuronal morphology revealed the formation of droplets inside the cytosol of neurons as early 
as 2 h and fragmented dendrites at 12 h after onset of treatment with 150 µM oleic acid.  
These vesicles contained free fatty acids or lipids as visualized by Nile blue staining, 
indicating that oleic acid had entered the cells and could potentially activate PP2C. Although 
Nile blue staining could not discriminate whether these “lipid droplets” contained acid oleic 
or some other acidic lipid, it is quite likely that oleic acid was a major compound. Formation 
of such lipid droplets has also been described in oleic acid-treated macrophages (Chen et al., 
2002). In this study, the neurons presumably lowered the concentration of oleic acid in the 
culture medium by storing in droplets inside their cytosol, thus allowing undissolved oleic 
acid to subsequently dissolve.  
To confirm the postulated specificity of oleic acid in inducing apoptosis in these cell culture 
systems, elaidic acid (“trans oleic acid”) was tested in rat embryonic cortical neurons. 
Previously, elaidic acid had been described to neither induce apoptosis in chick neuronal 
culture nor activate PP2C in vitro (Klumpp et al., 2002). In this study, 150 µM elaidic acid/ 
0.1 % DMSO in culture medium without B27 did not induce apoptosis nor morphological 
damage the cells up to 48 h, implicating that, indeed, only oleic acids with cis-conformation 
had negative effects on cell survival. 
To demonstrate changes in Bad phosphorylation after PP2C activation by oleic acid, protein 
levels of Bad, Bad-155P and PP2Cβ were examined in oleic acid-treated rat neuronal cultures 
by Western blot analysis. For technical reasons, only phospho-Bad-155 and total Bad 
including all phosphorylated and non-phosphorylated forms could be detected by Western 
blotting but not unphosphorylated Bad which should ideally have been measured. The only 
way to approach regulation of unphosphorylated Bad was to detect changes in ratios of Bad to 
Bad-155P and by that to draw conclusions about unphosphorylated Bad levels.  
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The Western blot analysis revealed a pronounced increase of Bad-155P protein as early as 1 h 
after onset of treatment in both neuronal cultures instead of an expected decrease due to PP2C 
activation. Total Bad was only very mildly upregulated at this time point while PP2Cβ levels 
remained unchanged. These results indicate that Bad-155P protein levels increased to a much 
higher percentage than Bad protein levels. However, since by Western blot analysis the ratio 
of Bad/Bad-155P under physiological, non-damaging conditions could not be determined, the 
changes of Bad-155P and Bad did not allow drawing conclusions about changes in 
unphosphorylated Bad. Therefore, the results of these experiments do not prove that after 
induction of apoptosis by oleic acid Bad-155P is dephosphorylated via activation of PP2C nor 
do they necessarily contradict this hypothesis.  
If increase of Bad-155P, however, was a real effect, this discrepancy could be explained by 
oleic acid as the substance of choice for induction of apoptosis in neuronal cell culture. Oleic 
acid is by no means a very specific activator of PP2C. It has been described to directly 
activate the protein kinases 2C which has been observed to phosphorylate Bad (Lu et al., 
1996) (Bertolotto et al., 2000). Oleic acid induces the release of neurotransmitters from 
synaptosomes and inhibits their re-uptake (Rhoads et al., 1983) (Troeger et al., 1984). It even 
triggers the production of ROS which could possibly damage cells as well (Lu et al., 1998). 
Bad dephosphorylation by PP2C might not be detectable due to strong phosphorylation of 
Bad by an activated kinase. 
Treatment of rat neurons with ginkgolic acids which have been shown to activate PP2C and 
induce apoptosis (Ahlemeyer et al., 2001) did not reveal any advantages over treatment with 
oleic acid. Not only did the same solubility problems occur, but both Bad-155P and total Bad 
proteins levels slightly increased at early time points and decreased at later time points and, 
therefore, did not allow to draw conclusions about regulation of unphosphorylated Bad. 
Ginkgolic acids also had the general disadvantage that they are composed of many 
compounds and, therefore, a possible effect could hardly be connected to one compound.  
For further studies to assess a role of PP2C in neuronal apoptosis, it is necessary to regulate 
the amount or the activity of PP2C either via specific inhibitors or activators. Potential 
strategies to down-regulate PP2C expression could be the use of anti-sense nucleotides or the 
RNA-interference (RNAi) method blocking the translation of PP2C. Specific activators of 
PP2C might be found by testing compounds fulfilling the same structural criteria of PP2C 
activators known so far. 
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Comparing each of the three experimental model systems employed in this thesis for the study 
of neuronal cell death and the answers obtained with other approaches from the literature 
which used apparently similar procedures allows to draw the conclusion, that already minor 
experimental variations affecting the fine tuned concert of interacting molecules can lead to 
contradictory results. Specific conclusions on the events after brain trauma at the cellular and 
molecular level apply preferentially or exclusively to the set of conditions chosen. General 
conclusions on factors and pathways involved in neuronal cell death emerge only gradually. 
On this background the results obtained in this thesis form small, although interesting, pieces 
in a puzzle the general picture of which is beginning to be visible, hopefully, guiding the 
development to a better therapeutic management of brain injuries. 
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5. Summary 
The purpose of this study was to elucidate the role of enzymes, the endogenous free radical 
scavengers superoxide dismutase 1 and 2 (SOD1/2) as well as protein phosphatase type 2C 
(PP2C), in different models of neuronal cell death. This should improve the understanding of 
cellular mechanisms after neuronal damage like stroke, trauma, or neurodegenerative diseases 
like Huntington’s disease in order to reveal new therapeutic targets. Two different in vivo-
models of neuronal damage, cold injury-induced brain trauma (CIBT) and intrastriatal 
injection of the toxin 3-nitropropionic (3-NP) acid in mice, were employed to study the 
influence of quantitative modulation of SODs on brain damage. The possible role of PP2C, an 
enzyme participating in the reversible phosphorylation of proteins, in the induction of 
apoptosis was elucidated in cultured rat neurons. 
In the first part of this study it was demonstrated that the cytosolic Cu/Zn-superoxide 
dismutase (SOD1) influences the development of the lesion after intrastriatal injection of 3-
NP. Overexpression of SOD1 in transgenic mice was neuroprotective in this predominantly 
necrotic model of 3-NP injection, reducing lesion size and edema development, while 
diminished expression of this enzyme in knock-out mutants only significantly enhanced 
edema formation. 
The results of this study support the notion that also in this model of intrastriatal injection free 
oxygen radical production is a crucial factor of 3-NP intoxication as had been previously 
demonstrated in milder, systemic models of 3-NP intoxication. Cellular energy deficits, the 
underlying mechanism for 3-NP toxicity, play an important role in neurodegenerative disease 
like Huntington’s disease. Therefore, understanding neuronal cell death due to lack of energy 
allows insight into neurodegenerative diseases and guides the search for therapeutic targets to 
treat these diseases. 
As a next step, the role of mitochondrial Mn-superoxide dismutase (SOD2) in mice was 
examined using a model of cold injury-induced brain trauma (CIBT). The results of these 
experiments elucidate, on the one hand, the role of mitochondrial free oxygen radical 
production and, on the other hand, the development of the lesion after cold injury brain 
trauma (CIBT) at later time points, especially BBB breakdown and inflammatory response.  
Reduced expression of SOD2 in knock-out mutants did not influence the development of 
damage after CIBT. However, increased free oxygen radical production inside the lesion of 
CIBT was detected by hydroethidine assay. This result supports findings of previous 
publications postulating reactive oxygen species (ROS) production to play a crucial role in the 
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damage after CIBT. Since SOD2 is localized in the mitochondria, this result allows to draw 
the conclusion that either the production of free radicals did not co-localize with SOD2 in the 
mitochondria, in which case SOD2 could not have an influence on the ROS level, or the 
amounts of ROS were already too devastating in wild type animals to allow an exacerbation 
of the lesion after reduction of SOD2.  
By observing the development of vasogenic edema and finding hemorrhagic transformations 
and inflammation at later time points, this study proved CIBT to be a reproducible model of a 
biphasic breakdown of the BBB. Stroke as well as trauma research might benefit from this 
model, since biphasic BBB breakdown and inflammation are factors contributing to the 
deterioration of these brain damages. Augmented knowledge gained from this study can 
contribute to the development of new therapies for improved prognosis of patients.  
The involvement of PP2C’s role in neuronal apoptosis was the third focus of research of this 
thesis. Protein kinases and phosphatases, including PP2C, regulate numerous cellular 
mechanisms by reversible phosphorylation of proteins. The results of this study support the 
hypothesis of PP2C being involved in programmed neuronal cell death (apoptosis).  
Activators of PP2C, such as oleic acid or ginkgolic acids, were shown to induce apoptosis in a 
time- and concentration-dependent manner in cultured rat neurons while using the enantiomer 
“trans-oleic acid” (elaidic acid), known not to activate PP2C  in vitro, instead of cis-oleic 
acid, did not induce apoptosis. A possible apoptotic mechanism, the induction of programmed 
cell death by dephosphorylation of the proapoptotic protein Bad by activated PP2C, was 
analyzed by Western blotting experiments. Bad phosphorylated at Ser155 and total Bad 
(phosphorylated + unphosphorylated) were detected in cultivated rat neurons which had been 
treated with oleic acid or ginkgolic acids. By the Western blotting method, changes in the 
amount of unphosphorylated Bad were not detectable since no antibody against 
unphosphorylated Bad was available. Without knowledge of the ratio of phosphorylated Bad 
to total Bad in non-treated cultured neurons, the proportion of phospho-Bad/total Bad in oleic 
acid-treated cells did not allow to draw conclusions about quantitative changes of 
unphosphorylated Bad.  
Oleic acid as well as ginkgolic acids are relatively unspecific activators. By their impact on 
other pathways of the cellular metabolism possible effects of PP2C activation might be 
masked. Therefore, in addition to searching for more specific activators, one important goal in 
the future must be to find specific substrates of PP2C whose dephosphorylation is measurable. 
Specific activators or inhibitors of PP2C could contribute to unequivocally prove the role of 
this enzyme in neuronal apoptosis. 
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6. Zusammenfassung 
Das Ziel dieser Arbeit war es, die Rolle von Enzymen, den endogenen 
Sauerstoffradikalfängern Superoxiddismutase 1 und 2 (SOD1/2) sowie der 
Proteinphosphatase Typ 2C (PP2C), in verschieden Modellen von neuronalem Zelltod zu 
beleuchten. Damit sollte ein Beitrag geleistet werden, das Verständnis der zellulären 
Vorgänge nach neuronaler Schädigung, wie Schlaganfall, Trauma oder neurodegenerativen 
Erkrankungen, wie Morbus Huntington, zu verbessern, mit dem Ziel, neue therapeutische 
Ansätze aufzuzeigen. Zwei verschiedene in vivo-Modelle, das Kälte-induzierte Hirntrauma 
(Cold injury-induced brain trauma, CIBT) und die intrastriatale Injektion des Toxins 3-
Nitropropionsäure (3-NP), fanden Anwendung in Mäusen, um den Einfluss der Menge an 
SOD auf das Ausmaß von Hirnschädigung zu untersuchen. Die mögliche Rolle der PP2C bei 
der Induktion der Apoptose, eines Enzyms, welches an der reversiblen Phosphorylierung von 
Proteinen beteiligt ist, wurde an kultivierten Rattenneuronen beleuchtet. 
Im ersten Teil dieser Arbeit wurde demonstriert, dass das zytosolische Enzym Cu/Zn- 
Superoxiddismutase (SOD1) den Verlauf der Schädigung nach intrastriataler Injektion von 3-
NP beeinflusst. Vermehrte Expression von SOD1 in transgenen Mäusen wirkte in diesem 
überwiegend nekrotischen Schädigungsmodell neuroprotektiv, verkleinerte die Läsion und 
verminderte Ödembildung, während eine Verminderung dieses Enzyms in „knock-out“- 
Mutanten allein die Ödembildung signifikant verstärkte.  
Die Ergebnisse dieser Studie untermauern die Hypothese, welche zuvor anhand von milderen, 
systemischen 3-NP-Intoxikationsmodellen formuliert wurde, dass auch im Modell der 
intrastriatalen Injektion die Bildung von freien Sauerstoffradikalen ein wichtiger Faktor der 
Intoxikation durch 3-NP ist. Zelluläre Energiedefizite, welche die Ursache für die Schädigung 
durch 3-NP sind, spielen auch bei neurodegenerativen Erkrankungen, wie der Chorea 
Huntington, eine wichtige Rolle. Daher erlauben Erkenntnisse über den Zelluntergang durch 
Energiemangel Einblicke in neurodegenerative Erkrankungen und erleichtern so die Suche 
nach therapeutischen Zielen zur Behandlung dieser Erkrankungen.  
Weiterhin wurde in dieser Arbeit die Rolle der mitochondrialen Mn-Superoxiddismutase 
(SOD2) anhand eines Modells von Gehirntrauma durch Kälteschädigung (CIBT) untersucht. 
Die Ergebnisse dieser Experimente beleuchteten auf der einen Seite die Rolle der 
mitochondrialen Produktion von freien Sauerstoffradikalen, auf der anderen Seite die 
Entwicklung der Läsion nach CIBT, im Besonderen den Zusammenbruch der Blut-
Hirnschranke und Entzündungsreaktionen zu späteren Zeitpunkten. 
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Es zeigte sich, dass die verminderte Expression von SOD2 in “knock-out” Mutanten den 
Schädigungsverlauf nach CIBT nicht beeinflusst. Allerdings wurde ein Anstieg der 
Produktion von freien Sauerstoffradikalen in der Läsion durch den Hydroethidin-Test 
detektiert. Dieses Resultat unterstützt Funde in früheren Publikationen, welche postulieren, 
dass die Bildung reaktiver Sauerstoffspezies (ROS) eine wichtige Rolle in der Schädigung 
nach CIBT spielt. Da SOD2 in den Mitochondrien lokalisiert ist, erlaubt dieses Ergebnis den 
Rückschluss, dass entweder die Produktion von freien Radikalen nicht mit der SOD2 in den 
Mitochondrien kolokalisiert war, wobei SOD2 keinen Einfluss auf den Spiegel freier 
Sauerstoffradikale haben konnte, oder dass die Menge an freigesetzten Sauerstoffradikalen in 
Wildtyptieren schon zu schädigend war, um eine Verschlimmerung der Läsion nach 
Verringerung von SOD2 zuzulassen.Außerdem zeigte diese Studie durch Verfolgen der 
Ödementwicklung und den Befund von haemorrhagischen Veränderungen und 
Entzündungsreaktionen, dass CIBT ein reproduzierbares Modell für einen biphasischen 
Zusammenbruch der Blut-Hirnschranke ist. Dieses Modell kann sowohl in der Schlaganfall- 
als auch der Trauma- Forschung genutzt werden, da dort ein biphasischer Zusammenbruch 
der Blut-Hirnschranke und Entzündungsreaktionen Faktoren sind, welche zur 
Verschlechterung des Krankheitsbildes dieser Hirnschädigungen führen. Das an diesen 
Modellen erarbeitete Wissen kann dazu beitragen, neue Therapien zu entwickeln, um die 
Prognose der Patienten zu verbessern. 
Die Untersuchung der Rolle der PP2C in der neuronalen Apoptose war der dritte 
Forschungsschwerpunkt dieser Arbeit. Proteinkinasen und Phosphatasen, darunter PP2C, 
üben durch reversible Proteinphosphorylierung eine entscheidende regulierende Funktion in 
vielen zellulären Mechanismen aus. Die Ergebnisse dieser Arbeit unterstreichen die 
Hypothese, daß PP2C am programmierten neuronalen Zelltod (Apoptose) beteiligt sein 
könnte. Es wurde gezeigt, daß Aktivatoren der PP2C, wie Ölsäure oder Ginkgolsäuren, in 
kultivierten Rattenneuronen zeit- und konzentrationsabhängig Apoptose hervorrufen. 
Dagegen zeigt sich bei Verwendung des Enantiomers trans-Ölsäure (Elaidinsäure), welche 
PP2C in-vitro nicht aktiviert, anstelle von cis-Ölsäure keine Induktion von Apoptose. Ein 
möglicher apoptotischer Mechanismus, die Induktion von Apoptose durch 
Dephosphorylierung des proapoptotischen Proteins Bad durch aktivierte PP2C, wurde durch 
Bestimmung der Menge an Ser155-phosphoryliertem Bad  sowie von Gesamt-Bad 
(phosphoryliert + unphosphoryliert) in kultivierten Rattenneuronen, welche mit Ölsäure oder 
Ginkgolsäuren behandelt wurden, beleuchtet. Veränderungen von unphosphoryliertem Bad 
konnten durch die hier eingesetzte Westernblot-Methode nicht bestimmt werden, denn für den 
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Nachweis von unphosphoryliertem Bad standen keine Antikörper zu Verfügung. Andererseits 
ließen die gemessenen Phospho-Bad/Gesamt-Bad-Veränderungen in behandelten Zellen ohne 
die Kenntnis über das Verhältnis von Gesamt-Bad zu phosphoryliertem Bad in unbehandelten 
Zellen ebenfalls keinen indirekten Rückschluss auf unphosphoryliertes Bad zu.  
Sowohl Ölsäure als auch Ginkgolsäuren sind relativ unspezifische Aktivatoren. Durch deren 
Einfluss auf andere Stoffwechselwege können mögliche Effekte der PP2C-Aktivierung 
verdeckt werden. Außer der Suche nach spezifischen Aktivatoren muß es ein wichtiges Ziel in 
der näheren Zukunft sein, spezifische Substrate für PP2C zu finden, deren 
Dephosphorylierung messbar ist. Spezifische Aktivatoren oder Hemmstoffe der PP2C können 
wesentlich zur Aufklärung einer möglichen Rolle dieses Enzyms in der neuronalen Apoptose 
beitragen.  
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9. Abbreviations 
3-NP   3-Nitropropionic acid 
dUTP   Deoxyuridine triphosphate 
AB   Antibody 
APS   Ammonium persulfate 
ATP   Adenosine triphosphate 
Bad   Bcl-2/Bcl-xL-antagonist, causing cell death 
Bad-GST  Bad, Glutathione-S-transferase-tagged  
Bad-155P  Bad, phosphorylated at Ser155 
BBB   Blood brain barrier 
BH3    Bcl-2 homology 3 
BSA   Bovine serum albumine 
cAMP   Cyclic adenosine monophosphate 
cA-PK   Catalytic subunit of protein kinase type A 
CIBT   Cold injury-induced brain trauma 
CNS   Central nervous system 
DAB   N-N’-Diaminobenzidine  
DMF   Dimethylformamide 
DMSO  Dimethylsulfoxide 
DNA   Desoxyribonucleic acid 
dNTP   Deoxynucleosid triphosphate 
EAA   Excitatory amino acids 
EDTA   Ethylendiamin tetraacetic acid 
EGTA   Ethylenglycol tetraacetic acid 
HD   Huntington’s disease 
H&E    Hematoxylin and eosin 
HEPES  N-(2-Hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) 
HEt   Hydroethidine 
HRP   Horseradish peroxidase 
ICC   Immunocytochemistry 
IgG   Immunoglobuline Type G 
kDa   Kilo Dalton 
MAP-kinase  Mitogen-activated protein kinase 
MEM   Minimal essential medium  
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MOPS   3-(N-Morpholino) propanesulfonic acid 
MPO   Myeloperoxidase 
Mr   Relative molecular weight 
mRNA  Messenger-RNA 
NADPH  Nicotinamide adenine dinucleotide phosphate 
NB   Neurobasal medium 
NB-B27  Neurobasal medium without supplement B27 
NB+B27-AO  Neurobasal medium with supplement B27 without antioxidants 
NBT   Nitro-blue tetrazolium  
NMDA  N-methyl-D-aspartate 
N2O    Nitrogen dioxide 
NO.   Nitric oxide 
O2   Oxygen 
O2-.   Superoxide anion radical 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PEG   Polyethylene glycole 
PEI   Polyethylenimine  
PK   Protein kinase 
PKA/PKB  Protein kinase type-A/B 
PP    Protein phosphatase 
PP2C   Protein phosphatase type-2C 
PPP    Phosphoprotein phosphatases  
PPM   Protein phosphatase Mg2+-dependent 
p-Ser   Phospho-serine 
PTP   Protein tyrosine phosphatase 
RNA   Ribonucleic acid 
ROS   Reactive oxygen species 
RT   Room temperature 
SDS   Sodiumdodecylsulfate 
Ser   Serine 
SOD   Superoxide dismutase 
SOD1   Cu/Zn-Superoxide dismutase, Cu/Zn-SOD 
SOD1-TG  SOD1 transgenic mice 
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SOD1-KO  SOD1 knock-out mice 
SOD2   Mn-Superoxide dismutase, Mn-SOD 
SOD2-KO  SOD2 knock-out mice 
TB   Trypan blue 
TBI   Traumatic brain injury 
TEMED  N,N,N’,N’-tetramethyl-ethylene-diamine  
TdT   Terminal deoxynucleotidyl transferase 
Thr   Threonine 
TNF-α   Tumor necrosis factor alpha  
Tris   Tris-hydroxymethyl aminomethan 
TUNEL  Transferase-dUTP-Nick-End-Labelling 
U   Unit 
UV   Ultra violet 
WT   Wild-type mice 
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